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Johannes C. Walter  Tamara Jeannine Slenn 
The ubiquitin ligase CRL4Cdt2 targets thymine DNA glycosylase for 
destruction during DNA replication and repair 
Abstract 
The E3 ubiquitin ligase CRL4Cdt2 targets proteins for destruction during DNA replication and 
following DNA damage (Havens and Walter, 2011). Its substrates contain “PIP degrons” that 
mediate substrate binding to the processivity factor PCNA at replication forks and damage sites. 
The resulting PCNA-PIP degron complex forms a docking site for CRL4Cdt2, which ubiquitylates 
the substrate on chromatin. Several CRL4Cdt2 substrates are known, including Cdt1, multiple 
CDK inhibitors, Drosophila E2f1, human Set8, S. pombe Spd1, and C. elegans Polη (Havens 
and Walter, 2011). An emerging theme is that CRL4Cdt2 targets proteins whose presence in S 
phase is toxic.  
Here, I used Xenopus egg extract to characterize a new CRL4Cdt2 substrate, thymine DNA 
glycosylase (TDG). TDG is a base excision repair protein that targets G-U and G-T mispairs, 
which arise from cytosine and 5-methylcytosine deamination (Cortázar et al., 2007). Thus, TDG 
may function in epigenetic gene regulation via DNA demethylation, in addition to its canonical 
DNA repair function. A yet unknown E3 ubiquitin ligase triggers TDG destruction during S phase 
(Hardeland et al., 2007). Understanding TDG proteolysis in S phase is relevant to the regulation 
of DNA replication, DNA repair, and epigenetic control of gene expression.  
I discovered that TDG contains a variant of the  “PIP degron” consensus and that TDG is 
ubiquitylated and destroyed in a PCNA-, Cdt2-, and degron-specific manner during DNA repair 
and DNA replication in Xenopus egg extract. I further characterized what features of TDG 
contribute to its proteolysis. Interestingly, I could not identify any defects during DNA replication 
or during Xenopus embryonic development in response to a non-degradable form of TDG. 
Additionally, I examined how interactions between CRL4Cdt2 and multiple subunits of the 
PCNA homotrimer contribute to CRL4Cdt2 function. In a popular model, PCNA functions as a 
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“tool belt” on DNA, binding three separate proteins through its individual subunits to facilitate 
rapid exchange of DNA replication and repair proteins as they are needed on DNA. To address 
this model, I generated a single chain polypeptide with three PCNA subunits connected through 
flexible linker sequences. I used this tool to determine how multiple PCNA subunits contribute to 
CRL4Cdt2 function. I found that a single wildtype subunit is sufficient for modest destruction of the 
CRL4Cdt2 substrate Cdt1, but complete Cdt1 destruction requires two separate wildtype subunits. 
Additionally, a single subunit was sufficient for leading strand elongation, challenging the “tool 
belt” model during DNA replication. I also discuss implications and future use of the single-chain 
PCNA. 
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Chapter 1  
 
Background
 2 
1.1 DNA replication and repair 
All eukaryotic cells undergo the same basic cell cycle progression, and many cellular processes 
are highly conserved across all species of the three domains of life. After cell division, cells 
enter their first gap phase, G1, during which they grow, metabolize energy, and prepare for the 
subsequent phase. After G1, cells enter a synthesis phase, S phase, in which they generate 
cellular organelles and copy their entire genome exactly once. After S phase, cells enter their 
second gap phase, G2, and prepare for the act of cell division. Finally, in mitosis (M phase), the 
nuclear envelope dissolves to allow for equal DNA segregation between two daughter cells. As 
new nuclear envelopes form, the cellular membrane invaginates to create two new, distinct cells. 
Many important events critical for progression through the cell cycle occur during S phase, 
including DNA replication, which is the focal point of the work described here. During DNA 
replication, each cell must make one complete copy of its genome and epigenome (inheritance 
of some epigenetic modifications is discussed in Chapter 1.3). Replication of a region of the 
genome more than once (re-replication) or failure to complete DNA replication leads to genomic 
instability, a hallmark of cancer. To ensure that exactly one round of DNA replication occurs 
during each S phase, cells employ multiple safeguards. First, to guarantee that cells complete 
replication before segregating their chromosomes during mitosis, checkpoint signaling pathways 
detect single-stranded DNA (ssDNA) to prevent progression into M phase before replication is 
complete. Additionally, cells prepare DNA for replication during G1 phase but actually replicate 
their DNA during S phase of the cell cycle. After replication is complete, cells cannot prepare for 
another round of DNA replication until after segregating their chromosomes into separate 
daughter cells. Finally, cells repair DNA damage throughout the cell cycle to allow for accurate 
DNA replication and transcription. 
In all eukaryotes, DNA replication is remarkably similar, with conserved proteins and 
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mechanisms spanning from yeast to mammals (Sclafani and Holzen, 2007). A group of proteins 
called Cyclin-dependent kinases (Cdks), along with their partners, cyclins, control progression 
through the cell cycle. Although the complete repertoire of Cdks is typically present throughout 
the cell cycle, their corresponding partners, Cdk-specific cyclins, are synthesized and rapidly 
destroyed to control waves of Cdk activity (Murray, 1995; Murray and Kirschner, 1989). During 
G1, S phase-specific Cdk activity is low in nuclei so DNA replication cannot initiate, but cells 
prepare for DNA replication during this stage. Upon the transition to S phase, S phase-specific 
Cdk activity increases, and the chromatin decondenses to allow DNA replication (Heller et al., 
2011; Masai et al., 2010). During these preparatory events in G1, termed “DNA licensing” (Blow 
and Laskey, 1988; Blow et al., 2011; Masai et al., 2010), the origin recognition complex (ORC) 
first assembles on DNA, either at sequence-defined origins in S. cerevisiae or at sequence-
independent locations along the genome in most other eukaryotes (Cvetic and Walter, 2005). 
The ORC proteins then recruit the licensing factors Cdc6 (Cocker et al., 1996) and Cdt1 
(Maiorano et al., 2000), which in turn recruit the MCM 2-7 helicase (Masai et al., 2010; 
Romanowski et al., 1996). Together, this complex is called the pre-replication complex (pre-RC). 
Once the MCM2-7 helicase has loaded, the DNA is considered to be licensed (Figure 1.1). 
Though the helicase is responsible for unwinding DNA during S phase to allow replication, it is 
inactive during G1 (Arias and Walter, 2007; 2004). 
After entry into S phase, high levels of S phase-specific Cdks trigger the activation and 
relocalization of many proteins, including Cdc45, GINS, and other components of the “replisome 
progression complex” from the cytoplasm to the nucleus or from one complex to another within 
the nucleus (Arias and Walter, 2007; Masai et al., 2010) (Figure 1.1). Cdc45 and GINS 
associate with MCM2-7 to form the functional eukaryotic replicative helicase, referred to as the 
CMG (Cdc45, MCM2-7, and GINS) complex (Ilves et al., 2010; Makarova et al., 2012; Watase 
et al., 2012). This pre-initiation complex (pre-IC) is capable of unwinding DNA (Ilves et al., 2010)
 4 
Figure 1.1: The events of DNA replication. DNA is first licensed in G1 to form pre-RCs. Upon 
the transition to S phase, Cdk activity and a multitude of other factors convert the pre-RC to a 
pre-IC, thereby converting the inactive MCM2-7 helicase into a the functional CMG (Cdc45-
MCM-GINS) replicative helicase. The helicase separates the two DNA strands, exposing single-
stranded DNA that is coated by RPA, allowing origin firing to occur. Polα/primase then 
generates short RNA/DNA primers, allowing PCNA loading by RFC and processive DNA 
synthesis by Polδ and Polε. Polδ teams up with Polα, PCNA, flap endonuclease machinery, and 
DNA ligase to complete discontinuous lagging strand synthesis. Polε couples with PCNA to 
perform continuous leading strand synthesis.  
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Figure 1.1 (continued) 
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 (Figure 1.1). During origin firing, the helicase unwinds a portion of DNA, allowing additional 
replication proteins to load, including the ssDNA binding protein replication protein A (RPA), 
which stabilizes the unwound DNA and prevents rehybridization (Wold, 1997). Concurrently, the 
polymerase (Pol) Polα/primase complex generates short primers of newly synthesized RNA and 
DNA (Wold, 1997). Next, the replication processivity factor proliferating cell nuclear antigen 
(PCNA), often called the sliding clamp, can be loaded onto the junction of RPA-coated ssDNA 
and Polα-generated double-stranded DNA (Figure 1.1) by replication factor C (RFC). PCNA 
contains three identical subunits that encircle the DNA and serve as a binding platform for other 
replication proteins (Moldovan et al., 2007), including the leading and lagging strand DNA 
polymerases Polε and Polδ, respectively (Burgers, 2008; Nick McElhinny et al., 2008). These 
polymerases synthesize new DNA during the course of S phase. Because of the antiparallel 
structure of DNA and the unidirectionality of polymerase activity, the leading strand is 
synthesized continuously, while the lagging strand is synthesized discontinuously in short 
Okazaki fragments (Figure 1.1). Hundreds of other DNA replication and repair proteins also use 
PCNA as a scaffold to access DNA (Moldovan et al., 2007). 
Importantly, pre-IC and pre-RC formation are temporally distinct; pre-RCs form during G1, and 
they are only converted to pre-ICs during S phase. New pre-RCs cannot form once replication 
has initiated. Cells accomplish this temporal exclusivity through several redundant mechanisms 
that prevent MCM2-7 recruitment during S phase. Among these devices are the activity of 
geminin (McGarry and Kirschner, 1998; Tada et al., 2001), a Cdt1 inhibitor that is not present 
during G1 but is active during the rest of the cell cycle, and the export of Cdc6 from the nucleus 
once replication has initiated (Kim and Kipreos, 2008; Saha et al., 1998). Additionally, Cdt1 is 
destroyed via replication-dependent proteolysis due to the ubiquitin ligase CRL4Cdt2 after origins 
fire and replication elongation begins. These redundant mechanisms are important to prevent 
re-replication. If origin licensing continued during S phase, pre-RCs could assemble on newly 
 7 
replicated DNA, leading to additional pre-IC formation and origin firing. Several other regulatory 
mechanisms exist to prevent ORC formation, change the localization of pre-RC components, 
and to regulate MCMs. 
Various types of DNA damage that can impede replication fork progression must be repaired 
during either S phase or other stages of the cell cycle to allow for accurate replication and 
mitosis. Some types of damage, such as thymine dimers caused by UV irradiation, can be 
bypassed during DNA replication (Prakash et al., 2005; Sale et al., 2012). Other types of 
damage, like interstrand crosslinks and double-strand breaks, must be repaired before 
replication can progress. Two main repair pathways handle the smaller lesions that affect single 
nucleotides and stall the replication fork: nucleotide excision repair (NER) and base excision 
repair (BER). Though many of these lesions can be bypassed, repair is necessary to minimize 
mistakes during replication and transcription. NER involves the detection of bulky lesions by 
machinery that scans the genome for damage, either globally or at sites of transcription. After 
lesion detection, the DNA is unwound, stabilized by RPA, and incised by endonucleases to 
generate a ssDNA gap that is then filled by DNA polymerases in a PCNA-dependent manner 
(Kamileri et al., 2012). Finally, the gap is sealed by a DNA ligase. Several of the factors involved 
in NER are DNA replication proteins themselves, such as PCNA, RPA, and the replicative 
polymerases. The BER pathway repairs many aberrant DNA bases and modifications that are 
not recognized by NER. For example, BER restores guanine from 8-oxoguanine, which forms 
due to metabolically generated reactive oxygen species. Additionally, BER is responsible for the 
repair of certain DNA mispairs and for removal of aberrant bases. For instance, the 
glycosylases thymine DNA glycosylase (TDG) and Mbd4 initiate regeneration of correct G-C 
base pairs from G-T or G-U mispairs (Krokan et al., 2002; Sjolund et al., 2012). Several other 
glycosylases, such as the uracil-N-glycosylases UNG1 and UNG2, are also capable of repairing 
G-U mispairs (Krokan et al., 2002). 
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BER involves several steps. First, a specific glycosylase, like TDG or Mbd4, detects its cognate 
aberrant DNA base, modification, or mispair. The glycosylase hydrolyzes the N-glycosidic bond 
of the aberrant base from the sugar-phosphate backbone, generating an abasic site (also called 
an apurinic site or AP site). Next, an AP endonuclease incises the DNA sugar-phosphate 
backbone to generate a nick that is detected by a DNA polymerase: in short-patch BER, Polβ 
fills in the single-nucleotide gap and removes the remaining sugar-phosphate fragment, 
whereas in long-patch BER, PCNA-associated Polβ, Polδ, or Polε perform a strand 
displacement reaction that is subsequently processed and ligated (Kim and Wilson, 2012). 
According to a popular model, the substrate channeling or “hand-off” model for BER, each 
enzyme-product complex serves to recruit the next player in the pathway to ensure nicked and 
broken DNA is not left unrepaired. For example, the glycosylase-bound abasic site recruits the 
AP endonuclease so the vulnerable abasic site is never exposed (Prasad et al., 2011; 2010; 
Wilson and Kunkel, 2000).  
PCNA directs many processes during DNA replication and repair, from polymerase processivity, 
to Okazaki fragment processing, to protein turnover during S phase. As described above, the 
homotrimeric PCNA forms a clamp around DNA, thereby providing a scaffold for proteins to 
associate with DNA and to interact with each other. Each subunit of PCNA contains an 
interdomain connector loop (IDCL) that can bind proteins containing a PCNA interacting peptide 
motif (PIP box) (Moldovan et al., 2007). This interaction is further defined in Section 1.2. Some 
groups have proposed that PCNA and other sliding clamps function as a “tool belts” that can 
bind multiple proteins at once to allow these proteins rapid access to DNA upon a change in 
conditions (Freudenthal et al., 2011; Indiani et al., 2005; Sutton, 2010; Zhuang and Ai, 2010). In 
this scenario, PCNA could bind three proteins necessary for one process or bind repair proteins 
during replication in order to be prepared in the case of a problem. Other groups have proposed 
a “dynamic hand-off model,” in which DNA-associated proteins recruit the next protein in line for 
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a given pathway (Prosperi, 2006), similar to the “hand-off” model for BER. In this scenario, one 
complex forms a scaffold for the formation of another, and only one PCNA-bound protein is 
necessary at a time. 
Despite the plethora of coordinated recruitment events, redundant regulatory pathways, and 
DNA repair pathways, mistakes do occur during DNA replication, and DNA damage can persist 
during S phase, leading to double-strand breaks or replication fork failures. DNA lesions that 
stall replicative polymerases activate the Ataxia-telangiectasia mutated and Rad3-related 
(ATR)-dependent checkpoint pathway. The ATR checkpoint pathway delays the cell cycle, 
prevents late origin firing, and stabilizes replication forks to prevent collapse. ATR, through its 
effector checkpoint kinase 1 (Chk1), causes a cell cycle delay by inhibiting mitotic Cdk activity. 
The role of ATR in replication fork stabilization and inhibition of late origin firing is not well 
understood. Several laboratories have focused on determining how damaged DNA activates the 
ATR kinase and how ATR activates Chk1. Current models suggest that the primary damage 
detection mechanism requires DNA replication (Lupardus et al., 2002; Stokes, 2002). When 
replicative polymerases stall, their associated helicases continue unwinding DNA, exposing 
regions of ssDNA (Byun, 2005). Replication likely restarts with the generation of a primer 
downstream of the stalled polymerase (Lopes et al., 2006), and the new 5’ DNA or RNA end is 
required for checkpoint activation (MacDougall et al., 2007; Yan and Michael, 2009). The 
resulting DNA structure contains a ssDNA gap adjacent to the 5’ end of a newly synthesized 
primer. Together, RPA-coated ssDNA and the 5’ end of the primer coordinate the assembly of 
core checkpoint signaling components, leading to the activation of ATR and Chk1. The Ataxia-
telangiectasia mutated (ATM) checkpoint signaling pathway similarly delays cell cycle 
progression in response to double-strand breaks (Andreassen, 2005). 
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Mutations in any of these critical pathways responsible for transactions on DNA—DNA 
replication, DNA repair, or checkpoint signaling—are linked to genome instability and cancer. 
Advances in understanding the molecular details of these events could therefore be valuable to 
the fields of cancer biology and pharmacology. 
1.2 PCNA-dependent proteolysis through the CRL4Cdt2 ubiquitin ligase 
During DNA replication and repair, PCNA acts as a processivity factor, director, and scaffold for 
proteins that bind it through their PIP boxes. One class of PIP box-containing proteins is a set of 
substrates for the Cullin 4-RING-based ubiquitin ligase (CRL4Cdt2), composed of the proteins 
Cul4, Ddb1, and the putative substrate receptor, Cdt2 (Abbas and Dutta, 2011). Unlike other 
ubiquitin ligases, CRL4Cdt2 functions specifically during DNA replication or following DNA 
damage. CRL4Cdt2 negatively regulates the stability of many proteins whose presence in S 
phase is detrimental. The best-characterized substrate of CRL4Cdt2 is Cdt1 (Jin et al., 2006), 
which recruits the replicative MCM2-7 helicase during origin licensing. After cells progress into S 
phase, Cdt1 activity could facilitate detrimental origin licensing on regions of the genome that 
have already been replicated (Arias and Walter, 2005). To prevent aberrant licensing, CRL4Cdt2 
marks Cdt1 for destruction upon entry into S phase. CRL4Cdt2 also targets Cdt1 for destruction in 
response to DNA damage, though the reasons are unclear (Hu et al., 2004). One potential 
explanation is that damage-dependent Cdt1 destruction might be necessary to suppress re-
replication after checkpoint activation in G2. Checkpoint signaling inhibits mitotic Cdk activity, 
and mitotic Cdk activity is important to block pre-RC formation in mitosis (Arias and Walter, 
2004). 
Fewer than ten CRL4Cdt2 substrates are known, but all have a role in DNA replication or repair 
(Havens and Walter, 2011). Other substrates of CRL4Cdt2 include Drosophila E2f1(Shibutani et 
al., 2008), human Set8 (Centore et al., 2010), Xenopus Xic1 (Kim et al., 2010), S. pombe Spd1 
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(Liu et al., 2003; Salguero et al., 2012), C. elegans POLH-1 (the DNA Polη homologue) (Kim et 
al., 2010) and p21 in multiple organisms (Kim et al., 2008). Destruction of each CRL4Cdt2 
substrate helps to ensure proper DNA replication, and most CRL4Cdt2 substrates are toxic during 
S phase. Addressing why each substrate must be destroyed has helped us understand 
important molecular details about DNA replication and repair. For example, the CRL4Cdt2 
substrate Set8 is a histone methyltransferase that methylates histone H4 on lysine 20 (H4K20). 
Failure to destroy Set8 during replication has been associated with aberrant H4K20 methylation 
at replication origins and re-replication (Abbas et al., 2010; Beck et al., 2012; Tardat et al., 
2010). The link between re-replication and Set8 function is still not clear, but a prevailing model 
proposes that H4K20 methylation during DNA replication leads to relicensing (Beck et al., 2012). 
Before the discovery that Set8 is a CRL4Cdt2 substrate, the relationship between H4K20 
methylation and cell cycle progression was unknown. Now, the connection between H4K20 
methylation and origin firing is an area of active study. Therefore, I expect that identification of 
novel CRL4Cdt2 substrates will similarly improve our knowledge of DNA replication and repair, as 
well as help us gain more insight into the activities of new substrates. 
CRL4Cdt2 substrates must bind PCNA through their PIP boxes (Figure 1.2) to function as 
degradation targets (Arias and Walter, 2006); however, CRL4Cdt2 does not target all PIP box-
containing proteins for destruction. To the contrary, the majority of PCNA interacting proteins 
are stable when bound to PCNA; PCNA facilitates their recruitment and function on DNA 
(Moldovan et al., 2007). All known CRL4Cdt2 substrates contain a basic residue four amino acids 
downstream of the PIP box (the B+4 position relative to the PIP box) (Havens and Walter, 2009) 
that is not present in stable PCNA interacting proteins (Figure 1.2). These features (a PIP box 
and “B+4” residue) create a “PIP degron.” The binding surface for CRL4Cdt2 includes residues on 
both the substrate and on DNA-bound PCNA (Figure 1.2) (Havens and Walter, 2009). Our 
current model proposes that the PCNA-bound substrate recruits CRL4Cdt2 through contacts
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Figure 1.2: CRL4Cdt2 substrates contain a “PIP degron.” A) Most CRL4Cdt2 substrates 
contain a conserved PIP box (consensus sequence shown at the top), threonine and aspartate 
at positions 5 and 6 of the PIP box (a “TD motif”), and a basic residue four amino acids 
downstream of the PIP box (a “B+4 residue”). Together, these features constitute a “PIP 
degron,” whereΨ represents any hydrophobic residue (I/L/V/M), and θ represents any aromatic 
residue (Y/F/W). Residues shown in green are part of the conserved PIP box, and residues 
shown in blue additionally contribute to the “PIP degron.” B) The PIP degron residues interact 
with the IDCL of PCNA (shown in gray) to generate a binding surface for Cdt2, the substrate 
specificity factor of CRL4Cdt2. The p21 PIP degron is shown, and the residue colors are the 
same as in (A). PCNA residues D122 and E124, thought to be involved in ligase recruitment 
(Havens et al., 2012), are highlighted in orange. This figure was generated in PyMol by 
Benjamin Morris of the Walter lab using PDB accession number 1AXC (Gulbis et al., 1996).  
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Figure 1.2 (continued) 
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between Cdt2 and the PCNA-substrate degron, but that recruitment of the ubiquitin ligase does 
not require protein interactions on any PCNA subunits other than the substrate-bound subunit 
(Figure 1.3A). The ligase then polyubiquitylates the substrate, targeting it for proteasomal 
degradation. In an alternate model, Cdt2 recruitment requires its own interaction with another 
PCNA subunit in addition to its interaction with the substrate-bound PCNA subunit (Figure 1.3B). 
Though we have a general idea how CRL4Cdt2 functions, many details are unclear. In the Walter 
lab, we are interested in identifying new substrates, expanding on the known sequence and 
structural requirements for substrates, and uncovering more details about the contributions of 
individual ligase components, the substrate, DNA, and PCNA to CRL4Cdt2 function. 
1.3 A role for base excision repair in DNA methylation 
DNA methylation is a critical epigenetic mark that controls gene expression. The DNA base 
cytosine can have a methyl group attached, generating 5-methylcytosine (5mC). Most often, 
animal cells methylate their DNA in CpG sequences (Chen and Riggs, 2011; Niehrs, 2009; 
Suzuki and Bird, 2008; Wu and Zhang, 2010). This alters chemical interactions between DNA 
and DNA binding proteins, leading to changes in chromatin compaction and transcription. 
Typically, methylation of gene promoters leads to gene silencing, though methylation of gene 
bodies has also been associated with gene activation (Chen and Riggs, 2011; Maunakea et al., 
2010; Suzuki and Bird, 2008). Additionally, regions of heavily methylated DNA tend to exist as 
heterochromatin, a structure most often associated with repression of gene expression (Suzuki 
and Bird, 2008). A number of DNA methyltransferases (Dnmts) are specialized to either 
methylate unmodified DNA or to maintain its methylation status, particularly during DNA 
replication (Chen and Riggs, 2011; Wu and Zhang, 2010). Newly replicated DNA is 
hemimethylated: the parental strand retains its methylation status while the nascent strand is 
unmethylated. Maintenance Dnmts recognize this hemimethylated DNA and use it to direct their 
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Figure 1.3: Models for CRL4Cdt2 function. A) The substrate binds to DNA-bound PCNA 
through its PIP box. The resulting complex then recruits the ubiquitin ligase through contacts 
between Cdt2 and the substrate-PCNA surface. CRL4Cdt2 ubiquitylates the substrate, which is 
subsequently destroyed by the proteasome. This pathway is not processive: the ligase 
dissociates after one round of ubiquitylation. B) An alternate model for CRL4Cdt2 function. This 
model is identical except that in this case, Cdt2 directly binds to a separate subunit on PCNA to 
facilitate its recruitment and substrate destruction. This could potentially lead to processive 
substrate destruction.  
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Figure 1.3 (continued) 
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activity toward the nascent strand, thereby preserving the methylation status of individual genes 
through each round of DNA replication (Chen and Riggs, 2011; Jeltsch, 2006). Newly replicated 
DNA therefore inherits this sequence-independent epigenetic information through each cell 
division. 
How cells initially decide to methylate or demethylate individual genes varies and is an area of 
active study. Although the key players in DNA methylation have been identified, proteins and 
pathways responsible for demethylation in animals are largely unknown. In plants, BER is 
responsible for DNA demethylation: several DNA glycosylases directly detect and hydrolyze 
methylated cytosine from the DNA backbone. After this initial base excision step, a cascade of 
BER steps occurs, resulting in the insertion of an unmethylated cytosine across from the 
guanine, thereby restoring the original unmethylated DNA sequence (He et al., 2011a; Wu and 
Zhang, 2010). In animals, however, no direct DNA glycosylase activity has been detected on 
5mC, so the mechanism of DNA demethylation has remained a mystery. Some demethylation 
might occur passively; inhibiting the activity of maintenance methyltransferases toward 
hemimethylated DNA during replication leads to dilution of the epigenetic mark, so 
demethylation can occur over the course of multiple rounds of DNA replication (Niehrs, 2009). 
Passive DNA demethylation can be regulated at the level of maintenance Dnmts. However, 
many studies have observed active demethylation that does not require multiple rounds of 
replication. For example, in X. laevis oocytes, a reporter gene can be demethylated in the 
absence of DNA replication (Barreto et al., 2007; Simonsson and Gurdon, 2004). Notably, this 
demethylation does require DNA synthesis during DNA repair (Barreto et al., 2007; Wu and 
Zhang, 2010). Many examples of essential active demethylation have been described: 
mammalian zygotes rapidly demethylate the paternal genome before fusion of the maternal and 
paternal pronuclei (Iqbal et al., 2011; Mayer et al., 2000; Okada et al., 2010; Oswald et al., 
2000; Wu and Zhang, 2010), cells of several developing organisms demethylate specific genes 
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during tissue differentiation (Ji et al., 2010; Kress et al., 2006; Wu and Zhang, 2010), and adult 
neurons demethylate certain genes to support memory and learning (Grayson and Guidotti, 
2012; Guo et al., 2011; Leach et al., 2012; Niehrs and Schäfer, 2012). 
Roles for both NER and BER have been proposed in discussions about DNA demethylation 
(Niehrs, 2009), but here I will focus on a putative role for BER in DNA demethylation. Several 
studies have identified a role for BER in transcriptional regulation through a role in DNA 
demethylation (Reviewed in Chen and Riggs, 2011; Nabel and Kohli, 2011; Niehrs, 2009; 
Sjolund et al., 2012; Wu and Zhang, 2010). Although the animal BER proteins TDG and MBD4 
have no direct activity on 5mC, both act preferentially within large stretches of CpGs. This is not 
surprising since G-T mispairs often arise from spontaneous 5mC deamination or from the 
activity of other enzymes on 5mC; however, it is also possible that deamination and other 
modifications of 5mC occur in a controlled manner, leading to active demethylation upon their 
repair (Fritz and Papavasiliou, 2010; Niehrs, 2009; Wu and Zhang, 2010). A number of enzymes 
can act on 5mC to change this moiety to another DNA base. For example, the activation-
induced cytosine deaminases AID and Apobec1 process 5mC directly to thymine, generating a 
G-T mispair (Morgan et al., 2004; Rai et al., 2008). Additionally, the more recently identified Ten 
eleven translocation (Tet) proteins iteratively oxidize 5mC to generate 5-hydroxymethylcytosine 
(5hmC) (Tahiliani et al., 2009), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) (Ito et al., 
2011). AID can also further process 5hmC to generate 5-hydroxymethyluracil (5hmU) (Guo et 
al., 2011). All of these products generated by 5mC-modifying enzymes could potentially serve 
as substrates for BER, allowing enzymes involved in the modification of 5mC to cooperate with 
BER to facilitate DNA demethylation. Notably, mutation of Tet proteins has been linked to both 
cancer and cellular differentiation defects (Cimmino et al., 2011; Williams et al., 2012). 
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1.4 Thymine DNA glycosylase 
TDG is a BER protein that binds to specific mispairs and aberrant bases in DNA such as G-T or 
G-U mispairs, uracil analogs like 5-fluorouracil (Kunz et al., 2009; Morgan et al., 2007), and 5-
methylcytosine derivatives generated through Tet-mediated oxidation. After binding the mispair 
or aberrant base, TDG removes the incorrect base from the sugar-phosphate backbone through 
hydrolysis of the N-glycosidic bond (Cortázar et al., 2007). Most often, the aberrant base resides 
opposite a guanine in the complementary strand. Following base hydrolysis by TDG, AP 
endonuclease displaces TDG and cleaves the sugar-phosphate backbone so that DNA 
polymerase Polβ can insert cytosine across from guanine (Waters et al., 1999). TDG typically 
participates in short-patch BER, which does not involve a strand displacement reaction or PCNA 
(Kim and Wilson, 2012). Importantly, TDG binds virtually irreversibly to its abasic product; its 
removal depends on SUMOylation of the C-terminus, which decreases TDG’s affinity for DNA 
(Baba et al., 2005; Hardeland et al., 2002; Smet-Nocca et al., 2011).  
TDG also interacts with proteins involved in transcriptional regulation and has a role in 
epigenetic inheritance (Cortázar et al., 2007). In mice, TDG is essential, as TDG-/- embryos die 
during embryonic day 11.5, when cellular differentiation has just started (Cortázar et al., 2011; 
Cortellino et al., 2011; Saito et al., 2012). This phenotype appears to be a consequence of 
aberrant DNA methylation (Cortázar et al., 2011; Cortellino et al., 2011). In support of a direct 
role for TDG in DNA demethylation, a recent study showed that targeting TDG directly to 
specific genes results in demethylation of these genes (Gregory et al., 2012). Additionally, TDG 
physically interacts with the de novo methyltransferase Dnmt3a, though the purpose of this 
interaction is unclear (Li et al., 2006). 
Two main models for TDG’s role in demethylation have been proposed, both involving an initial 
modification of 5mC to another moiety followed by TDG activity. First, Tet proteins could oxidize 
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5mC to 5hmC and then to 5fC and 5caC. Though 5hmC is not a TDG substrate, both 5fC and 
5caC are TDG substrates, and TDG-dependent BER of these modified bases would generate 
unmodified cytosine. In support of this first model, He and colleagues found that Tet2 catalyzes 
the formation of 5caC in human cells and that this modification accumulates in the absence of 
TDG (He et al., 2011b). Several other groups have expanded on this model and shown that Tet 
activity is important for demethylation of the paternal genome upon fertilization, that TDG can 
act on products of Tet enzymatic activity, and that Tet activity on methylated DNA also promotes 
DNA demethylation in adult tissue (Guo et al., 2011; Hashimoto et al., 2012; Inoue and Zhang, 
2011; Inoue et al., 2011; Iqbal et al., 2011; Ito et al., 2011; Maiti and Drohat, 2011; Wossidlo et 
al., 2011; Zhang et al., 2012). This theory has been reviewed extensively (Cimmino et al., 2011; 
Nabel and Kohli, 2011; Williams et al., 2012). Alternatively, TDG could cooperate with AID or 
APOBEC, which generate G-T, G-U, or G-5hmU mispairs from G-5mC, G-C, and G-5hmC 
respectively. Again, TDG can act on each of these mispairs (Cortázar et al., 2007). In support of 
this second model, Cortellino and colleagues showed that TDG forms a complex with AID and 
Gadd45a, another protein implicated in DNA demethylation (Cortellino et al., 2011). Additionally, 
global erasure of DNA methylation during reprogramming of mouse primordial germ cells 
requires AID (Popp et al., 2010), and demethylation in zebrafish involves AID, Gadd45, and a 
glycosylase (Rai et al., 2008). It is possible that TDG cooperates with both Tet-mediated 
oxidation and AID-mediated deamination under different circumstances, but it is clear that TDG 
does have a fundamental role in DNA demethylation.  
The domain organization and structure of TDG relevant to BER has been well characterized 
(Figure 1.4). The central catalytic core of TDG is conserved among DNA glycosylases and 
possesses a DNA-binding domain (Cortázar et al., 2007). Although the detailed atomic structure 
of the N-terminal regulatory domain has not been determined, it clearly has a role in DNA 
binding and undergoes structural rearrangement upon SUMOylation of the C-terminus  
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Figure 1.4: The structure of TDG. A) The domain structure of TDG. The N-terminal regulatory 
domain is unstructured, especially at the extreme N-terminus, shown in blue. TDG is both 
acetylated and phosphorylated in the N-terminal regulatory domain close to the catalytic core. 
The catalytic core shares sequence homology with other uracil DNA glycosylases. The C-
terminal regulatory domain contains a SUMOylation site. B) TDG (catalytic core) is shown tightly 
bound to its catalytic product, the abasic site. This structure was generated in PyMol using PDB 
accession number 2RBA (Maiti et al., 2008). C) TDG (catalytic core) is shown upon modification 
with SUMO-1 (shown in light purple). This structure was generated in PyMol using PDB 
accession number 1WYW (Baba et al., 2005). For both (B) and (C), residues highlighted in 
orange are part of the catalytic site, and the residue highlighted in yellow is the critical 
asparagine in the active site. The region highlighted in green is where the N-terminus connects 
to the catalytic core. The N-terminus was not crystalized. 
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(Baba et al., 2005). The N-terminal region also contains several sites for modification, including 
acetylation and phosphorylation (Mohan et al., 2010). The C-terminus also serves a regulatory 
role and contains the SUMOylation site (Cortázar et al., 2007). A number of post-translational 
modifications—acetylation, phosphorylation, and SUMOylation—regulate the function of TDG in 
DNA repair, transcriptional regulation, and epigenetic regulation (Cortázar et al., 2007; Mohan et 
al., 2010). Additionally, TDG is absent from human cells during S phase due to proteasome-
dependent destruction (Hardeland et al., 2007), making it an ideal potential candidate for 
regulation by CRL4Cdt2. However, the requirements for its proteolysis are unknown. 
Understanding how this destruction is controlled and what other factors contribute to TDG 
regulation will contribute to a better understanding of DNA repair and epigenetics. 
1.5 Xenopus egg extract and X. laevis development 
To study DNA replication and repair, the Walter lab uses extracts prepared from unfertilized 
eggs of the African clawed frog Xenopus laevis. In X. laevis, females store mature oocytes that 
are arrested in metaphase II of meiosis by an unknown signal known as the cytostatic factor 
(CSF) (Masui and Markert, 1971). CSF prevents the destruction of high levels of cyclin B, which 
cooperates with Cdk1 to prevent separation of chromosomes during metaphase (Wu and 
Kornbluth, 2008). Female frogs lay CSF-arrested eggs that are then fertilized by sperm secreted 
by male frogs. Fertilization by sperm triggers cyclin B destruction through a signaling cascade 
triggered by calcium release from the smooth endoplasmic reticulum (Liu et al., 2007). After the 
egg transitions from metaphase II into interphase and the maternal and paternal genomes are 
united, the zygote enters a series of cell cycles consisting of only DNA replication (S phase) and 
mitosis (M phase) with no intermittent gap phases (Newport and Kirschner, 1982a). During 
these early cell stages, DNA licensing takes place at the end of mitosis (Gillespie et al., 2012; Li 
and Blow, 2004; McGarry and Kirschner, 1998). The total length of each cell cycle is only 35 
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minutes on average (Newport and Kirschner, 1982a). During this time, cells do not grow; the 
volume of the embryo remains the same size as the pre-fertilized egg, about 1 µL in volume 
(Arias and Walter, 2004).  
The stages of Xenopus development have been well characterized by Nieuwkoop and Faber 
(Bowes et al., 2007; Faber and Nieuwkoop, 1994). Cell divisions are synchronous until the 
midblastula transition after the 12th division (Nieuwkoop and Faber Stage 8.5 (Faber and 
Nieuwkoop, 1994)), when progression through S phase slows, and the cell cycle expands to 
include G1 and G2 phases (Bowes et al., 2007; Newport and Kirschner, 1982a). The timing of 
these early cleavage divisions is controlled by cyclin fluctuations throughout the cell cycle, and 
embryos are insensitive to checkpoint-dependent cell cycle slowing in response to DNA damage 
(Clute and Masui, 1997; Conn et al., 2004; Hensey and Gautier, 1998; Kappas et al., 2000; 
Kimelman et al., 1987). High numbers of replication forks likely contribute to the embryo’s ability 
to progress through S phase so rapidly (Walter and Newport, 1997). After the early cleavage 
divisions, the blastula stage (stages 7-9) spans the mid-blastula transition and marks the start of 
zygotic transcription (Newport and Kirschner, 1982b). Next, during the gastrula stage (stages 
10-12), cells migrate (Davidson et al., 2002; Solnica-Krezel and Sepich, 2012; Winklbauer et al., 
1996), apoptosis becomes part of the developmental program (Greenwood and Gautier, 2005; 
Hensey and Gautier, 1998), and regulated gene expression begins (Bouvet et al., 1994; Rupp 
and Weintraub, 1991; Veenstra et al., 1999; Wormington and Brown, 1983). Neurulation (stages 
13-21), during which the nervous system develops and cell differentiation continues, follows 
gastrulation. After neurulation, embryos undergo further tissue differentiation, organogenesis, 
and growth during the tailbud stage (stages 22-44) and tadpole stages (Bowes et al., 2007). 
Tadpoles then proceed through metamorphosis to become frogs.  
By crushing unfertilized eggs via centrifugation, we can stimulate calcium release and simulate 
 24 
fertilization. Cyclin levels in the resulting crude extract fluctuate like they would in fertilized eggs. 
When provided with demembranated sperm chromatin, Xenopus egg extract supports the 
assembly of nuclei around DNA, origin licensing, and a single round of genome replication 
(Blow and Laskey, 1988; Newport, 1987). After S phase is complete, extracts can progress into 
mitosis, segregate their chromosomes into distinct nuclei, and repeat the complete cycle up to 
five times (Arias and Walter, 2004). DNA damage and fork stalling can also trigger a checkpoint 
response and DNA repair in extract (Dasso and Newport, 1990; Kumagai and Dunphy, 1999; 
Kumagai et al., 1998). To specifically study S phase-specific processes, progression into mitosis 
can be blocked through the addition of the translation inhibitor cycloheximide to inhibit the 
production of cyclin B and other proteins. Therefore, S phase Xenopus egg extract behaves like 
an in vivo system with the advantages of an in vitro system.  
We can further process crude S phase extract into other fractions that serve different purposes: 
Low speed supernatant (LSS) (Blow, 1993): Because crude S phase extract contains 
mitochondria, it cannot be frozen and subsequently thawed; mitochondria would lose 
their structural integrity and trigger apoptosis of the extract. To make LSS, we remove 
the mitochondria and other contaminants from crude S phase extract via centrifugation, 
allowing the production of large quantities of extract at one time for future use. 
Importantly, LSS still contains the membranes necessary to form nuclei. LSS behaves 
similarly to crude S phase extract; it supports the assembly of nuclei around 
chromosomal DNA, origin licensing, a single round of DNA replication, DNA repair, 
checkpoint signaling, and CRL4Cdt2 function. DNA replication depends on nuclear 
envelope formation; however, LSS and crude S phase extract will not support replication 
of small DNA molecules like plasmids because these DNA templates do not support the 
formation of nuclei. 
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High speed supernatant (HSS) (Hua et al., 1997; Newport, 1987): In addition to 
removing the mitochondria from crude S phase extract, we can also remove the 
membranes and other organelles via centrifugation to generate HSS. HSS supports 
PCNA-dependent repair of damaged DNA templates and licensing of sperm chromatin 
but does not contain the membranes to form nuclei or support chromosomal replication. 
This allows us to separate licensing from replication through the use of different extracts, 
much like somatic cells separate these events into G1 and S phase. 
Nucleoplasmic extract (NPE) (Lebofsky et al., 2009; Walter et al., 1998): After adding 
sperm chromatin to crude S phase extract, nuclei assemble around the DNA. From this 
crude S phase extract nuclear assembly reaction, we can separate the nucleoplasm, 
containing high levels of S phase-specific Cdk activity, from the cytoplasm to generate 
NPE. Because the nucleoplasm contains high levels of S phase-specific Cdks, it triggers 
origin firing of licensed DNA. However, high levels of geminin in NPE are incompatible 
with pre-RC formation, so only one round of replication is permitted. NPE mimics a 
nuclear environment in the absence of a physical nucleus, allowing the replication of 
plasmids. HSS or LSS must first license DNA before the addition of NPE in order for 
replication to occur. The same environment (a mixture of HSS and NPE) also supports 
DNA repair, checkpoint signaling, and destruction of CRL4Cdt2 substrates. 
This extract-based system has many advantages over both cell-based systems and standard 
reconstituted systems. Extracts lack a cellular membrane that restricts the entry and exit of 
specific proteins. Removal of proteins in cells requires lengthy techniques like siRNA or genetic 
manipulations and can, in some cases, only result in partial removal of the target protein. In 
Xenopus egg extract, we can remove proteins through immunodepletion in just a few hours 
before initiating replication or repair, so no indirect effects of the removal accumulate over time 
and mask events of interest. Because most DNA replication proteins are essential, their removal 
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has pleiotropic detrimental effects over multiple cell cycles that can be unrelated to their specific 
functions. Additionally, adding mutant proteins to extracts has advantages over expressing 
proteins in cells, such as providing the capacity to ensure specific protein concentrations directly. 
Finally, Xenopus egg extract will replicate or repair almost any DNA template, including 
plasmids engineered to contain site-specific damage. Nonetheless, compared to traditional in 
vitro systems, Xenopus egg extract has the same advantage as cells: extract will recapitulate all 
the events of replication and repair without requiring the characterization and purification of 
every protein and molecule involved. Because many of the DNA replication, repair, and 
checkpoint signaling pathways involve so many players, many of which have not been identified, 
reconstituted systems are not yet an option to study these pathways on a molecular level. 
Consequently, Xenopus egg extract allows us to study DNA replication and repair on a 
biochemical and molecular level not possible in tissue culture or in in vitro systems based on 
purified recombinant proteins. 
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Chapter 2  
 
Thymine DNA glycosylase is a 
CRL4Cdt2 substrate 
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2.1 Introduction 
Thymine DNA glycosylase (TDG), a base excision repair (BER) protein, has taken the spotlight 
in the fields of DNA repair and epigenetics in recent years due to its potential role in DNA 
demethylation. DNA methylation is an epigenetic mark that regulates gene expression. Though 
we have a general understanding of how DNA methylation occurs, DNA demethylation remains 
enigmatic in animals (He et al., 2011a). BER is responsible for DNA demethylation in plants and 
is proposed to be part of a two-step pathway for demethylation in animals in which 5mC-
modifying enzymes first process 5mC to another moiety that can then be removed through BER, 
generating unmethylated cytosine as a result (Chen and Riggs, 2011; Dalton and Bellacosa, 
2012; Fritz and Papavasiliou, 2010; Nabel and Kohli, 2011; Niehrs, 2009; Wu and Zhang, 2010).  
In current models, TDG is the most likely candidate for the BER glycosylase involved in this two-
step pathway. TDG and other BER proteins cooperate with AID and APOBEC1, deaminases 
that process 5mC to thymine, which TDG and downstream BER proteins can convert into an 
unmodified cytosine (Cortellino et al., 2011; Morgan et al., 2004; Popp et al., 2010; Rai et al., 
2008). Additionally, TDG functionally interacts with Tet proteins, enzymes that iteratively oxidize 
5mC to 5hmC, 5fC, and 5caC. TDG then acts on the resulting 5fC and 5caC, ultimately leading 
to cytosine demethylation (Guo et al., 2011; Hashimoto et al., 2012; He et al., 2011b; Inoue and 
Zhang, 2011; Inoue et al., 2011; Iqbal et al., 2011; Ito et al., 2011; Maiti and Drohat, 2011; 
Wossidlo et al., 2011; Zhang et al., 2012). A more detailed discussion of these models is 
provided in Chapter 1. 
TDG is essential for development. Mice lacking TDG die at embryonic day 11.5. Leading up to 
their death, the fetal mice suffer from aberrant DNA methylation due to a failure to demethylate 
gene promoters that must be activated during tissue differentiation (Cortázar et al., 2011; 
Cortellino et al., 2011). This observation further supports the hypothesis that TDG is important 
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for DNA demethylation. Moreover, a recent study showed that targeting TDG directly to specific 
genes results in demethylation of these gene promoters (Gregory et al., 2012), suggesting that 
localization of TDG is sufficient for DNA demethylation.  
Understanding the regulation of a protein involved in so many DNA transactions, ranging from 
BER to regulation of epigenetic inheritance, is of interest to cell and molecular biologists of all 
specialties. During BER, TDG is product-inhibited due to virtually irreversible binding to an 
abasic site; its removal depends on SUMOylation of the C-terminus, which decreases TDG’s 
affinity for DNA (Baba et al., 2005; Hardeland et al., 2002; Smet-Nocca et al., 2011). 
Additionally, TDG is absent from human cells during S phase due to proteasome-dependent 
destruction after ubiquitylation by an unknown ubiquitin ligase (Hardeland et al., 2007). The 
authors who identified this S phase-specific destruction proposed that during DNA replication, 
the TDG-abasic site interaction could be too strong for the replication fork to overcome, leading 
to fork stalling during S phase (Hardeland et al., 2007). In support of this model, massive 
overexpression of TDG causes an accumulation of cells in S phase (Hardeland et al., 2007). 
CRL4Cdt2 negatively regulates many proteins whose presence in S phase is detrimental (Abbas 
and Dutta, 2011; Havens and Walter, 2011). CRL4Cdt2 targets its substrates for destruction 
specifically during DNA replication or following DNA damage. Fewer than ten CRL4Cdt2 
substrates are known, but all have a role in DNA replication or repair (Havens and Walter, 2011). 
The Walter lab has characterized the CRL4Cdt2 degron as well a role for PCNA in CRL4Cdt2 
recruitment to the substrate. CRL4Cdt2 substrates must bind to DNA-associated PCNA through 
their PCNA interacting peptide (PIP) boxes (Figure 1.2) to function as degradation targets (Arias 
and Walter, 2006). Ubiquitin ligase recruitment involves contact between Cdt2 and residues on 
both PCNA and the substrate (Havens and Walter, 2009; Havens et al., 2012). However, 
CRL4Cdt2 does not target all PIP box-containing proteins for destruction. It accomplishes 
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substrate specificity for a small subset of PCNA-binding proteins through additional degron 
features: all known CRL4Cdt2 substrates contain a basic residue four amino acids downstream of 
the PIP box (the B+4 position relative to the PIP box), and most also contain a threonine and 
aspartate at positions 5 and 6 of the PIP box (a “TD motif”) (Havens and Walter, 2009), while 
stable PCNA interacting proteins do not (Chapter 1, Figure 1.2). These features create a “PIP 
degron” necessary for targeting by CRL4Cdt2. 
Given our interest in CRL4Cdt2-dependent proteolysis, I was intrigued by the cell cycle profile of 
TDG. The ubiquitin ligase responsible for S phase-specific proteolysis of TDG (Hardeland et al., 
2007) has not been identified. Here, I report that CRL4Cdt2 regulates TDG, which contains a PIP 
degron in its N-terminal regulatory region. However, wildtype TDG is destroyed with slower 
kinetics than the well-characterized CRL4Cdt2 substrate Cdt1 in response to damage and not at 
all during normal replication in Xenopus egg extract. Improving TDG’s PIP degron expedites 
TDG destruction in response to damage and triggers its destruction during DNA replication, 
suggesting that it is a weaker CRL4Cdt2 substrate due to decreased PCNA binding compared to 
other substrates. In developing embryos, non-degradable TDG is regulated similarly to wildtype 
TDG during the early cleavage divisions but accumulates during gastrulation and beyond, 
suggesting that CRL4Cdt2-dependent destruction of TDG changes during development. 
Nevertheless, I was unable to identify replication or developmental defects in response to a non-
degradable TDG mutant and anticipate that other redundant mechanisms restrict the access of 
TDG to DNA, thereby masking the effects of non-degradable TDG. 
2.2 Materials and Methods 
2.2.1 Preparation of testes and sperm chromatin from X. laevis males 
The methods for isolation of testes and production of sperm chromatin from post-mortem male 
frogs was previously reported (Lebofsky et al., 2009; Tutter and Walter, 2006). Male frogs were 
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sacrificed, and their testes were isolated through dissection. For subsequent fertilization, testes 
were stored in 1x Marc’s Modified Ringer Solution (MMR; 100 mM NaCl, 2 mM KCl, 1 mM 
MgCl2, 2 mM CaCl2, 2 mM NaHCO3, 5 mM HEPES, pH 7.8) containing 50 µg/mL gentamycin. 
To isolate sperm chromatin, testes were harvested and immediately minced with a razorblade 
and diluted in Buffer X (80 mM KCl, 15 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 10 mM HEPES, 
pH 7.4) supplemented with 200 mM sucrose. Sperm was released from the testes by repetitive 
rounds of vortexing and centrifugation at 1000 rpm in an IEC CL2 tabletop centrifuge for 10 
seconds. The soluble sperm was removed to a new tube and centrifuged at 1500 rpm to remove 
any contaminating tissue. Sperm was pelleted by centrifugation in a Sorvall HB6 rotor at 4000 
rpm, 4°C for 10 minutes. Sperm was then resuspended in Buffer X supplemented with 2 M 
sucrose and isolated from red blood cells and other contaminants by centrifugation through a 
sucrose cushion (Buffer X containing 2.3 M sucrose underlaid with Buffer X containing 2.5 M 
sucrose) in a TL100 Beckman Ultracentrifuge rotor at 33,000 rpm, 2°C for 25 minutes. Purified 
sperm was washed in Buffer X containing 200 mM sucrose and recovered through 
centrifugation in a Sorvall HB6 rotor at 5000 rpm, 4°C for 10 minutes. Sperm was 
demembranated in Buffer X containing 200 mM sucrose, 10 µg/mL aprotinin, 10 µg/mL 
leupeptin, 1 mM DTT, and 0.4% Triton X-100 through gentle agitation at 4°C for 30 minutes. 
Detergent was removed by centrifugation through a sucrose cushion containing Buffer X 
supplemented with 500 mM sucrose, 10 µg/mL aprotinin, 10 µg/mL leupeptin, 1 mM DTT, and 
3% bovine serum albumin (BSA; Sigma) and two washes with sperm chromatin storage buffer 
(Buffer X containing 200 mM sucrose, 10 µg/mL aprotinin, 10 µg/mL leupeptin, 1 mM DTT, and 
3% BSA). The amount of recovered sperm chromatin was determined, and the chromatin was 
stored in the same buffer in single use aliquots at -80°C.  
2.2.2 Unfertilized egg collection 
Female frogs were injected with 75 international units of pregnant mare serum gonadotropin 
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(PMSG; Calbiochem) 2-7 days before injection with 625 units of human chorionic gonadotropin 
(HCG; Sigma) to induce egg laying. 20 frogs were injected to make NPE or 6 frogs were 
injected to make HSS. For microinjection and development experiments, eggs were freshly 
squeezed from a single female frog injected for a separate extract preparation. 
2.2.3 Xenopus egg extract  
Eggs were harvested 15-22 hours after injection with HCG. Crude S phase extract was 
prepared as previously reported (Tutter and Walter, 2006) and is described here. To make 
crude S phase extract as an endpoint or to subsequently make NPE or HSS, eggs were 
harvested and dejellied with 2.2% cysteine (Spectrum), pH 7.7, washed with ½x MMR, and then 
washed with egg lysis buffer (ELB; 250 mM sucrose, 2.5 mM MgCl2, 50 mM KCl, 10 mM 
HEPES, pH 7.7) containing 50 µg/mL cycloheximide and 1 mM DTT. Eggs were packed at 1100  
rpm in an IEC CL2 centrifuge at room temperature and supplemented with 5 µg/mL aprotinin 
and leupeptin and 2.5 µg/mL cytochalasin B. Eggs were activated by crushing via centrifugation 
at 10,000  rpm, 4°C for 15 minutes in a Sorvall HB6 rotor equilibrated to room temperature. 
Following centrifugation, crude S phase extract (the middle, soluble layer) was harvested using 
a syringe. Crude S phase extract was supplemented with 50 µg/mL cycloheximide, 1 mM DTT, 
10 µg/mL aprotinin and leupeptin, and 5 µg/mL cytochalasin B and stored on ice until the 
addition of sperm chromatin or further processing. 
HSS was also prepared as previously described (Hua et al., 1997; Newport, 1987; Walter et al., 
1998). To make HSS, crude S phase was centrifuged in a TL100 Beckman Ultracentrifuge rotor 
for 90 minutes at 55,000 rpm, 2°C. The lipids were removed, and HSS was harvested and 
centrifuged again for 30 minutes at 2°C to remove any additional lipids. HSS was flash frozen in 
liquid nitrogen and stored at -80° until use. 
NPE was prepared according to Walter et al., 1998 with a few modifications. To make NPE, 
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crude S phase extract was supplemented with 3.3 µg/mL nocodazole, optionally diluted up to 
10% by volume with ELB containing cycloheximide and DTT, and further centrifuged for 15 
minutes in a Sorvall HB6 rotor at 4°C to eliminate any remaining lipids, mitochondria, and yolk 
proteins. Lipids were aspirated, and the clean crude S phase extract was decanted, leaving the 
mitochondria and yolk proteins behind. Clean crude S phase extract was supplemented with 2 
mM ATP (Sigma), 20 mM phosphocreatine (Sigma), and 5 µg/mL creatine kinase (Sigma) and 
equilibrated to room temperature. Demembranated sperm chromatin was added to a final 
concentration of 4400/µL and allowed to form nuclei. The nuclei assembly reaction was 
incubated at room temperature and mixed every 10 minutes by gentle inversion for 90 minutes 
or until nuclei reached an average diameter of 25-30 µm. Nuclei were collected by centrifugation 
for two minutes at 10,000 rpm, 4°C in a Sorvall HB-6 rotor. The upper nuclear layer was 
removed and centrifuged at 55,000 rpm (260,000xg) at 2°C in a TL55 swinging bucket rotor in a 
Beckman TL100 tabletop ultracentrifuge. Any contaminating lipids were removed, and the 
nucleoplasm was harvested, frozen on liquid nitrogen, and stored at -80°C until use. 
Before use, NPE was diluted with 40-60% ELB to elicit optimal DNA replication. All extracts 
were supplemented with an energy regeneration mix (2 mM ATP, 20 mM phosphocreatine, and 
5 µg/mL creatine kinase). HSS and crude S phase extract were also supplemented with 
nocodazole (3-5 µg/mL), and diluted NPE was supplemented with an additional 10 mM DTT.  All 
experiments in Xenopus egg extract described in this chapter were performed in a 2:1 mixture 
of diluted NPE:HSS, unless otherwise noted. DNA was incubated first in HSS before the 
addition of diluted NPE for replication assays (described below in section 2.2.9). 
2.2.4 Egg fertilization 
Eggs were fertilized according to published protocols (Sive et al.); Eggs were harvested directly 
into a petri dish containing 1x MMR. Fertilization was carried out at 18°C. Liquid was removed, 
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and a small piece of testes that was lightly minced with a razorblade before use was waved over 
the eggs. Remaining testes chunks were homogenized with a pestle, resuspended in a small 
volume of 1xMMR, and drizzled over the eggs. The sperm were activated through the addition 
of an excess of water to the sperm-covered eggs for a final MMR concentration of 
approximately 0.1x. Fertilized eggs oriented themselves with the animal pole facing upwards. 
Embryos were dejellied with 2% cysteine, pH 7.8 and washed well with 0.1xMMR approximately 
25 minutes after fertilization and stored in 0.1xMMR containing 50 µg/mL gentamycin. 
2.2.5 X. laevis microinjections and developmental experiments 
To prepare mRNA for microinjections, pCS2+TDG plasmid (described below) was linearized 
with a NotI (NEB) overnight digest and purified using a PCR purification kit (Qiagen). mRNA 
was prepared using the mMessage mMachine Sp6 kit (Ambion) and purified using an RNeasy 
mini kit (Qiagen). Purified mRNA was ethanol precipitated and diluted in RNase-free water. 
200 pg or 1 ng TDG mRNA (10 nL at 2 ng/mL or 10 ng/mL in water) was microinjected into each 
cell of dejellied Stage 2 embryos in 0.1x MMR+5% Ficoll containing gentamycin (50 µg/mL) at 
18°C. Embryos were allowed to heal in 0.1x MMR+5% Ficoll containing gentamycin for 1-2 
hours at 18°C and then moved to 0.1x MMR containing gentamycin and stored at 14°C until 
they reached the midblastula transition (N-F Stage 8.5). Development was then monitored at 
23°C. Embryos were staged according to the Nieuwkoop and Faber anatomical stages (Bowes 
et al., 2007; Faber and Nieuwkoop, 1994). Two microinjected embryos were harvested at the 
appropriate stages by freezing with liquid nitrogen and storing at -80°C. To monitor endogenous 
protein levels, pools of 10 uninjected embryos were harvested. 
Frozen embryos were lysed in 15 µL embryonic lysis buffer per embryo (250 mM sucrose, 1% 
NP-40, 10 mM EDTA, 25 mM HEPES, pH 7.5 supplemented with a Roche Complete protease 
inhibitor tablet) via homogenization with a pipet tip and light vortexing. Yolk proteins were 
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removed via centrifugation at 10,000xg, 4°C for 10 minutes. The soluble fraction was recleared 
of yolk proteins with a second spin. 
2.2.6 Plasmid construction, mutagenesis, and protein purification 
A cDNA library was generated from purified X. laevis egg mRNA (generated by Dr. Courtney 
Havens), and the TDG gene was amplified with primers 5’-GCTAAGGATCCATGGAGGCCC 
AGGACCCAAGC-3’ and 5’-TTTTTCTCGAGTCAAGCGTTGCTGCCTCCTTGC-3’. The TDG 
gene was inserted into a modified pET28 vector that contains a Prescission Protease (GE 
Healthcare) cleavage site for expression in bacteria or into a pCS2+ vector for mRNA 
production at BamHI and XhoI (NEB) sites in the respective vector. TDG point mutants were 
generated with a QuikChange II Site-Directed Mutagenesis Kit (Agilent). 
To obtain native, functional TDG, expression of His-tagged TDG was induced in Arctic Express 
cells (Agilent) with 0.1 mM IPTG for 24 hours at 15°C, and TDG was purified via batch 
purification. Cells were lysed via sonication in lysis buffer (750 mM NaCl, 20% glycerol, 10 mM 
β-mercaptoethanol, 10 mM imidazole, 50 mM sodium phosphate, pH 8.0, and protease 
inhibitors (0.5 mM PMSF; Amresco, 1 mM benzamidine; Sigma, 10 µg/mL aprotinin, 10 µg/mL 
leupeptin)) and cleared via centrifugation at 30,000g. Soluble His-tagged TDG was bound to Ni-
NTA beads (Qiagen) for one hour and washed twice with lysis buffer containing 20 mM 
imidazole and once with lysis buffer containing 50 mM imidazole (aprotinin and leupeptin were 
omitted from these wash buffers). To separate the chaperonin protein from TDG, an additional 2 
hour wash was performed in an ATP-based chaperonin removal buffer (375 mM NaCl, 20% 
glycerol, 10 mM β-mercaptoethanol, 10 mM imidazole, 10 mM MgCl2, 150 mM KCl, 5 mM ATP, 
and 50 mM sodium phosphate, pH 7.6) modified from a previous report on removal of co-
purifying chaperonin from Arctic express cells (Joseph and Andreotti, 2008). Finally, the beads 
were washed again twice with lysis buffer containing 20 mM imidazole and once with lysis buffer 
 36 
containing 50 mM imidazole before eluting in lysis buffer containing 400 mM imidazole. 10 units 
of Prescission Protease was added to the native protein eluate, which was then dialyzed 
overnight in 50 mM NaCl, 50 mM Tris, 10% glycerol, 10 mM β-mercaptoethanol, and 1 mM 
EDTA, pH 8. TDG was used at a final concentration in extract of 1 ng/µL in this chapter unless 
otherwise indicated. 
To obtain denatured TDG for antibody production, TDG was expressed in BL21 (DE3) cells via 
induction with 0.25 mM IPTG at 37°C for three hours. Cells were lysed in 7 M urea, 10 M 
sodium phosphate, and 10 mM Tris, pH 8.0, cleared via centrifugation at 30,000xg, and bound 
to Ni-NTA beads for one hour. Beads were washed with 8 M urea, 100 mM sodium phosphate, 
10 mM Tris, pH 6.3. His-TDG was eluted directly into 2x SDS-PAGE loading buffer (20% 
glycerol, 6.1% SDS, 125 mM Tris-HCl, pH 6.8, 0.01% Bromophenol Blue), and separated on an 
SDS-PAGE gel. Protein was stained with Gelcode Blue (Thermo Scientific) and electroeluted 
into SDS-PAGE running buffer (0.1% SDS, 250 mM glycine, 25 mM Tris, pH 8.3). The resulting 
purified TDG was >99% pure as measured by Coomassie staining. 
Human TDG was donated by Dr. Primo Schär from the University of Basel in Switzerland. p21 
peptides (previously described by (Arias and Walter, 2006)) were synthesized commercially. 
Wildtype p21 peptide (CKRRQTSMTDFYHSKRRAIAS) was synthesized by Invitrogen 
(Carlsbad, CA); mutant peptide (CKRRATSATDAAHSKRRAIAS) was synthesized by the 
Biopolymers Laboratory (Harvard Medical School, Boston, MA). 
2.2.7 Immunological methods 
Denatured His-TDG was sent to Pocono Rabbit Farm and Laboratory (Canadensis, PA) for 
antibody production in two rabbits. Serum from rabbit #197 was used for all TDG 
immunoblotting at a concentration of 1:5000-1:2500. Serum from rabbit #198 was used for 
immunoprecipitation. Antibodies to Xenopus Cdt1 (Arias and Walter, 2005), Cdt2 (Jin et al., 
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2006), Orc2 (Walter et al., 1998), MCM7 (Walter and Newport, 2000), Rcc1 (Dasso and 
Newport, 1990), and RPA (Walter and Newport, 2000) were generated and described previously. 
Commercial antibodies were used to blot for PCNA (Santa Cruz), human Cdt1 (Bethyl), human 
Cdt2 (Bethyl), phospho-Chk1 (S345, Cell Signaling), and total Chk1 (Cell Signaling). Antibodies 
to human TDG were donated by Dr. Primo Schär. 
Immunodepletions were performed using a 3:1 ratio of antibody serum prebound to Protein A 
Sepharose Fastflow resin (Amersham Biosciences). Antibody-bound resin was used at a 1:5 
ratio to egg extract. To deplete Cdt2, either one or two one-hour rounds were performed, both 
leading to the same results shown. 
To immunoprecipitate TDG from extract, 1 µL crude serum (rabbit #198) was added to 10 µL 
Protein A Sepharose Fastflow resin and incubated at 4°C overnight to bind the TDG antibody to 
the beads. The beads were washed five times with PBS and two times with ELB containing 500 
mM NaCl. Extract reactions (HSS/NPE) were diluted 6-fold in ELB and applied to the beads for 
1 hour at 4°C. Bead-bound proteins were washed five times in ELB containing 0.1% Triton X-
100 and eluted directly into 2x sample buffer. 
2.2.8 Generation of MMS-damaged DNA and DNA recovery from extract 
Methylated plasmid or linear DNA was generated as previously described (Stokes, 2003): DNA 
was diluted to a concentration of 250 ng/µL in TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0) and 
then diluted 1:1 with 1xM9 salts (Sambrook and Russell, 2001) containing 0.1 mM MgSO4. MMS 
was added to a final concentration of 450 mM and incubated with DNA at 30°C for 30 minutes. 
MMS was removed through ethanol precipitation. 5-15 ng of MMS-damaged plasmid DNA was 
used to trigger TDG destruction in extract. Unless otherwise indicated, MMS-damaged plasmid 
was used at 10 ng/µL in this chapter.  
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To make linear, bead-bound, MMS-damaged DNA, PCR was used to generate a double-
stranded 1kb linear DNA fragment that was biotinylated on both ends. The DNA fragment was 
purified using a PCR purification kit (QIAGEN) before MMS treatment. The resulting damaged, 
biotinylated fragment was bound to M-280 streptavidin Dynabeads (100 ng DNA per 10 mg 
Dynabeads; Invitrogen) by incubating the DNA and beads for 2-4 hours at 23°C in binding buffer 
(10 mM Tris 8.0, 100 mM NaCl, and 1 mM EDTA) and subsequently incubating overnight at 4°C. 
Unbound DNA was removed, and an excess of streptavidin was added to block any free biotin 
ends before washing the bead-bound DNA three times with the binding buffer. Beads were 
stored in binding buffer at the original bead volume. Approximately fifty percent of the DNA 
bound to beads. Buffer was removed before the addition of extract.  
To recover immobilized MMS-damaged DNA from extract, samples were resuspended in ELB 
containing 50-150 mM KCl and 0.6% Triton X-100 and then layered over an ELB cushion 
containing 500 mM sucrose and 50-150 mM KCl. Following centrifugation through the sucrose 
cushion, the beads were washed with resuspension buffer. 
2.2.9 DNA replication assays and nascent strand analysis in Xenopus egg extract (NPE) 
DNA was licensed in HSS before the addition of diluted NPE containing trace amounts of α-32P-
dATP. Where indicated, licensing was inhibited with 400 nM geminin. NPE mimics the nuclear 
environment, allowing origin firing. At the desired time points, replication was stopped in 
replication stop buffer (8 mM EDTA, 10% Ficoll, 5% SDS, 0.2% bromophenol blue, 80 mM Tris, 
pH 8) and subsequently treated with proteinase K (1 mg/mL; Roche) before separation on a 
0.8% agarose gel. Gels were dried on filter paper and visualized with a phosphorimager. 
Replication was monitored by the incorporation of α-32P-dATP and normalized to total 
radioactive signal in each sample. The concentration of dATP in each extract preparation was 
calculated separately by measuring the effect of adding a known concentration of unlabeled 
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dATP. Total replication was quantified based on the normalized α-32P-dATP incorporation, 
concentration of dATP in extract, and concentration of total parental DNA in each sample. 
For nascent strand analysis, the plasmid products were digested with PvuII to generate a 448nt 
parent-strand fragment hybridized to nascent strands of varying lengths. Samples were diluted 
in formamide loading dye (Ambion) and separated on 42 cm long, 7% polyacrylamide 
sequencing gels (7 M urea, 0.8x glycerol-tolerant buffer (USB), the desired concentration of 
acrylamide (from a 40% Rapid Gel XL concentrate; USB), and APS and TEMED for 
polymerization). Gels were dried on filter paper and visualized with a phosphorimager. 
Sequencing ladders were prepared with the Cycle Sequencing Kit (USB) and included on each 
gel to measure band sizes with nucleotide resolution. 
2.2.10 TDG activity assays 
Base release assays were used to measure TDG activity on a short oligo template and on a 
plasmid containing a G-T mispair (Figure 2.1) (Hardeland et al., 2000; He et al., 2011b; Maiti 
and Drohat, 2011). 29mer double-stranded oligonucleotides were prepared by end labeling the 
strand containing the base to be hydrolyzed by TDG (5’-CCGCTGAGGGATATNGAATTCC 
TGCAGGC-3’, where N=C, T, or U) with γ-32P-ATP and annealing an unlabeled complementary 
strand (5’-GCCTGCAGGAATTCGATATCCCTCAGCGG-3’) by heating the mixture to 85°C and 
allowing it to cool slowly to 23°C. Polynucleotide kinase (PNK; NEB) was used to attach the 
radiolabeled phosphate in PNK buffer (10 mM MgCl2, 5 mM DTT, 70 mM Tris pH 7.6). The DNA 
strands were annealed in the same buffer. Free label was removed with G-50 Probequant 
columns (GE Healthcare). 
Plasmid containing a single G-T mispair was generated in the Takahashi lab at Osaka 
University in Japan by annealing a mispaired oligonucleotide to a single-stranded plasmid and 
performing strand extension and ligation. 
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TDG was incubated with either double-stranded 29mer or plasmid in extract, ELB, or activity 
buffer (20 mM NaCl, 0.5 mM EDTA, 1 mM DTT, 50 mM Tris, pH 7.5, and 10 µg/µL aprotinin and 
leupeptin, along with trace amounts of β-mercaptoethanol and aprotinin and leupeptin 
contributed by the protein itself). Activity assays were incubated for 40 minutes at 23°C unless 
otherwise indicated. For plasmid activity assays, the reaction was then stopped in stop solution 
(25 mM EDTA, 0.5% SDS, 50 mM Tris, pH 7.5). Proteinase K was added to remove TDG from 
the plasmid, and a phenol chloroform extraction was performed to isolate the DNA. If the activity 
assay took place in extract, samples in stop solution were incubated with RNase (80 ng/µL; 
Roche) for 30 minutes at 37°C before the addition of Proteinase K to eliminate RNA from the 
reaction. The plasmid was concentrated via ethanol precipitation and subsequently digested 
with PvuII (NEB) to release a 443 base pair fragment for subsequent treatment. For activity 
assays on the short oligonucleotides, the DNA was processed directly without any further 
digests or purification steps. The TDG-generated abasic sites were cleaved after the addition of 
90 mM NaOH and heating to 95° for three minutes. An equimolar volume of acetic acid was 
added to neutralize the reaction, and samples were diluted in formamide loading dye (Ambion). 
Samples were reheated to 75°C and loaded immediately on a small urea-PAGE gel (7 M urea, 
0.8x glycerol-tolerant buffer (USB), 7% polyacrylamide (from a 40% Rapid Gel XL concentrate; 
USB), and APS and TEMED for polymerization) that had been pre-run for 20 minutes at 200V in 
0.8x glycerol-tolerant buffer. Gels were run at 200V until the size range of interest reached the 
middle of the gel. TDG activity was visualized by a change in the size of the end-labeled DNA 
strand upon exposure with a phosphorimager.  
2.2.11 Human cell tissue culture and siRNA 
HeLa cells were maintained in DMEM (Invitrogen). Reverse siRNA methods were used to 
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Figure 2.1: TDG activity assay scheme. A) A base release assay using short oligos as a 
template is shown. In a base release assay, following TDG activity and treatment with NaOH, 
the substrate and product are separated on a 20% urea-PAGE gel. TDG activity results in the 
generation of a 14nt product, whereas an EcoRV digest of the correctly paired oligos results in a 
12nt product. B) TDG activity assay on a plasmid containing a G-T mispair. After TDG activity, 
the plasmid is repurified with a phenol-chloroform extraction and ethanol precipitation. The 
plasmid is then digested with PvuII to generate a short fragment that is treated like the oligos in 
(A). TDG activity results in the generation of a single end-labeled product of 306nt along with an 
uncleaved end-labeled complement of 448nt. A NotI digest of the correctly paired plasmid 
results in complete digest to two end-labeled fragments of 306nt and 142nt. Substrate and 
product are separated on a 5% urea-PAGE gel.  
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Figure 2.1 (continued) 
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eliminate Cdt2 from HeLa cells: siRNA was combined with RNAi Max transfection reagent 
activated in Optimem (Invitrogen) and mixed with cells in suspension. siRNA-containing media 
was removed after the cells adhered to the plate, and cells were treated for 72 hours before any 
experimentation. siRNA was purchased from Invitrogen (siRNA1:DTLHSS182090, 
siRNA2:DTLHSS122293, siRNA3:DTLHSS122295). To damage cells with UV irradiation, media 
was removed, and cells were placed in a warmed up UV Stratalinker set to 50J/m2. To arrest 
cells at the start of S phase, a double thymidine block was performed with media containing 2.5 
mM thymidine. Cells were treated with thymidine for 16-18 hours, released for 8 hours, and 
treated again for 16 hours before releasing into S phase. The timing of the thymidine block was 
coordinated with the timing of siRNA treatment. 
For cell cycle analysis, cells were fixed in 70% cold ethanol in PBS for at least 4 hours at 20°C. 
Ethanol was removed by washing with PBS washing, and cells were resuspended in PBS 
containing 15 µg/mL propidium iodide and 200 µg/mL RNase. DNA content was analyzed with a 
FACS machine (BD). 
2.3 Results 
2.3.1 Identification of a putative PIP degron in TDG’s N-terminus 
Given that TDG levels specifically drop in S phase due to proteasome-dependent destruction 
(Hardeland et al., 2007), we looked for and identified a putative PIP degron in the N-terminus of 
TDG (Figure 2.2). Though TDG lacks one of the two conserved aromatic residues in its putative 
degron, it contains the other conserved elements of a PIP box (a Q or N at position 1, a 
hydrophobic residue at position 4, and an aromatic residue at position 8), a basic residue four 
amino acids downstream of the PIP box (B+4 residue), and a threonine and aspartate (TD 
motif) at positions 5 and 6 (Figure 2.2). These features create a “PIP degron” that is critical for 
full destruction of all known CRL4Cdt2 substrates (Havens and Walter, 2009).
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Figure 2.2: The putative PIP degron of TDG. The PIP degrons of confirmed CRL4Cdt2 
substrates are shown above TDG’s putative PIP degron in human, mouse, chicken, and frog. 
TDG of lower eukaryotes, including Drosophila, does not contain a PIP box in the same region 
of the protein or elsewhere. Ψ represents any hydrophobic residue (I/L/V/M), and θ represents 
any aromatic residue (Y/F/W). Residues shown in green are part of the conserved PIP box, and 
residues shown in blue additionally contribute to the “PIP degron.”
!"#$%&'()! " # $
QXX XX
*+,-./012)
*34$*25")56/7158)
9:9);+<)
N
= = = =
XXXX
!")*25! QRRVTDFFARRR# !$
!")>"! QTSMTDFYHSKR!$$ !%%
#$)?"@ SNDITNYYKVKR!%! !&"
%&)9A4BC! PKSLESFFKKKK%'" %(#
!")D15( NRKLTDFYPVRR!'( !(E
'()F.G! TTPITDYFPKRK!'H !(!
)$)IJK QEKITDAFKVKR!H% !!&
*+)IJK QEKITDTFKVKRE! !H"
'()IJK ) QEKITDAFKVKR!"E !$H
DGGGDQAAKPKE!H& !!'#$)IJK
!")IJK QEKITDTFKVKR'H (!
 45 
2.3.2 TDG is destroyed in a Cdt2-dependent manner in human cells 
So far, all bona fide vertebrate CRL4Cdt2 substrates are destroyed in both Xenopus egg extract 
and human cells during DNA replication and repair. I therefore monitored TDG levels following 
DNA damage in human cells. TDG levels decreased in HeLa cells and in T98G cells after UV 
irradiation with 50J/m2 UV-C light (Figure 2.3A and data not shown). In addition, siRNA against 
Cdt2 (Figure 2.3B) stabilized TDG after UV damage (Figure 2.3C, compare lanes 4-12 with 
lanes 1-3) and during S phase in HeLa cells (Figure 2.3D, compare lanes 4-8 with 10-14), 
suggesting that human TDG is a CRL4Cdt2 substrate. siRNA against Cdt2 also stabilized Cdt1 
(Figure 2.3C, D). However, siCdt2 also caused substantial G2/M arrest (Figure 2.3E), so I 
cannot rule out an indirect effect of siCdt2 on TDG levels due to its effect on the cell cycle from 
these data alone.  
2.3.3 Purification and characterization of Xenopus TDG 
To characterize TDG as a CRL4Cdt2 substrate on a molecular level, I moved to the Xenopus egg 
extract system. I purified recombinant Xenopus TDG from bacteria (Figure 2.4A) and used it to 
immunize rabbits. The resulting Xenopus TDG antiserum detects recombinant Xenopus TDG 
(Figure 2.4B, lanes 1-5).  
It was difficult to detect TDG in unfertilized egg extract (Figure 2.4B, C), leading us to suspect 
that TDG might be developmentally regulated. A high throughput analysis of absolute mRNA 
levels during X. laevis development previously showed that TDG mRNA levels are high 
compared to many developmentally-regulated transcripts (Yanai et al., 2011). TDG mRNA 
levels reported in this published study are shown compared to Pax6 mRNA (Yanai et al., 2011), 
which is not expressed until the midblastula transition, in Figure 2.4D. I monitored TDG levels 
during the course of X. laevis development and found that they were very low (less than 5 nM) 
during the early cleavage divisions and blastula stage despite fairly high TDG mRNA levels 
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Figure 2.3: Human TDG is destroyed during DNA repair and S phase in a Cdt2-dependent 
manner in HeLa cells. A) TDG is destroyed following exposure to 50J/m2 UV irradiation. B) 
siRNA against Cdt2 eliminates Cdt2 protein from cells. C) siRNA against Cdt2 stabilizes TDG 
during DNA repair. Three independent siRNAs were used. D) siRNA against Cdt2 leads to 
accumulation of TDG during S phase. Cells were arrested at the transition to S phase with a 
double thymidine block and then released into S phase and monitored for TDG destruction. A 
number of bands detected by the human TDG antibody accumulate upon siCdt2 treatment. 
Recombinant human TDG is shown in lane 1, and recombinant TDG after incubation in HSS is 
shown in lane 2 to indicate the expected size of human TDG. E) Removing Cdt2 from HeLa 
cells leads to a substantial G2 arrest. A fraction of cells from (D) were analyzed by FACS for 
DNA content. PCNA is shown in all panels as a loading control. The experiments shown in this 
figure were performed with the assistance of Dr. Malavika Raman of the Harper lab at Harvard 
Medical School. 
  
 47 
Figure 2.3 (continued)
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Figure 2.4: Characterization of Xenopus TDG. A) Denatured TDG was prepared from the 
insoluble fraction of BL21(DE3) E. coli (left) to generate specific antibodies to Xenopus TDG, 
and native TDG was prepared from the soluble fraction of Arctic Express E. coli. B) Anti-TDG 
(1:2500) generated from denatured TDG as an antigen detects even low levels of recombinant 
TDG and endogenous TDG in HSS, while pre-immune serum (1:1000) does not. C) Anti-TDG 
detects low levels of TDG in all extracts used in this work (0.6 µL HSS, 0.6 µL LSS, 0.3 µL NPE, 
and 0.6 µL diluted NPE/HSS) but detects much higher levels of TDG in lysates from Stage 20 X. 
laevis embryos (0.13 µL). D) TDG mRNA levels increase slightly during the course of X. laevis 
development. Pax6 mRNA, which is not substantially expressed until after the mid-blastula 
transition, is shown for comparison. mRNA (y-axis) is reported as log10 relative concentrations of 
mRNA abundance over three separate probes for a given gene. Values for (D) were obtained 
from published mRNA levels measured in three separate batches of fertilized eggs (Yanai et al., 
2011). E) TDG is barely detectable in early X. laevis embryos but dramatically increases during 
gastrulation and early neurulation. PCNA is shown as a loading control. 
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Figure 2.4 (continued) 
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throughout early development (Figure 2.4D, E). TDG levels increased more than 10-fold during 
gastrulation and neurulation (>50 nM) (Figure 2.4E), even though TDG mRNA levels did not 
increase similarly (Figure 2.4D). These results suggest that early embryos regulate TDG at the 
translational or post-translational level, but that this regulation is lifted later in development.  
I tested recombinant Xenopus TDG for activity on G-T and G-U mispairs in a base release 
assay: after TDG hydrolyzed the base from the backbone, sodium hydroxide and heat caused 
backbone breakage at the abasic site, generating a 14-nucleotide product visible on a 
denaturing polyacrylamide gel (Figure 2.1). As a control, I digested correctly paired DNA with a 
restriction enzyme that cleaves near the mispair (Figure 2.5A, lanes 1 and 10). TDG and all 
mutants expected to retain catalytic activity were active on short oligos containing a G-T mispair 
(Figure 2.5A, lanes 4-8 and 12-1). As expected, a catalytically inactive mutant (“CI,” N173A) 
failed to cause base hydrolysis (Figure 2.5A, lanes 9 and 18). TDG also acted on G-T and G-U 
mispairs in the context of a plasmid (Figure 2.5B, lanes 6-7 and Appendix A4, Figure A4.3).  
After confirming that recombinant TDG is active, I added it to extract to study its regulation. 
Recombinant TDG was rapidly modified in extract (Figure 2.5C), and I noticed that a fraction of 
endogenous TDG was also modified to a higher molecular weight (Figure 2.4B, C, E). I mutated 
the known SUMOylation site on TDG (“TDG ΔSUMO,” K364A) and found that this modification 
disappeared (Figure 2.5D). SUMOylation decreases TDG’s affinity for DNA to enhance 
dissociation from its catalytic product, an abasic site, during base excision repair (Baba et al., 
2005; Hardeland et al., 2002; Smet-Nocca et al., 2011). In agreement, I found that TDG 
ΔSUMO associated with DNA more stably than wildtype TDG (Figure 2.5D). SUMOylation in 
extract did not depend on the addition of DNA or the presence of a nuclear environment (Figure 
2.5C), suggesting that Xenopus egg extract and embryos regulate the access of TDG to DNA 
via SUMOylation, even in the cytoplasm. 
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Figure 2.5: Characterization of recombinant Xenopus TDG. A) Recombinant wildtype TDG 
and all mutants used in this work are active in a base release assay on the 29mer template (see 
Figure 2.1) B) TDG acts on a G-T mispair in a plasmid. 250 nM TDG ΔSUMO/ΔPIP was used in 
this reaction. C) Recombinant TDG is rapidly modified upon addition to HSS. No DNA was 
present in this reaction. D) Mutation of the SUMOylation site (K364A) eliminates modification of 
TDG to a higher molecular weight and increases TDG’s affinity for DNA. Methyl ubiquitin was 
included in to allow monoubiquitylation on multiple sites but to prevent polyubiquitylation and 
destruction. An extract-specific but non-TDG band detected by the TDG antibody was used as a 
loading control in total extract, and Orc2 was used as a loading control for the DNA-bound 
fraction. 
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2.3.4 Proteasome- and Cdt2-dependent TDG destruction during DNA repair in Xenopus 
egg extract  
To study the regulation of TDG by CRL4Cdt2, I added recombinant TDG to HSS/NPE, which 
contains very low levels of endogenous TDG (Figure 2.4). Known CRL4Cdt2 substrates must 
interact with PCNA on DNA to be targeted for destruction, either during DNA repair or during 
DNA replication. I therefore asked whether TDG would be destroyed during DNA repair of a 
DNA template containing methylation damage (but not 5mC) that was generated by treating a 
plasmid with methyl-methanesulfonate (MMS). Both cells and egg extract repair MMS damage 
through PCNA-dependent nucleotide excision repair (NER), during which CRL4Cdt2 substrates 
interact with DNA-associated PCNA and are destroyed. I found that an MMS-damaged plasmid 
triggered TDG destruction, while an otherwise identical undamaged plasmid did not (Figure 
2.6A). 
In human cells, TDG destruction during S phase depends on the proteasome (Hardeland et al., 
2007). I confirmed that this damage-dependent destruction is also proteasome-dependent by 
adding the proteasome inhibitor MG132. MG132 impaired TDG destruction in response to 
damaged DNA (Figure 2.6B). I next tested whether destruction depends on CRL4Cdt2 itself. 
Immunodepletion of Cdt2, the substrate specificity factor for CRL4Cdt2, stabilized TDG (Figure 
2.6C), suggesting that TDG is a true CRL4Cdt2 substrate. 
2.3.5 The role of SUMOylation in the destruction of TDG 
Though TDG destruction depends on Cdt2, DNA damage, and the proteasome, it is much 
slower than destruction of other known CRL4Cdt2 substrates, like Cdt1. Because SUMOylation 
decreases the affinity of TDG for DNA and TDG ΔSUMO interacts with DNA more stably than 
wildtype TDG (Figure 2.5C), I hypothesized that SUMOylation might protect TDG from 
destruction, which is triggered on DNA. If this hypothesis is correct, then the SUMOylation site
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Figure 2.6: TDG is destroyed in a DNA damage-, proteasome-, and Cdt2-dependent 
manner in Xenopus egg extract. A) TDG is destroyed during DNA repair. Damaged plasmid 
was added to trigger DNA repair and CRL4Cdt2-dependent proteolysis. B) TDG destruction 
depends on the proteasome. The proteasome inhibitor MG132 or DMSO (vehicle) was added 
before the addition of damaged DNA. C) Depletion of Cdt2 stabilizes TDG. Cdt2 was 
immunodepleted from both HSS and NPE before the two extracts were combined and 
supplemented with TDG and damaged plasmid. For (A) and (B), an extract-specific, non-Cdt1 
band detected by the Cdt1 antibody was used as a loading control. For (C), the extract-specific, 
non-TDG band detected by the TDG antibody was used as a loading control. Benjamin Morris 
performed the experiment shown in (C). 
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Figure 2.6 (continued) 
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mutant (TDG ΔSUMO) should be destroyed more quickly than its wildtype counterpart. I found 
that SUMOylation marginally impaired wildtype TDG destruction, as the SUMOylated fraction 
(Figure 2.7A, B, dotted blue lines) of TDG was destroyed with slower kinetics compared to the 
unmodified fraction (Figure 2.7A, B, dashed blue lines), but this protective modification was not 
significant enough to influence destruction of the total TDG pool (SUMOylated+unmodified, 
Figure 2.7A, B, solid blue line), which was destroyed with near-identical destruction kinetics as 
TDG ΔSUMO (Figure 2.7A, B, shown in orange). This suggests that SUMOylation is transient 
and that TDG reassociates with DNA quickly. Destruction of TDG ΔSUMO also depends on 
damaged DNA, the proteasome, and Cdt2 (Figure 2.8A-B, D). 
Because TDG ΔSUMO behaves almost identically to wildtype TDG with respect to destruction 
kinetics, but it binds to DNA better than the wildtype protein, I used TDG ΔSUMO to study how 
TDG is modified when it is associated with DNA. To confirm that TDG destruction depends on 
ubiquitylation when it is bound to DNA, I immobilized MMS-damaged, linear DNA on magnetic 
beads and added it to egg extract containing methyl-ubiquitin, which prevents polyubiquitin 
chain formation and destruction but allows monoubiquitylation on multiple sites. Upon 
recovering the bead-bound DNA, I detected ubiquitylated TDG ΔSUMO (Figure 2.8C). As 
expected, depletion of Cdt2 eliminated this ubiquitylation (Figure 2.8C). 
2.3.6 The role of PCNA binding in TDG destruction 
The TDG PIP box is not perfect; it is missing one of the two conserved aromatic residues 
important for productive contact with PCNA. Thus, I next confirmed that TDG destruction 
depends on its interaction with PCNA. I added a tightly binding PIP box peptide derived from 
p21 (shown binding PCNA in Chapter 1, Figure 1.2B), another CRL4Cdt2 substrate. The PIP box 
peptide binds to the IDCL of PCNA and decreases RFC-dependent loading of PCNA onto DNA. 
This peptide also prevents other PIP box-containing proteins from associating with PCNA. As a 
 56 
 
Figure 2.7: SUMOylation does not affect the destruction kinetics of the total pool of TDG. 
A) A comparison of wildtype TDG (WT) and TDG ΔSUMO. Recombinant TDG was added to 
HSS/NPE to a final concentration of 20 nM. Destruction was triggered with 5 ng/µL MMS-
damaged plasmid. B) Quantification of (A). Quantifications were performed by calculating band 
density with Image J software. All relevant bands were normalized to a loading control, and the 
starting concentration was set to 100%. An extract-specific, non-Cdt1 band detected by the 
Cdt1 antibody was used as a loading control. 
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Figure 2.8: TDG ΔSUMO is destroyed in a DNA damage-, proteasome-, and Cdt2-
dependent manner in Xenopus egg extract. A) TDG ΔSUMO is destroyed during DNA repair. 
Damaged plasmid was added to trigger DNA repair and CRL4Cdt2-dependent proteolysis. B) 
TDG ΔSUMO destruction depends on the proteasome. The proteasome inhibitor MG132 was 
added before the addition of damaged DNA. C) Depletion of Cdt2 eliminates ubiquitylation of 
DNA-bound TDG ΔSUMO. Cdt2 was immunodepleted from both HSS and NPE before the two 
extracts were combined and supplemented with TDG, methyl ubiquitin and linear DNA. The 
asterisk indicates a band consisting partially of specific signal (ubiquitylated TDG) and partially 
of non-specific signal. D) Depletion of Cdt2 stabilizes TDG ΔSUMO. Extracts were 
immunodepleted as in (C) and supplemented with TDG and MMS-damaged plasmid. For (A) 
and (B), an extract-specific, non-Cdt1 band detected by the Cdt1 antibody was used as a 
loading control. PCNA was used as a loading control for (C). For (D), the extract-specific, non-
TDG band detected by the TDG antibody was used as a loading control. 
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control, I used the same peptide with a mutated PIP box. Addition of the PIP box peptide 
stabilized recombinant TDG, while addition of the control peptide did not (Figure 2.9A). Hence, 
destruction of wildtype TDG depends on PCNA. The same was true for TDG ΔSUMO (Figure 
2.9B). I confirmed that destruction of endogenous TDG also depends on PCNA by monitoring 
total TDG levels and through TDG immunoprecipitation after the addition of damaged DNA 
(Figure 2.9C). Endogenous TDG levels dropped upon the addition of damaged DNA (Figure 
2.9C, lanes 3-4 for total extract, lanes 9-10 for immunoprecipitated samples), and the PIP box 
peptide stabilized endogenous TDG (Figure 2.9C, lanes 5-6 for total extract, lanes 11-12 for 
immunoprecipitated samples).  
I next queried the role of TDG’s putative PIP degron in damage-dependent destruction. 
Complete destruction of all known CRL4Cdt2 substrates requires a basic residue four amino acids 
downstream of the PIP box in addition to the PIP box itself (Havens and Walter, 2011). In some 
substrates, like Set8, other basic residues upstream or downstream of the PIP box also 
contribute to destruction (Centore et al., 2010). I mutated either the PIP box itself or the 
downstream basic residues (Figure 2.10A). Importantly, mutation of these downstream residues 
does not impair the substrate’s interaction with the PCNA IDCL (Havens et al., 2012). Mutation 
of the conserved TDG PIP box (ΔPIP) residues stabilized TDG completely (Figure 2.10, lanes 4-
6), confirming that TDG destruction depends entirely on its ability to interact with PCNA. 
Mutation of the residue four amino acids downstream of the TDG PIP box (ΔB+4) impaired 
protein destruction, but TDG levels still decreased slightly at later time points, unlike with the 
PIP box mutant (Figure 2.10, compare lanes 7-9 to lanes 4-6). Mutation of both the B+3 and 
B+4 residues together (ΔB+3/4) further stabilized TDG (Figure 2.10, lanes 10-12), suggesting 
that the B+3 residue can function in TDG destruction. These observations support classification 
of TDG as a CRL4Cdt2 substrate.
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Figure 2.9: Blocking the IDCL of PCNA prevents TDG destruction. A) PCNA inhibition 
prevents the destruction of wildtype recombinant TDG. B) PCNA inhibition prevents the 
destruction of recombinant TDG ΔSUMO. In all panels, the PIP box peptide was added to a final 
concentration of 200 µM. For (A) and (B), an extract-specific, non-Cdt1 band detected by the 
Cdt1 antibody was used as a loading control. C) PCNA inhibition prevents the destruction of 
endogenous TDG. TDG was immunoprecipitated from extract to enrich samples for endogenous 
TDG, which is present at very low levels. 
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Figure 2.10: CRL4Cdt2-dependent TDG destruction requires the TDG PIP degron. A) TDG 
PIP degron mutants (ΔPIP: Q128A/I131A/F135A, ΔB+4: R139A, ΔB+3/4: K138A/R139A, PIP*: 
A134F) B) Mutation of the TDG PIP box or downstream basic residues stabilizes TDG. C) 
Mutation of the same residues in the context of TDG ΔSUMO leads to stabilization. Note that 
mutation of the B+4 residue alone does not cause complete stabilization. The extract-specific, 
non-TDG band detected by the TDG antibody was used as a loading control. 
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I postulated that the slower destruction kinetics of TDG compared to Cdt1 could be due to its 
imperfect PIP box. TDG lacks one of the typically conserved aromatic residues in its PIP box, so 
I mutated the alanine residue at the 7 position of TDG’s PIP box to phenylalanine (A134F) to 
improve the PIP degron (PIP*, Figure 2.10A). TDG PIP* was destroyed much faster than 
wildtype TDG, with kinetics much closer to those of Cdt1 (Figure 2.11). Thus, an imperfect PIP 
box can still trigger CRL4Cdt2-dependent destruction, but with slower kinetics than those that 
associate with PCNA better than wildtype TDG. Improving TDG’s PIP box allowed it to access 
PCNA more efficiently despite the presence of other PCNA-binding proteins, in effect leading to 
faster destruction. Hence, CRL4Cdt2 prioritizes substrates based on their ability to associate with 
PCNA. In Xenopus egg extract, CRL4Cdt2 prefers substrates with a perfect PIP degron like Cdt1, 
but it is still capable of targeting lesser substrates during DNA repair. 
Moreover, improving the TDG PIP box led to greater ubiquitylation on DNA (Figure 2.11C, lane 
3). Addition of the short PIP box-containing peptide of p21 eliminated this ubiquitylation (Figure 
2.11C, lane 4) and that of the wildtype protein (Figure 2.11C, lane 2), indicating the 
ubiquitylation is most likely PCNA-dependent. Mutation of the conserved PIP residues 
eliminated all TDG ubiquitylation (Figure 2.11D, lane 2), and mutation of the B+4 residue led to 
decreased ubiquitylation (Figure 2.11D, lane 3). Additional mutation of the B+3 residue 
eliminated TDG ubiquitylation (Figure 2.11D, lane 4). I confirmed that mutation of the degron 
residues also stabilized TDG ΔSUMO and that improvement of the PIP box triggered its more 
rapid destruction (Figure 2.10C and data not shown). Therefore, TDG is a CRL4Cdt2 substrate 
during DNA damage in both human cells and Xenopus egg extract, but CRL4Cdt2 preferentially 
targets substrates with a perfect PIP box.
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Figure 2.11: Improving TDG’s PIP box results in faster destruction and increased 
ubiquitylation on DNA. A) MMS-damaged plasmid was added to a final concentration of 5 
ng/µL in HSS/NPE and destruction of WT TDG and TDG PIP* was monitored. B) Quantification 
of (A). TDG destruction was calculated as in Figure 2.7. Improvement of the TDG PIP box led to 
more rapid destruction, similar to Cdt1 destruction. C) Improving the TDG PIP box leads to more 
robust ubiquitylation of TDG on chromatin. Addition of a PIP box competitor peptide abolished 
ubiquitylation of both wildtype TDG and TDG PIP*. D) Mutation of TDG’s conserved PIP degron 
residues eliminates TDG ubiquitylation on DNA. Conversely, improving the PIP box improves 
ubiquitylation. The extract-specific, non-Cdt1 band detected by the Cdt1 antibody was used as a 
loading control for (A). Orc2 was used as a loading control for (C), and RPA-14 was used as a 
loading control for (D).
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Figure 2.11 (continued) 
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2.3.7 TDG destruction during S phase  
CRL4Cdt2 substrates are also destroyed during the transition into S phase. Indeed, TDG is 
destroyed during S phase in human cells (Hardeland et al., 2007) and was stabilized in 
response to siCdt2 (Figure 2.3). I therefore monitored TDG levels during DNA replication in egg 
extracts. Unlike Cdt1, wildtype TDG and TDG ΔSUMO remained stable during the course of 
DNA replication in HSS/NPE (Figure 2.12A, lanes 1-4 and D, lanes 1-4). In contrast, TDG PIP* 
and TDG ΔSUMO/PIP* were destroyed rapidly in a replication-dependent manner during DNA 
replication (Figure 2.12A, lanes 5-12 and D, lanes 5-12), showing that TDG can serve as a 
CRL4Cdt2 substrate during DNA replication in Xenopus egg extract when it can access PCNA 
through an improved PIP box.  
Though total wildtype TDG levels did not change during DNA replication in extract, it is possible 
that TDG is destroyed locally on DNA when the replication fork approaches, and failure to 
destroy TDG could generate a replication fork block because TDG binds so tightly to abasic 
sites (its catalytic product). To study the effects of TDG on DNA replication, I monitored 
replication of a plasmid containing a G-T mispair, which is the cognate substrate for TDG, in the 
presence and absence of high levels of TDG. To eliminate possible CRL4Cdt2-independent 
reduction of DNA-bound TDG, I performed these experiments using TDG ΔSUMO. TDG acted 
on this G-T mispaired plasmid substrate in a base release assay in either activity buffer or egg 
lysis buffer, which is most similar to extract buffer conditions (Figure 2.5A, lanes 6-7). However, 
TDG ΔSUMO/ΔPIP had no effect on bulk DNA replication of the plasmid containing a G-T 
mispair or on the resolution of replication intermediates, despite the fact that it should not be 
removed from DNA via SUMOylation or via CRL4Cdt2-dependent destruction (Figure 2.13A, B). I 
also looked for transient fork stalling at the site of the mispair and found no pausing above 
background levels (Figure 2.13C, D). I therefore questioned whether TDG acts on the mispair in 
Xenopus egg extract. After one hour in extract, the mispair remained unrepaired (Figure 2.13E),
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Figure 2.12: Replication-dependent TDG destruction requires an improved PIP box in 
Xenopus egg extract. A) TDG was added to extract at the start of replication (when NPE was 
added to HSS containing licensed plasmid), and TDG levels were monitored during replication. 
Wildtype TDG remained stable, while TDG PIP* was destroyed. Geminin was added to HSS to 
inhibit licensing. B) Corresponding DNA replication during the destruction assay shown in (A). 
C) Quantification of (B). D-F) The same experiment was repeated with TDG ΔSUMO. Note that 
the slight increase in DNA replication in (C) “PIP*+geminin, 10 minutes” is due to signal from the 
ΔPIP 60 minute lane and not due to actual replication. The extract-specific, non-Cdt1 band 
detected by the Cdt1 antibody was used as a loading control. In (B) and (E), RI stands for 
replication intermediates, N stands for nicked, and S stands for supercoiled. 
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Figure 2.13: High levels of TDG ΔSUMO/ΔPIP do not affect DNA replication in Xenopus 
egg extract. A) 250 nM TDG or TDG ΔSUMO/ΔPIP was added to HSS/NPE containing a 
licensed plasmid containing a G-T mispair (see Figure 2.1), and bulk replication was monitored. 
B) Quantification of (A). C) Approach used to monitor for transient stalling triggered by TDG at 
the site of the G-T mispair. The mispaired plasmid was digested with PvuII, as in Figure 2.1. D) 
Transient fork stalling was monitored with a sequencing gel that measures accumulation of the 
nascent strand at various lengths. TDG did not affect fork progression.  
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lanes 5-9) and did not generate an abasic site (Figure 2.13F, lanes 3-6) in extract despite the 
extremely high TDG concentration that triggers base hydrolysis in the standard activity buffer 
and ELB (Figure 2.5A, lanes 6-7). Experiments addressing TDG activity must be expanded and 
repeated to be conclusive, but this preliminary data suggests that a redundant mechanism might 
restrict TDG access to or activity on DNA during replication in Xenopus egg extract, even when 
TDG is presented with its cognate DNA substrate. In summary, I have found that failure of 
CRL4Cdt2 to trigger destruction of TDG does not lead to replication defects, but I cannot rule out 
a role for CRL4Cdt2 in preventing TDG-dependent problems in the absence of unidentified forms 
of TDG regulation. 
2.3.8 Checkpoint signaling is not required for TDG destruction 
In egg extract, Xenopus TDG requires an improved PIP box for S phase-specific proteolysis, 
while in tissue culture, human TDG is destroyed despite its imperfect degron. I reasoned that 
checkpoint signaling, one major difference between the nuclear environments of Xenopus egg 
extract and human cells, might be necessary for TDG destruction. In response to damaged DNA, 
Xenopus egg extract mounts a checkpoint response that is not present during DNA replication 
(Clute and Masui, 1997; Conn et al., 2004; Dasso and Newport, 1990; Hensey and Gautier, 
1998; Kappas et al., 2000; Kimelman et al., 1987; Kumagai and Dunphy, 1999; Kumagai et al., 
1998). Thus, I inhibited checkpoint signaling with caffeine during DNA repair and monitored 
TDG levels. Damage-dependent TDG ΔSUMO destruction did not change upon the addition of 
caffeine, despite diminished ATR checkpoint signaling as measured by Chk1 phosphorylation 
(Figure 2.14, compare lanes 5-8 to lanes 1-4).  TDG ΔSUMO/ΔPIP was stable regardless of the 
presence of caffeine (Figure 2.14, lanes 9-14). Therefore, TDG destruction does not require 
checkpoint signaling, and differences in checkpoint signaling between S phase human cells and 
replicating Xenopus egg extract do not explain the CRL4Cdt2 requirement for an improved TDG 
PIP box in Xenopus egg extract.
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Figure 2.14: TDG proteolysis does not require checkpoint signaling. 3 mM caffeine was 
added to inhibit ATR, ATM, and DNA-PKCS activity during DNA repair. TDG destruction occurred 
normally in the presence of caffeine. The extract-specific, non-Cdt1 band detected by the Cdt1 
antibody was used as a loading control.
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2.3.9 The physiological relevance of CRL4Cdt2-dependent TDG destruction 
Another possible explanation for the differences in S phase-specific proteolysis between 
Xenopus egg extract and human cells is that CRL4Cdt2-dependent TDG proteolysis is 
developmentally regulated. Since TDG is maintained at very low levels until mid-gastrulation in 
developing embryos (Figure 2.4E) we reasoned that CRL4Cdt2 might not destroy TDG until later 
in development, when TDG is normally present. Only after CRL4Cdt2-dependent TDG proteolysis 
becomes active would we expect the degron mutant to cause problems that wildtype TDG does 
not. In mice, the essential role of TDG is related to its function in DNA demethylation. Mice 
lacking TDG suffer from aberrant DNA methylation and repression of genes involved in tissue 
differentiation (Cortázar et al., 2011; Cortellino et al., 2011). Moreover, forced TDG recruitment 
to specific genes leads to localized demethylation (Gregory et al., 2012). I therefore rationalized 
that failure to destroy TDG during S phase could cause aberrant demethylation of certain genes, 
which in turn might induce epigenetic changes and affect embryonic development. To study this 
possibility, I microinjected each cell of Stage 2 Xenopus embryos with either wildtype TDG or 
TDG ΔPIP mRNA and monitored them at different stages of development. 
As expected, embryos injected with wildtype TDG mRNA contained more TDG than uninjected 
controls, and protein levels steadily increased throughout early development (Figure 2.15A, 
compare lanes 1-4 to lanes 9-12). Levels of wildtype TDG and TDG ΔPIP protein were similar 
during the early cleavage divisions (wildtype and ΔPIP levels are identical at Stage 6 in Figure 
2.15A, compare lanes 5 and 9). However, after the blastula stage, TDG ΔPIP accumulated to 
much higher levels than wildtype TDG (Figure 2.15A, compare lanes 6-8 to lanes 10-12). Given 
that the microinjected RNA is identical except at the mutated nucleotides encoding PIP box 
residues and that a PIP box has not been shown to affect translation, it is unlikely that this
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Figure 2.15: TDG ΔPIP is stabilized in X. laevis embryos after the early cleavage divisions 
but does not affect development. A) Embryos microinjected with TDG mRNA were harvested 
and lysed at the stages indicated. Embryos injected with wildtype TDG mRNA express similar 
levels of TDG protein as embryos injected with an equivalent amount of TDG ΔPIP at N-F Stage 
6. TDG ΔPIP accumulates to much higher levels than WT TDG by early gastrulation (N-F Stage 
10). WT TDG-injected embryos express higher TDG levels than uninjected controls. PCNA was 
used as a loading control. B) Embryos were microinjected as in (A) and monitored for 
developmental defects. Embryos expressing TDG ΔPIP developed normally into the tadpole 
stages despite accumulation of degron-mutant TDG.  
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accumulation is due to differences in RNA translation. Instead, this accumulation is consistent 
with a failure to destroy TDG ΔPIP at times when wildtype TDG is destroyed, suggesting that 
TDG becomes a CRL4Cdt2 substrate during normal cell cycles in developing Xenopus embryos 
some time between the blastula and early gastrula stages. Benjamin Morris of the Walter lab 
plans to confirm that injected mRNA levels were equal between WT TDG and TDG ΔPIP 
through qPCR in the future. 
I closely followed the development of microinjected embryos from fertilization into the tadpole 
stage. However, I observed no developmental defects, despite a large excess of TDG ΔPIP 
over TDG WT, indicative of a failure to destroy TDG during S phase (Figure 2.15B, showing the 
animal and vegetal poles of single embryos from stages 10-20). Therefore, CRL4Cdt2-dependent 
TDG proteolysis is not required for normal X. laevis development through the early tadpole 
stage. It is possible that TDG proteolysis is required for later development, but injected mRNAs 
only persist in embryos for approximately two days (Blitz et al., 2006). Although the TDG ΔPIP 
protein is stable during S phase, it will not persist indefinitely, as proteins are ultimately turned 
over regardless of cell cycle-specific proteolysis. Therefore, we cannot use this approach to 
study the effects of stabilizing TDG during later developmental stages. 
I have now identified two new forms of TDG regulation: 1) TDG abundance is regulated at the 
translational or post-translational level early in development, since mRNA levels are high even 
in the unfertilized egg, but protein levels are very low; and 2) TDG is a CRL4Cdt2 substrate during 
DNA repair in egg extract and during normal cell cycles of X. laevis embryos after the blastula 
stage. Additionally, previous reports have shown that SUMOylation, acetylation, and 
phosphorylation control the access of TDG to DNA (Baba et al., 2005; Hardeland et al., 2002; 
Mohan et al., 2010; Smet-Nocca et al., 2011). With so many different types of regulation to 
restrict TDG’s access to DNA, I reasoned that TDG must be detrimental to DNA replication or 
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negatively affect another S phase-specific process. However, I could not identify any replication 
or developmental defects upon stabilizing TDG. 
2.4 Discussion  
In recent years, TDG has emerged as a key player not only in DNA repair but also in regulating 
epigenetic inheritance through demethylation. TDG is an essential gene, likely due to its role in 
regulating DNA methylation, and several theories have emerged as to how TDG contributes to 
establishing and maintaining methylation patterns on DNA. Several forms of TDG regulation 
have been discovered: 1) SUMOylation facilitates TDG turnover on DNA, 2) both acetylation 
and phosphorylation regulate its access to DNA, and 3) S phase-specific proteolysis eliminates 
TDG during DNA replication. I have identified new mechanisms of TDG regulation. I found that 
TDG is destroyed in a DNA damage-, proteasome-, Cdt2-, PCNA-, and PIP-degron-dependent 
manner in Xenopus egg extract, making it a bona fide CRL4Cdt2 substrate. Regulation by 
CRL4Cdt2, which targets its substrates for destruction during both DNA repair and DNA 
replication, explains S phase-specific TDG proteolysis that has been previously reported. 
However, during the rapid cell cycles during early cleavage divisions and in Xenopus egg 
extract, TDG required an improved degron to be destroyed in S phase. Nonetheless, a wildtype 
PIP degron was sufficient to prevent aberrant accumulation of TDG after the early cleavage 
divisions during Xenopus development, suggesting that CRL4Cdt2 begins to target TDG during 
normal cell cycles in the blastula or early gastrula stages. Before the early gastrula stages, TDG 
levels are also regulated through another undefined pathway that limits protein expression 
despite relatively high mRNA levels. 
Somewhat surprisingly, I found no detrimental effects of stabilizing TDG on DNA replication or 
development in Xenopus. One possibility is that another redundant mechanism regulates TDG, 
so the effect of stabilizing TDG was masked in our experiments. In the case of the well-
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characterized CRL4Cdt2 substrate Cdt1, multiple redundant pathways regulate its activity after 
initiation of DNA replication. Defects in replication (re-replication, in the case of Cdt1) only occur 
when more than one regulatory pathway is compromised. It is therefore possible that unknown 
redundant pathways prevent TDG from acting on DNA during replication, and TDG only causes 
defects during S phase if TDG overcomes other regulators. 
All known substrates of CRL4Cdt2 are in some way toxic during S phase (Havens and Walter, 
2011), but failure to destroy TDG had no effect on progression through replication. However, 
recombinant TDG is not active in extract on its cognate substrate, a G-T mispair, at a 
concentration where it is active in multiple buffer conditions, suggesting that another unknown 
form of regulation might restrict it from DNA or block its activity in egg extract. It is possible that 
eliminating CRL4Cdt2-dependent regulation in addition to other unknown forms of regulation 
would affect DNA replication. At this point, I can only speculate as to why TDG is destroyed 
during S phase. High overexpression of TDG (20-30-fold) causes S phase arrest in 293T cells, 
and such high overexpression blocks cell proliferation (Hardeland et al., 2007). It is possible that 
product-inhibited TDG, which binds tightly to an abasic site, causes replication blocks that 
cannot be resolved in S phase. We have several theories as to why TDG destruction would be 
evolutionarily favorable. For example, TDG cannot distinguish the parental strand from the 
nascent strand during replication, so its destruction would allow the mismatch repair system 
sole access to G-T mispairs that arise due to replication error. Mismatch repair is better 
equipped to handle mistakes during replication because it can discern the newly synthesized 
DNA strand. If we can uncover conditions that support TDG activity in egg extract, we can easily 
test this theory by monitoring the effect of TDG on the error rate during replication, especially in 
CpGs. 
Alternatively, the presence of TDG on DNA during replication could disrupt epigenetic 
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inheritance by interfering with proper DNA methylation or demethylation in S phase. In support 
of this idea, the putative PIP degron sequence is highly conserved throughout higher eukaryotes 
that regulate epigenetic inheritance through DNA methylation. It is absent from organisms that 
display low or no DNA methylation, like Drosophila (Figure 2.2 and Cortázar et al., 2007). TDG 
homologues in lower eukaryotes cannot process thymine or 5-methylcytosine derivatives and do 
not contain a PIP box (Hardeland et al., 2003). In mice, the essential role of TDG is likely related 
to its function in epigenetic regulation (Cortázar et al., 2011; Cortellino et al., 2011), so its 
destruction could be necessary to grant another pathway control over proper inheritance of DNA 
methylation during S phase without interference from TDG. Again, if we can develop conditions 
that support TDG activity in egg extract, we can test this theory by adding methylated DNA and 
monitoring its methylation state and the methylation state of the nascent strand during DNA 
replication. 
TDG acts on mispairs that arise from modification of cytosine and 5meC by other proteins, 
including activation-induced deaminase (AID) and Tet proteins. Cells also contain another G-T 
specific glycosylase, MBD4, that associates with methylated DNA in heterochromatin regions 
(Sjolund et al., 2012). During DNA replication, heterochromatin must decondense to allow 
passage of replication forks. It is possible that during DNA replication, TDG could gain aberrant 
access to these regions normally maintained by MBD4, triggering aberrant demethylation and 
activation of silent genes. CRL4Cdt2 might be one of multiple redundant mechanisms that restrict 
TDG access to these regions. 
Finally, regardless of the identification of defects due to TDG stabilization, the knowledge that 
TDG is a CRL4Cdt2 substrate can be applied to the medical field. TDG is responsible removal of 
5-fluorouracil (5-FU) from DNA by BER (Cortázar et al., 2007; Hardeland et al., 2000; 2003; 
Kunz et al., 2009). 5-FU is a widely used chemotherapeutic drug; it is one of the primary 
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treatments for colorectal and breast cancers (Longley et al., 2003). Upon entry into cells, 5-FU 
is converted to a number of different metabolites that cause S phase arrest and could potentially 
trigger cancer cell death in several ways. 5-FU inhibits thymidylate synthase, in effect causing 
decreased thymidine levels and increased uracil levels (Longley et al., 2003). This not only 
impairs DNA replication but also leads to frequent misincorporation of both uracil and 5-FU into 
DNA. Because our understanding of 5-FU action is vague and 5-FU is so frequently used in 
cancer treatment, understanding what factors contribute to 5-FU resistance and sensitivity is 
important to improve cancer treatment in the future.  
A recent study found that TDG is important for 5-FU sensitivity in mouse embryonic fibroblasts 
and HeLa cells (Kunz et al., 2009). Cells lacking TDG had much higher survival rates upon 
treatment with the drug, and cells expressing additional TDG showed greater sensitivity (Kunz 
et al., 2009). It is possible that by acting on so many 5-FU lesions, TDG and the BER pathway 
cause an irreparable number of DNA nicks that lead to double-stranded breaks when they are in 
close proximity to each other. Though these experiments must be repeated in the cell lines of 
cancers typically treated with 5-FU to confirm medical relevance, the link between TDG and 5-
FU sensitivity is promising. If the relationship is confirmed, then stabilizing TDG in patients 
undergoing 5-FU treatment could allow for lower doses of the drug and decreased resistance. 
The new knowledge that TDG is a CRL4Cdt2 substrate adds the possibility of modifying an 
existing cancer drug regimen to maximize 5-FU sensitivity. A general CRL inhibitor, MLN4924 
(Millennium Pharmaceuticals), is currently in clinical trials as a chemotherapeutic agent 
(information publicly available from the National Cancer Institute). MLN4924 inhibits the 
activation of all cullin ring ligases, in effect preventing proteolysis during many cellular 
processes (Soucy et al., 2009). MLN4924 would therefore be expected to stabilize TDG through 
inhibition of CRL4Cdt2. Therefore, combination therapy with 5-FU could be a successful cancer 
treatment regimen. This possibility could easily be tested in human cells.
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Chapter 3  
 
How the homotrimeric nature 
of PCNA contributes to 
CRL4Cdt2 function
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3.1 Introduction 
Unlike other ubiquitin ligases, CRL4Cdt2 functions specifically during DNA replication and 
repair to downregulate many proteins whose presence in S phase is detrimental. The 
best-characterized substrate of CRL4Cdt2 is Cdt1 (Jin et al., 2006), which functions to 
recruit the replicative MCM2-7 helicase during origin licensing. After cells progress into S 
phase, Cdt1 activity could facilitate detrimental origin licensing on regions of the genome 
that have already been replicated (Arias and Walter, 2005). For this reason, CRL4Cdt2 
marks Cdt1 for destruction upon entry into S phase. CRL4Cdt2 also targets Cdt1 for 
destruction in response to DNA damage, though the reasons are unclear (Hu et al., 
2004).  
CRL4Cdt2 substrates must bind PCNA through their PIP boxes (Figure 1.2) to become 
degradation targets (Arias and Walter, 2006), but CRL4Cdt2 does not target all PIP box-
containing proteins for destruction; in fact, most PCNA-interacting proteins are stable 
when bound to PCNA. All known CRL4Cdt2 substrates contain a basic residue four amino 
acids downstream of the PIP box (the B+4 position relative to the PIP box). This 
sequence contributes to a “PIP degron.” (Havens and Walter, 2009). PCNA-interacting 
proteins whose stability is not regulated by CRL4Cdt2 do not contain a complete PIP 
degron (Chapter 1, Figure 1.2). The binding surface CRL4Cdt2 includes residues on both 
the substrate and on DNA-bound PCNA (Chapter 1, Figure 1.2 and Havens and Walter, 
2009).  
CRL4Cdt2 detects its substrates only when they are bound to PCNA loaded on DNA. 
Residues on both PCNA and on the substrate itself recruit Cdt2, the putative substrate 
specificity factor for the ubiquitin ligase (Havens and Walter, 2009; Havens et al., 2012). 
Our current model envisions that a substrate binds one monomer of DNA-bound PCNA 
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via its PIP box, and the substrate-PCNA complex then recruits CRL4Cdt2 (Chapter 1, 
Figure 1.3A). Interestingly, a recent report from the Yew lab suggests that Cdt2 can bind 
PCNA directly, independently of its substrate (Kim et al., 2010). It is therefore possible 
that within the PCNA homotrimer, Cdt2 contacts two subunits: one via direct contacts 
with the substrate-IDCL complex and another through direct contacts between Cdt2 and 
an IDCL of an adjacent PCNA subunit (Chapter 1, Figure 1.3B). This second model 
predicts that CRL4Cdt2 can only function with PCNA that has at least two wildtype 
subunits with intact IDCLs. 
Because of the observation from the Yew lab that Cdt2 binds PCNA independently of its 
substrate (Kim et al., 2010), I am particularly interested in determining whether the “tool 
belt” model applies during CRL4Cdt2 function. The tool belt model for PCNA function—in 
which PCNA binds three separate proteins through its three separate subunits to allow 
for rapid exchange of DNA replication and repair proteins as they are needed on DNA—
is widely referenced and accepted in the field (Freudenthal et al., 2011; Indiani et al., 
2005; Sutton, 2010; Zhuang and Ai, 2010). However, there has been no way to 
distinguish this model from other models, like the “dynamic hand-off model” (Prosperi, 
2006) because replacement of individual PCNA subunits within the homotrimeric ring 
has not been possible.  
Here, I address how many functional PCNA subunits are required for CRL4Cdt2 function 
and DNA replication. I generated a single chain polypeptide in which all three PCNA 
subunits are connected through flexible linker sequences (“single chain PCNA,” or 
PCNASC), and determined how multiple IDCLs on PCNA contribute to CRL4Cdt2 function. 
I found that a single IDCL was sufficient for modest destruction of the well-characterized 
CRL4Cdt2 substrate Cdt1, but two separate IDCLs were necessary to support complete 
Cdt1 destruction. I was unable to determine whether this observation is due to 
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decreased substrate binding sites on PCNASC with only one wildtype IDCL or due to a 
requirement for multiple functional subunits on the same PCNA trimer for CRL4Cdt2 
function. Additionally, I found that a single subunit is sufficient for leading strand 
elongation, suggesting that the tool belt model does not apply for this process. 
Implications and future use of this new molecular tool, PCNASC, are discussed. 
3.2 Materials and Methods 
Sperm chromatin, HSS, and MMS-damaged DNA were prepared as described above 
(Chapter 2). Damaged linear, bead-bound DNA was also prepared and recovered as 
described above (Chapter 2). MMS damaged plasmid was used at 10 ng/µL in this 
chapter. 
3.2.1 Additional Xenopus egg extract methods 
To make LSS (modified from Blow, 1993), eggs were harvested and dejellied in 2.2% 
cysteine, pH 7.8 containing 1 mM ethylene glycol tetraacetic acid (EGTA; Sigma). Eggs 
were washed three times in Barth solution (88 mM NaCl, 2 mM KCl, 1 mM MgCl2, 0.5 
mM CaCl2, 15 mM Tris pH 7.4) and activated with the addition of the calcium ionophore 
A23187 (2 µg/mL; Sigma). After activation, A23187 was washed away with additional 
washes in Barth solution. Eggs were then washed thoroughly in chilled extraction buffer 
(50 mM KCl, 5 mM MgCl2, 2 mM DTT, 50 mM sucrose, 50 mM HEPES-KOH pH 7.6) and 
packed via centrifugation at 1100 rpm in an IEC CL2 tabletop centrifuge. Crude extract 
was then prepared by centrifugation in a Sorvall SB6 rotor as for crude S phase extract 
and supplemented with cycloheximide (50 µg/mL), DTT (1 mM), aprotinin (10 µg/mL), 
leupeptin (10 µg/mL), and cytochalasin B (2.5 µg/mL). This extract was diluted 10-15% 
with extract dilution buffer (EDBS; 50 mM KCl, 2 mM DTT, 0.4 mM MgCl2, 0.4 mM EGTA, 
10% sucrose, 50 mM HEPES-KOH, pH 7.6, 1 µg/mL aprotinin, 1 µg/mL leupeptin). 
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Extract was cleared by centrifugation at 30,000 rpm in an SW41 rotor (Beckman) for 40 
minutes. Lipids were removed and LSS was harvested, leaving the mitochondrial layer 
behind. LSS was filtered through a nitex membrane and frozen in liquid nitrogen before 
storing at -80°C in single use aliquots. 
3.2.2 Plasmid construction, mutagenesis, and protein purification 
Human PCNASC was generated in a multistep process. PCNA is highly conserved 
between Xenopus and humans, and human PCNA was previously used to study PCNA 
function in Xenopus egg extract (Arias and Walter, 2006; Havens and Walter, 2009; 
Havens et al., 2012). First, the PCNA gene (Arias and Walter, 2006), along with DNA 
encoding a Prescission Protease cleavage site 5’ to the PCNA gene and the desired 
linker sequences 3’ to the PCNA gene, was inserted into a pET28 vector using the 
primers 5’-AAAACATATGCTCGAAGTGTTGTTCCAAGGGCCCGAATTCGAGGCGCG 
CCTGGTCCAGG-3’ and 5’-TTTTCTCGAGTTTGCTAGCTTTGGATCCGTTGGACTGC 
GAATTAGATCCTTCTTCATCCTCGATCTTGGG-3’ paired with restriction enzyme 
digest with NdeI (NEB) and XhoI (NEB). Restriction enzyme recognition sites are 
underlined. The two linker sequences were nearly identical on the amino acid level 
(peptide linker #1=NSQSNGSGA, peptide linker #2=NSQASNSGA, differences are 
italicized). These linker sequences were chosen based on previous construction of yeast 
single chain PCNA (McNally et al., 2010). DNA encoding the first linker sequence 
contains a BamHI (NEB) restriction enzyme recognition site, and that of the second 
linker site contains a NheI (NEB) recognition site (underlined in primer sequences). 
Second, individual wildtype PCNA or pcna-79 genes were amplified from constructs 
previously published (Arias and Walter, 2006) with primers containing the corresponding 
restriction enzyme sites for insertion between the two linkers or between the linker and 
the stop codon: 5’-AAAAGGATCCGGAGCATTCGAGGCGCGCCTGGTC CAGGGC-3’ 
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and 5’-TTTTGCTAGCCTGGCTGTTAGATCCTTCTTCATCCTCGAT CTTGGG-3’ or 5’-
AAAAGCTAGCAACAGTGGCGCATTCGAGGCGCGCCTGGTCC AGGGC-3’ and 5’-
TTTTCTCGAGGTATACCTAAGATCCTTCTTCATCC TCGATCTTGGG-3’. Again, 
restriction enzyme recognition sites are underlined. The second and third PCNA 
subunits were inserted through restriction enzyme digest and ligation. Importantly, any 
mutagenesis of an individual subunit must be performed on the monomeric PCNA 
construct, not in the context of PCNASC, since the PCNA-coding region of each subunit 
within the PCNASC construct is identical. 
PCNASC expression was induced at 18°C overnight in BL21(DE3) cells with 0.5 mM 
IPTG. Cells were lysed via sonication in lysis buffer containing 300 mM NaCl, 10% 
sucrose, 5 mM imidazole, 5 mM β-mercaptoethanol, 50 mM Tris, pH 8, and protease 
inhibitors. After clearing the lysate at 30,000xg, the soluble fraction of PCNASC was 
bound to Ni-NTA beads for 1 hour. Beads were washed with lysis buffer containing 20 
mM imidazole and applied to an empty mini protein purification column (Biorad). Beads 
were additionally washed with 30 volumes of lysis buffer containing 20 mM imidazole 
and then eluted in buffer containing 500 mM imidazole and protease inhibitors 0.5 mM 
PMSF, 1 mM benzamidine, 10 µg/mL aprotinin, 10 µg/mL leupeptin. Elution fractions 
containing the most PCNASC were combined. The His tag was cleaved with Prescission 
Protease during dialysis into buffer containing 50 mM NaCl, 10% glycerol, 1 mM DTT, 1 
mM EDTA, and 50 mM Tris, pH 7.5. The presence of protease inhibitors did not prevent 
His tag cleavage by Prescission Protease. The resulting protein preparation was 
concentrated using concentrator columns (Millipore). In extract, PCNASC was added to a 
final concentration of 150 ng/µL (5 µM each subunit) unless otherwise indicated. 
Expression and purification of monomeric PCNA has been previously described (Arias 
and Walter, 2006): PCNA expression was induced at 37°C for 4 hours in BL21(DE3) 
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cells with 0.5 mM IPTG. Cells were lysed via sonication in the same lysis buffer used for 
PCNASC. After clearing the lysate at 30,000xg, the soluble fraction of PCNA was bound 
to Ni-NTA beads for 1 hour. Beads were washed with lysis buffer containing 50 mM 
imidazole and applied to an empty mini protein purification column (Biorad). Beads were 
additionally washed with 30 volumes of lysis buffer containing 100 mM imidazole and 
then eluted in lysis buffer containing 500 mM imidazole. The His tag was cleaved with 
Prescission Protease during dialysis into buffer containing 50 mM NaCl, 10% glycerol, 1 
mM DTT, 1 mM EDTA, and 50 mM Tris, pH 7.5. The resulting protein preparation was 
concentrated using concentrator columns (Millipore). 
Cdt11-243 was generated previously by Dr. Courtney Havens (Havens and Walter, 2009). 
3.2.3 Immunological methods 
Antibodies for immunoblotting (Human/Xenopus PCNA and Xenopus Cdt1, Cdt2, Orc2, 
and MCM7) are described above (Chapter 2). The GST antibody was purchased from 
Santa Cruz. A previously described polyclonal PCNA antibody (Kochaniak et al., 2009) 
was used to immunodeplete endogenous PCNA from HSS or LSS. Depletions were 
performed using a 3:1 ratio of PCNA antibody prebound to Protein A Sepharose 
Fastflow resin (Amersham Biosciences). Antibody-bound resin was used at a 1:5 ratio of 
resin to egg extract. HSS was depleted in three one-hour rounds at 4°C, and LSS was 
depleted in two one-hour rounds at 4°C. 
3.2.4 Recovery of His-tagged proteins from extract 
His-tagged proteins and their interacting partners were recovered with Ni-NTA beads in 
interaction buffer (5 µL beads per 25 µL sample; 100 mM NaCl, 5 mM MgCl2, 10% 
glycerol, 0.1% NP-40, 200 mM Tris, pH 8). Proteins were first incubated in extract or 
ELB for 30 minutes. Beads were bound to protein for 1 hour at 4°C and then washed 
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three times with interaction buffer containing increasing concentrations of imidazole (0, 5, 
and 20 mM). Bound proteins were eluted in 2x SDS-PAGE sample buffer. 
3.2.5 DNA replication assays in Xenopus egg extract (HSS and LSS) 
Replication assays were carried out according to the methods outlined for NPE (Chapter 
2) with the exception that there was no separate licensing step. The DNA (15 ng/µL M13 
mp18 ssDNA (NEB) for primer extension in HSS and demembranated sperm chromatin 
for replication in LSS) was added directly to extract containing α32P-dATP. Reactions 
were stopped at the desired time points, and the reaction products were visualized as 
described above (Chapter 2). 
3.3 Results 
3.3.1 The role of the Cdt2 C-terminal PIP box during CRL4Cdt2 function 
Recent data suggest that Cdt2 contacts more than one PCNA subunit (Kim et al., 2010). 
Indeed, Dr. Courtney Havens, a previous post-doctoral fellow in the Walter lab, identified 
a highly conserved PIP box in the C-terminus of Cdt2 (Figure 3.1). To determine whether 
Cdt2 must interact with an unoccupied subunit of PCNA in order to target its substrates 
for destruction, we took two different approaches: Havens mutated the PIP box of Cdt2 
and determined its effect on Cdt1 destruction, and I generated a single chain PCNA 
trimer (PCNASC) that contains one wildtype subunit and two IDCL mutant subunits 
connected through a flexible linker. 
Mutation of the putative Cdt2 PIP box had minimal effects on Cdt1 or Set8 ubiquitylation 
and destruction (Cdt1 destruction shown in Figure 3.2A, ubiquitylation shown in Figure 
3.2B), but it had a substantial effect on stable Cdt2 recruitment to chromatin (Figure 3.2B, 
compare to C). These data suggest that CRL4Cdt2 function does not require direct 
contact between the Cdt2 PIP box and the IDCL of a PCNA subunit despite improved 
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Figure 3.1: Cdt2 contains a PIP box in its C-terminus. The conserved PIP box and 
PIP degron residues are shown at the top. The putative C-terminal PIP box of Cdt2 is 
shown across several species and compared to the human PIP boxes of confirmed 
CRL4Cdt2 targets and stable PCNA binding proteins. Ψ represents any hydrophobic 
residue (I/L/V/M), and θ represents any aromatic residue (Y/F/W). Residues shown in 
green are part of the conserved PIP box, and residues shown in blue additionally 
contribute to the “PIP degron.”
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Figure 3.2: Mutation of Cdt2’s putative PIP box results in decreased Cdt2 
association with chromatin but does not affect substrate destruction. The data in 
this figure was generated by Dr. Courtney Havens, a previous post-doctoral fellow in the 
Walter lab. A) Cdt2 was immunodepleted and replaced with wildtype Flag-Cdt2 or Flag-
Cdt2 ΔPIP. Bulk Cdt1 destruction was monitored. B) Chromatin-associated Cdt2 and 
Cdt1 are shown. Cdt11-243 was optionally added because it does not associate with 
chromatin through Orc. Its association with depends only on association with PCNA. C) 
Cdt2 in total extract for the experiment shown in (B).
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PIP box-dependent Cdt2 association, at least for the well-characterized substrates Cdt1 
and Set8. However, the secondary contact could be necessary for destruction of weaker 
substrates that have not been tested. Also, this mutation analysis alone may not reveal 
whether Cdt2 associates with a PCNA subunit that is distinct from the substrate-bound 
PCNA subunit, as mutation of the putative PIP box might not be sufficient to eliminate 
interaction with PCNA. Because mutation of the Cdt2 PIP box affected stable Cdt2 
recruitment to chromatin but did not affect substrate ubiquitylation or destruction, this 
result is consistent with some direct Cdt2 contact with PCNA. However, the biological 
relevance of this contact is not clear and may not be related to CRL4Cdt2 function. 
3.3.2 Characterization of a single chain PCNA polypeptide 
I generated a single chain PCNA trimer (PCNASC) in which the three subunits of PCNA 
are fused into a single polypeptide via flexible sequences of amino acids (McNally et al., 
2010) (Figure 3.3). I then mutated the IDCL (depicted in detail in Figure 1.2, shown as a 
notch in Figure 3.3A) in one, two, or three subunits to establish how many PIP box 
interaction sites are required for PCNA function during CRL4Cdt2-dependent 
ubiquitylation and other PCNA-dependent processes. Changing the number of PIP box 
binding sites on each PCNA trimer allows us to ask whether an IDCL other than the one 
contacted by the substrate is required for CRL4Cdt2 activity. The IDCL mutation, 
designated pcna-79, eliminates interaction between PCNA and multiple conserved PIP 
box residues, and it inhibits DNA Polymerase δ binding in yeast (Eissenberg et al., 1997). 
Here, I will refer to each individual subunit within PCNASC as either wildtype (WT) or 
pcna-79 (79) (Figure 3.3A). If Cdt2 or another protein must bind to a separate IDCL on 
PCNA for CRL4Cdt2 function, then neither PCNASC(79-79-79) nor PCNASC(wt-79-79) 
should support Cdt1 destruction because they do not allow multiple PIP box-containing 
proteins to bind at the same time. 
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Figure 3.3: PCNASC constructs used in this work. A) Three PCNA monomers were 
attached through flexible linker sequences described in Materials and Methods (3.2.2) 
and shown here. One, two or three PCNA subunits were mutated to eliminate their ability 
to interact with PIP box-containing proteins. The mutation was designated pcna-79 
based on the mutagenesis screen that identified it (Eissenberg et al., 1997). A functional 
IDCL is portrayed as a notch in a single PCNA subunit. B) Individual PCNASC 
preparations. PCNASC contains a number of non-specific contaminants that are not 
detected by the PCNA antibody. 
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I first characterized PCNASC in our extract systems. To study CRL4Cdt2-dependent 
destruction, we usually use HSS (see Chapter 1). When supplemented with methylated 
DNA damaged by guanine methylation, HSS supports nucleotide excision repair (NER), 
the last step of which is PCNA-dependent gap filling. Thus, addition of methylated 
(MMS-damaged) DNA leads to CRL4Cdt2-dependent destruction of its substrates (Jin et 
al., 2006). To characterize PCNASC in HSS, I immunodepleted endogenous PCNA and 
replaced it with PCNASC. I observed that PCNASC binds chromatin (Figure 3.4A, lanes 1-
4), and an excess of the PIP box peptide of p21 (described in Chapter 2) inhibited 
loading (Figure 3.4, lanes 5-8). This outcome was expected because the PCNA clamp 
loader, replication factor C (RFC), must bind the IDCL to load PCNA onto DNA through 
its PIP box (Oku et al., 1998). A PIP box peptide in which the conserved PIP box 
residues have been mutated to alanine did not affect PCNASC association with chromatin 
(Figure 3.4, lanes 9-12).  
To study PCNA-dependent DNA replication in HSS, we used a primer extension assay. 
In this assay, Polα/primase primes a single-stranded plasmid template, and the 
replicative polymerases Polδ and Polε extend the primer in a PCNA-dependent manner, 
much like leading strand synthesis during chromosomal replication. Both PCNASC and 
wildtype PCNA supported this type of replication in HSS (Figure 3.4B, C). Most 
importantly for studying CRL4Cdt2-dependent destruction, PCNASC supported destruction 
of Cdt1 in the presence of damaged plasmid or damaged linear DNA, though it was 
somewhat slower than destruction triggered by wildtype PCNA (Figure 3.4D, compare 
lanes 11-14 to lanes 1-4). Finally, to confirm that in the presence of PCNASC the 
destruction of Cdt1 followed the established rules for CRL4Cdt2-dependent proteolysis, I 
compared destruction of wildtype Cdt1 to Cdt1 lacking the critical B+4 residue and saw 
stabilization of the mutant, as expected (Figure 3.4E). Together, these data show that  
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Figure 3.4: PCNASC is functional in HSS. A) PCNASC associates with DNA in an IDCL-
dependent manner. PIP box peptide was added to a final concentration of 100 µM. 
Chromatin spin downs were performed with 250 mM KCl. B) PCNASC rescues PCNA-
dependent primer extension on a single-stranded plasmid template in HSS. Replication 
of a single-stranded M13 plasmid was monitored. C) Quantification of (B). D) PCNASC 
promotes CRL4Cdt2 function as measured by Cdt1 destruction, albeit slower than 
wildtype monomeric PCNA. The asterisk (*) indicates a non-specific band due to 
contaminants in the PCNASC prep. An extract-specific, non-Cdt1 band detected by the 
Cdt1 antibody is shown as a loading control. E) Cdt1 destruction triggered by PCNASC 
depends on a PIP degron. Cdt11-243 cannot associate with ORC and is therefore 
completely dependent on PCNA for its association with DNA. 
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Figure 3.4 (continued) 
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PCNASC can replace endogenous PCNA in HSS, and that we can use PCNASC to study 
a number of PCNA-related events in HSS, including CRL4Cdt2-dependent protein 
destruction. 
I next tested whether PCNASC can substitute for wildtype PCNA, assembled of three 
individual PCNA monomers, during chromosomal replication and Cdt1 destruction in 
LSS. However, after depleting endogenous PCNA from LSS, I could not rescue 
chromosomal DNA replication or replication-dependent Cdt1 destruction under 
conditions where wildtype monomeric PCNA rescued both (Figure 3.5A, B, compare 
lanes 12-15 to lanes 1-4). One possible explanation for the failure of PCNASC to support 
chromosomal replication and Cdt1 destruction in LSS is that unlike wildtype PCNA, 
PCNASC fails to enter the nucleus. Though the linker sequences in PCNASC did not alter 
the PCNA nuclear localization sequence (NLS) (Kim and Lee, 2012), PCNASC is much 
larger than each PCNA monomer and might therefore require attachment of a different 
NLS to function in LSS. First, I looked at whether PCNASC could enter the nucleus and 
interact with sperm chromatin. I was able to recover PCNASC from the chromatin-
associated fraction in a traditional chromatin spin down experiment (Figure 3.5C, lane 
11). To ensure this association did not take place during the spin down itself, I performed 
two important controls: 1) I performed a chromatin spin down at the start of the reaction, 
before nuclei are expected to form, and found that PCNASC did not associate noticeably 
with sperm chromatin (Figure 3.5C, lane 9); and 2) I omitted Triton from the spin down to 
prevent permeabilization of the nucleus, and I still recovered PCNASC (Figure 3.5C, lane 
10). These results suggest that PCNASC can enter the nucleus and associate with sperm 
chromatin. In the presence of PCNASC, the association between endogenous PCNA and 
chromatin also became undetectable, suggesting that PCNASC competes with 
endogenous PCNA for chromatin loading (Figure 3.5C, compare lanes 9-11 to lanes 1-3). 
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Figure 3.5: PCNASC does not rescue PCNA depletion in LSS. A) Wildtype monomeric 
PCNA but not PCNASC supports chromosomal DNA replication in LSS. B) Wildtype 
monomeric PCNA, but not PCNASC supports Cdt1 destruction during replication in LSS. 
An extract-specific, non-Cdt1 band detected by the Cdt1 antibody is shown as a loading 
control. C) PCNASC associates with sperm chromatin in LSS. Triton X-100 was omitted 
in some samples to compare the total nuclear PCNASC (no Triton) with chromatin-bound 
PCNA (+0.6% Triton). 250 mM KCl was used to recover sperm chromatin. Detection of 
PCNASC in the recovered fraction did not depend on membrane permeabilization by 
Triton.  
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Figure 3.5 (continued) 
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Several other control experiments would be necessary to confirm this result, but based 
on this single experiment, it appears that there are no defects in the ability of PCNASC to 
enter the nucleus or to load onto sperm chromatin. Therefore, PCNASC cannot function 
in LSS, but the reason for this failure is yet unknown. To test whether PCNASC can 
support chromosomal replication and Cdt1 destruction in the absence of a nucleus, we 
would ideally test PCNASC function in NPE. However, this is not yet possible because 
the levels of endogenous PCNA are so high in NPE that immunodepletion is not possible.  
3.3.3 The role of multiple interdomain connector loops in CRL4Cdt2 function 
I next generated PCNASC constructs that contain two, one, or no wildtype subunits to 
determine how many intact IDCLs within an individual PCNA trimer are required in HSS 
for CRL4Cdt2-dependent destruction, Cdt2 recruitment to chromatin, substrate 
ubiquitylation, and substrate loading to chromatin. As expected, PCNASC(79-79-79), 
which consists of only mutant IDCL subunits, did not support Cdt2 recruitment or Cdt1 
destruction (Figure 3.6A-D; lanes 16-18 in A, lane 6 in D) because Cdt1 must bind 
PCNA through its own PIP box. Also as expected, PCNASC(WT-WT-79) supported 
complete Cdt1 destruction with similar kinetics to destruction triggered by PCNASC(WT-
WT-WT), indicating that CRL4Cdt2 function does not require all three intact PIP box 
binding sites (Figure 3.6A, B; compare lanes 6-9 to lanes 1-4 in A). PCNASC(WT-79-79) 
also supported Cdt1 destruction, but at a reduced rate compared to PCNASC(WT-WT-
WT) and PCNASC(WT-WT-79) (Figure 3.6A, B; compare lanes 11-14 to lanes 1-4 and 6-
9 in A), indicating that binding of multiple PIP box proteins to a single PCNA trimer is not 
absolutely required for all CRL4Cdt2 function, but it may enhance destruction.  
I wanted to address why PCNA containing only one intact IDCL supported only partial 
Cdt1 destruction. Therefore, I considered each step involved in CRL4Cdt2 function, 
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Figure 3.6: A single IDCL on PCNA is sufficient for partial CRL4Cdt2 function. A) 
PCNA-depleted HSS was rescued with PCNASC containing mutated IDCLs on varying 
numbers of subunits. PCNASC containing only a single wildtype subunit supported partial 
Cdt1 destruction. An extract-specific, non-Cdt1 band detected by the Cdt1 antibody is 
shown as a loading control. B) Quantification of (A). Cdt1 bands were quantified using 
Image J software. Each Cdt1-specific band was normalized to a loading control, and the 
starting levels of Cdt1 were set to 100%. N≥5 for all samples (N=10 for WT-WT-WT, N=7 
for WT-WT-79, N=6 for WT-79-79, N=5 for 79-79-79). C) Decreasing the number of 
IDCLs on PCNA leads to decreased Cdt1 binding and ubiquitylation on chromatin. 
Streptavidin is shown as a loading control. D) Quantification of (C). PCNA-dependent 
Cdt1 binding is reported as the difference between total Cdt1 signal and Orc-dependent 
Cdt1 signal (buffer control); Cdt1 binding stimulated by PCNASC(WT-WT-WT) is set to 
100%. The percent of ubiquitylated Cdt1 is reported as the ratio of ubiquitylated to total 
Cdt1. E) Decreasing the number of IDCLs on PCNA leads to decreased Cdt2 
recruitment. Chromatin spin downs were performed with 100 mM KCl. Orc2 was used as 
a loading control.  
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Figure 3.6 (continued) 
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starting with substrate binding. I found that decreasing the number of wildtype IDCLs by 
mutation of only one subunit in PCNASC(WT-WT-79) led to decreased Cdt1 recruitment  
and ubiquitylation (Figure 3.6C, compare lanes 3 and 4, see D for quantification); 
recruitment and ubiquitylation in extract containing PCNASC(WT-79-79) was even lower 
(Figure 3.6C (lane 5), D). Cdt2 recruitment to chromatin followed the same trend (Figure 
3.6E). It is therefore plausible that defects in Cdt1 destruction in the presence of 
PCNASC(WT-79-79) might simply be due to a decreased number of binding sites for 
CRL4Cdt2 substrates rather than an intrinsic requirement for at least two binding sites. 
Under these conditions, defects in bulk destruction might only become evident when 
ligase recruitment and substrate ubiquitylation are below a certain threshold. 
To distinguish the possibility that decreased Cdt1 proteolysis in the presence of 
PCNASC(WT-79-79) is due to decreased Cdt1 binding sites from the possibility that a 
second available PIP box binding site contributes to CRL4Cdt2 function, I repeated the 
destruction assays and monitored chromatin-bound Cdt1 and Cdt1 ubiquitylation in 
extract containing 1/3 the amount of PCNASC(WT-WT-WT) relative to PCNASC(WT-79-
79). Under these conditions, the molarity of intact IDCLs was the same in both reactions. 
Even after equalizing the molarity of intact IDCLs, PCNASC(WT-WT-WT) still supported 
more efficient Cdt1 destruction than PCNASC(WT-79-79) (Figure 3.7A, B; compare lanes 
16-19 to lanes 6-9 in A). Decreasing the total amount of PCNASC(WT-WT-WT) in extract 
did have a modest effect on Cdt1 binding and ubiquitylation, but equalizing the number 
of wildtype subunits in extract also did not restore decreased Cdt1 binding and 
ubiquitylation caused by mutation of additional IDCLs (Figure 3.7C, D; compare lanes 2-
4 in C).  However, the amount of PCNA that loads onto DNA relative to total PCNA in 
solution is very low. Though a pcna-79 mutation does not substantially affect RFC-
dependent PCNA loading in vitro (Eissenberg et al., 1997), RFC makes several contacts 
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Figure 3.7: Normalizing the number of available IDCLs in total extract does not 
resolve the partial rescue problem. A) Cdt1 destruction supported by indicated 
amounts of PCNASC relative to the amount used in Figure 3.6. An extract-specific, non-
Cdt1 band detected by the Cdt1 antibody is shown as a loading control. B) 
Quantification of (A). The average of two experiments is shown; error bars represent the 
standard deviation. C) Normalizing the number of available IDCLs does not restore 
equal Cdt1 loading or ubiquitylation. Orc2 is shown a loading control. D) Quantification of 
(C). Three separate experiments were averaged, and error bars represent the standard 
deviation.  
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Figure 3.7 (continued)
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with the IDCL (Oku et al., 1998), so it is possible that the number of wildtype IDCLs on 
DNA was still dissimilar in the two samples because of differences in PCNASC loading by 
RFC (Oku et al., 1998). Thus, I calculated how much of each PCNASC construct is 
necessary in total extract to generate a three-fold difference in the DNA-bound 
concentration of PCNASC(WT-79-79) relative to PCNASC(WT-WT-WT) (Figure 3.8A). 
When I added 2.5% of PCNASC(WT-WT-WT) and 33% of PCNASC(WT-79-79) relative to 
the amount used in the original destruction assays (150 ng/µL, Figure 3.6), the levels of 
wildtype IDCL subunits of PCNASC on chromatin were similar (Figure 3.8B, lanes 1-3 
contain the same sample at different dilutions, as do lanes 5-7). This low concentration 
of PCNASC(WT-WT-WT) did not cause defects in Cdt1 destruction like PCNASC(WT-79-
79), despite a level of chromatin-bound PCNASC that should correspond to an equivalent 
number of binding sites for PIP box containing proteins (Figure 3.8C, compare lanes 11-
14 to lanes 7-10). Hence, having a second IDCL present on the same PCNA trimer to 
which the substrate can bind seems to somehow facilitate CRL4Cdt2 function. 
Nonetheless, the observation that normalizing the amount of chromatin-bound wildtype 
PCNA subunits did not resolve differences in destruction could still be subject to multiple 
interpretations. If, for example, the PCNASC(WT-WT-WT) protein preparation contains 
contaminating monomeric PCNA fragments not present in the PCNASC(WT-WT-79) 
preparation, it could allow for a higher concentration of wildtype PCNA subunits on DNA 
than those contributed by PCNASC. Upon long exposure of the DNA-bound PCNA blot, I 
detected a faint band migrating at the expected size of monomeric PCNA (~35 kDa) in 
samples containing PCNASC(WT-WT-WT) that was not visible in samples containing 
PCNASC(WT-79-79) (Figure 3.8B, compare lanes 1-3 to lanes 5-7 in the middle panel), 
suggestive of contamination by monomeric PCNA molecules due to proteolysis of the 
linker regions or breakdown of PCNASC in the extract. This band was not visible in earlier  
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Figure 3.8: Normalizing the number of available IDCLs on chromatin does not 
resolve the partial rescue problem. A) PCNASC was titrated into extract to generate a 
binding curve for PCNASC loading to chromatin. Raw data points are shown along with 
the theoretical binding curve based on these data. B) Wildtype IDCLs on PCNASC were 
normalized on chromatin. Chromatin-bound samples were titrated to allow careful 
quantification. 100% of the PCNASC(WT-WT-WT) sample should contain 1/3 the amount 
of bound PCNASC as the 100% PCNASC(WT-79-79). MCM7 is shown as a loading 
control. C) Normalizing bound wildtype IDCLs does not restore equal Cdt1 destruction 
supported by PCNASC(WT-WT-WT) and PCNASC(WT-79-79). No quantification is shown 
because this is a single experiment. 
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experiments using PCNASC prepared at a different time from the PCNASC used in 
Figures 3.4-3.7 (data not shown).  
Alternatively, CRL4Cdt2 function could absolutely require multiple wildtype IDCLs on 
PCNA, but the single wildtype subunit of multiple PCNASC(WT-79-79) trimers could 
cooperate with the wildtype subunit on other trimers, stimulating the modest Cdt1 
destruction I observe. Two trimers could interact in trans, with Cdt2 binding to the single 
wildtype IDCL on one trimer and the substrate binding to the other trimer (Figure 3.9A), 
or two trimers could interact in cis, with multiple PCNASC polypeptides interacting to form 
a single trimer with additional attached subunits (Figure 3.9B). This second model 
seems unlikely for steric reasons but is still formally possible. In support of a potential 
interaction between PCNASC and other PCNA molecules, I found that His-tagged PCNA 
trimers pulled down PCNASC (Figure 3.9C, lane 9) even after PCNASC has had the His 
tag removed through Prescission Protease. This experiment needs to be repeated to be 
conclusive and to confirm that Ni-NTA beads do not recover PCNASC in the absence of 
His-tagged PCNA.  
Wildtype PCNA homotrimers also reassembled in extract: when His-tagged homotrimers 
were mixed with extract, the His-tagged PCNA pulled out endogenous PCNA, 
suggesting that individual timers are not stable and that subunits can exchange or 
interact (Figure 3.9B, lane 5). The same was true for a mixture of His-tagged PCNA and 
untagged PCNA in ELB (Figure 3.9B, lane 7).  
Collectively, these results suggest that multiple subunits on a single PCNA trimer may 
contribute to CRL4Cdt2 function but are not absolutely required; however, I was not able 
to exclude a number of alternative explanations for our data, such as contaminating 
monomeric PCNA in PCNASC protein preparations or the possibility that wildtype  
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Figure 3.9: Alternate explanations for the differences between PCNASC(WT-WT-
WT) and PCNASC(WT-79-79). A) Multiple PCNA heterotrimers could interact in trans to 
support Cdt2 binding to a separate IDCL from the CRL4Cdt2 substrate. B) Multiple 
PCNASC polypeptides could interact in cis to generate a single PCNA ring that contains 
more than one wildtype IDCL to support Cdt2 binding to a separate IDCL from the 
CRL4Cdt2 substrate. C) PCNASC interacts with monomeric PCNA in HSS and PCNA 
reassembles in extract. PCNASC and His-PCNA were added to HSS for 30 minutes at 
room temperature before recovering His-PCNA with Ni-NTA beads. 
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subunits on different PCNASC(WT-79-79) heterotrimers cooperate to allow CRL4Cdt2-
dependent proteolysis. 
3.3.4 A single IDCL on PCNA supports complete replication in HSS 
To study the role of multiple IDCLs on PCNA during DNA replication, I used a primer 
extension assay on a single-stranded plasmid template. Though this assay does not 
address a role for multiple IDCLs in licensing, chromatin unwinding, or lagging strand 
synthesis, it does explore whether multiple PIP box containing proteins must bind a 
single PCNA trimer during leading strand elongation. Since PCNASC can replace 
wildtype monomeric PCNA in such a replication assay (Figure 3.4B, C), I tested the 
effect of individual IDCL mutations in this assay. I immunodepleted PCNA and replaced 
it with each of the PCNASC mutants. Even PCNASC(WT-79-79) stimulated full replication 
(Figure 3.10). Notably, PCNASC(79-79-79) supported a partial rescue of primer extension 
in this assay (Figure 3.10). In yeast and in Xenopus egg extract, pcna-79 also supports a 
partial rescue of DNA replication on an M13 plasmid (Eissenberg et al., 1997; Havens, 
unpublished data), likely because this mutation does not completely abolish RFC-
dependent PCNA loading and because primer extension depends primarily on the 
activity of Polε, which can interact with pcna-79 almost as well as with wildtype PCNA 
(Eissenberg et al., 1997; Gomes and Burgers, 2000; Zhang et al., 1998). 
In summary, my preliminary results suggest that neither CRL4Cdt2-dependent proteolysis 
during DNA repair nor DNA replication in HSS strictly require multiple IDCLs on a single 
PCNA trimer, suggesting that at least for these two events, the “tool belt” model does not 
apply. However, further experimentation is necessary to resolve the described caveats. 
This does not mean these processes do not benefit from having adjacent IDCLs on 
PCNA. Indeed, a second IDCL seems to contribute to CRL4Cdt2-dependent proteolysis, 
though it is unclear whether this contribution is simply due to the presence of additional 
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Figure 3.10: PCNASC(WT-79-79) supports PCNA-dependent primer extension as 
well as PCNASC(WT-WT-WT). PCNASC was added to HSS containing single-stranded 
M13 plasmid DNA and radiolabeled dATP. Replication was monitored over time. Shown 
here is a quantification of the incorporation of radiolabeled dATP. 
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substrate binding sites because of the described stipulations. In conclusion, these data 
challenge a generally accepted model for PCNA function but require confirmation.  
3.4 Discussion and Future Directions 
Until now, there has been no way to study the roles of individual subunits within the 
PCNA trimer. Though we can imagine PCNA as a “tool belt” on DNA, holding proteins 
poised for action should problems in replication arise (Freudenthal et al., 2011; Indiani et 
al., 2005; Sutton, 2010; Zhuang and Ai, 2010), heterotrimeric PCNA has not been 
available, so testing this model in eukaryotic systems has been difficult. I have 
generated a useful tool to study the contributions of distinct PCNA subunits to any 
biochemical process during S phase in Xenopus egg extract. I used PCNASC to test the 
role of individual IDCLs in a single PCNA trimer during CRL4Cdt2-dependent destruction 
and during primer extension in HSS. I found that only a single IDCL is necessary for 
primer extension on a single-stranded plasmid and for modest CRL4Cdt2-dependent 
destruction of the well-characterized substrate Cdt1. However, PCNASC containing only 
a single wildtype IDCL supported only partial Cdt1 destruction, and I was not able to 
conclusively determine whether this was simply due to decreased substrate binding or 
due to differences in ubiquitin ligase function.  
In theory, PCNASC should allow testing of a number of unanswered questions in the field 
of DNA replication: How many functional IDCLs does PCNA require to support full DNA 
replication? Does switching from a replicative polymerase to a translesion synthesis 
polymerase require multiple binding sites on PCNA? How do individual PCNA subunits 
contribute to DNA repair? How do PCNA modifications on individual subunits affect 
replication fork dynamics? Does PCNA unloading from DNA require protein interactions 
with multiple PCNA subunits? Does chromatin assembly require coordinated recruitment 
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of multiple factors to a single PCNA molecule? All of these processes affect the overall 
progression through S phase, and we have yet to understand the role of individual 
PCNA subunits. Unfortunately, addressing most of these questions requires either LSS 
or NPE: PCNASC does not function in LSS (Figure 3.5), and we cannot immunodeplete 
endogenous PCNA from NPE since the levels are so high. Thus, so far it is impossible to 
replace endogenous PCNA with PCNASC in NPE. Further studies utilizing PCNASC will 
require fine-tuning to allow function in LSS, potentially by modifying the protein 
preparation to eliminate contaminants. Additionally, generating a protocol for successful 
depletion of PCNA from NPE would allow us to address almost any of these interesting 
questions. With additional effort, PCNASC will be a useful tool for the future study of other 
PCNA-dependent events.  
Finally, I was unable to resolve the difference in CRL4Cdt2 function supported by 
PCNASC(WT-WT-WT) compared to PCNASC(WT-79-79). It remains possible that 
CRL4Cdt2 requires multiple subunits of PCNA to function but that multiple PCNASC 
molecules cooperate to facilitate substrate proteolysis. Confirmation of this phenomenon 
would introduce a new perspective on PCNA function that has not been seriously 
considered. Two reports from the Lee lab in Ontario have shown that two PCNA 
homotrimers can dimerize into a back-to-back doublet and that such dimerization is 
essential for concurrent binding of Polδ and chromatin assembly factor-1 (CAF1) 
(Naryzhny et al., 2006; 2005). The presence of such trimer dimers was independently 
confirmed using another method, but this study found that only a small fraction of PCNA 
molecules existed in such a configuration (De Biasio et al., 2011). However, this 
configuration places PCNA molecules loaded onto DNA in opposite directions, which is 
inconsistent with our current understanding of PCNA structure and function. 
Nevertheless, it is possible that two PCNA molecules could interact this way in trans in 
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the context of a replication factory. Determining whether two PCNASC(WT-79-79) 
molecules interact in this fashion could address whether PCNA trimers do in fact 
dimerize and whether dimerization is important for PCNA function during CRL4Cdt2-
mediated proteolysis. My preliminary data showed that having more than one IDCL on a 
single trimer is beneficial and that a single trimer can interact with other PCNA 
molecules. If confirmed, these data are consistent with a model in which PCNA 
dimerization becomes necessary for CRL4Cdt2 function only when a separate IDCL is 
unavailable on the same PCNA trimer to which the substrate is bound, but this 
cooperation in trans between two PCNA trimers is not as efficient at supporting CRL4Cdt2 
function as cooperation between two subunits on the same trimer.
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Appendix A1 
 
Polη and the ATR checkpoint 
and  
Polη regulation by CRL4Cdt2
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The work presented in this appendix was partially conducted in Dr. W. Matthew 
Michael’s lab at Harvard University, currently at The University of Southern California. 
Polη constructs and antibodies were generated in the Michael Lab, and the data 
presented in Figure A1.1 was performed in the Michael lab. Experiments presented in 
Figure A1.2 and Figure A1.3 were performed in the Walter lab. 
A1.1 Introduction 
During the course of DNA replication, replicative polymerases can stall at sites of DNA 
damage. Unassisted, such obstacles lead to replisome dissociation at the site of 
damage, replication fork collapse, double-strand breaks, and ultimately to chromosome 
breaks and translocations. This genome instability can lead to cancer. Nonetheless, 
exposure to genotoxic mutagens is common to all cells. As a result, replication 
checkpoints have evolved to stabilize replication forks and halt the cell cycle, blocking 
mitosis until replication has resumed and preventing chromosome loss. Additionally, 
several specialized translesion synthesis (TLS) polymerases are able to bypass DNA 
lesions, allowing replication to continue in the face of damage and leaving the lesion 
behind for repair pathways to resolve. Together, replication checkpoints and TLS 
polymerases allow continued replication but prevent mitosis until replication is complete.  
One mechanism of resuming replication at sites of stalled replicative polymerases, 
allowing S phase to resume, is TLS. The low processivity, low fidelity TLS polymerases 
lack 3’à5’ exonuclease activity and have large active sites to accommodate DNA 
lesions. Polη specializes in bypassing cis-syn cyclobutane pyrimidine dimers (CPDs) 
(Johnson et al., 1999) and 6-4 photoproducts (Johnson et al., 2001) generated by UV 
damage, though it is also capable of bypassing other types of DNA lesions. Recently, 
Polη was also shown to have a role in PCNA ubiquitylation, which affects recruitment of 
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other TLS polymerases and homology-directed DNA repair (Durando et al., 2013). 
Despite its general low fidelity, Polη successfully bypasses double thymidine dimers by 
inserting two adenines opposite the adjoined bases (Johnson et al., 1999; McCulloch 
and Kunkel, 2008), earning it the distinction “error-free” when replicating this cognate 
lesion. A Polη deficiency causes Xeroderma pigmentosum variant (XPV) in humans 
(Masutani et al., 1999), a condition characterized by extreme susceptibility to skin cancer 
due to a high rate of mutagenesis following exposure to UV light.  
In early C. elegans embryos, Polη is important for regulating developmental timing. Early 
embryos of many animals rely on a timing-specific sequence of events for proper 
development, so a delay in the cell cycle is detrimental to survival. Many organisms have 
evolved mechanisms to evade a checkpoint response during the early steps of 
development. In early C. elegans embryos, Polη is necessary for ATR checkpoint 
silencing (Holway et al., 2006). Additionally, in human XPV cells, which lack functional 
Polη, S phase arrest is lengthened and accompanied by increased checkpoint signaling 
(Bullock et al., 2001); adding Polη to these cells prevents delays in the cell cycle and 
excessive checkpoint signaling (Albertella, 2005). Together, these observations suggest 
a functional interaction between Polη and ATR checkpoint signaling. 
Also in early C. elegans embryos, CRL4Cdt2 targets Polη for destruction. (Kim and 
Michael, 2008). Polη is first SUMOylated, which protects it from proteolysis (Kim and 
Michael, 2008). Importantly, both deletion of the SUMOylation machinery and high 
amounts of MMS damage are necessary to detect Polη destruction (Kim and Michael, 
2008). Polη is error-prone on undamaged DNA and must not be granted unlimited 
access to DNA during lesion bypass. Therefore, mechanisms must exist to ensure that a 
replicative polymerase replaces the TLS polymerase after bypass is complete. Some 
models propose that its low processivity causes the TLS polymerase to simply fall off the 
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DNA after bypass. Kim and Michael hypothesized that CRL4Cdt2-dependent destruction 
of Polη might be necessary for polymerase exchange to the replicative polymerase after 
TLS. They hypothesized that Polη is protected from destruction briefly via SUMOylation 
on DNA, but it then becomes susceptible to CRL4Cdt2-dependent destruction, which 
facilitates the polymerase switch (Kim and Michael, 2008). Sequence alignments show 
that Xenopus Polη contains elements of the conserved PIP box and basic +4 residue 
necessary for Cdt2-dependent destruction (Havens and Walter, 2009), suggesting that 
CRL4Cdt2 regulation of Polη might be conserved in higher eukaryotes. In this appendix, I 
present my work studying the regulation of Polη by CRL4Cdt2 and its interaction with ATR 
checkpoint signaling in Xenopus egg extract. 
A1.2 Materials and Methods 
Extract preparation, replication assays, and chromatin spin downs are described above 
(Chapter 2, Chapter 3) 
A1.2.1 Plasmid construction, mutagenesis, and protein purification 
PCNA purification is described in Chapter 3. 
The construct for Xenopus Polη was previously donated to the Michael lab. From this 
construct, three overlapping His-tagged Polη fragments were produced for the 
generation of an antibody against Xenopus Polη. Recombinant Xenopus Polη was 
expressed and purified from E. coli according to published methods (Yagi et al., 2005). 
A1.2.2 Immunological Methods 
Antibodies to PCNA, Cdt1, Rcc1, Orc2, phospho-Chk1, and Chk1 are described above 
(Chapter 2, Chapter 3). Anti-Polη antibodies were generating using the C-terminal 
fragments described above (A1.2.1) as an antigen for injection into two rabbits. The C-
terminus of Polη shares the least sequence homology with other TLS polymerases. Polη 
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antibodies were produced by Cocalico Biologicals. 
A1.3 Results 
A1.3.1 Polη in crude S phase extract 
To study Polη, both in relation to the S phase checkpoint and as a potential CRL4Cdt2 
substrate, I generated an antibody that works for Western blotting and immunodepletion 
in the Michael lab. I also generated recombinant full-length Polη (Yagi et al., 2005). 
Purified Polη had strand displacement activity immediately after purification, but any 
subsequent dialysis or other manipulations rendered it inactive, likely due to 
denaturation (data not shown). I therefore focused on studying endogenous Polη. In 
agreement with classification of UV damage as the cognate substrate of Polη, UV 
damage led to increased Polη binding sperm chromatin in crude S phase extract (Figure 
A1.1A). Additionally, Polη depletion from crude extract led to decreased replication of 
UV-damaged chromatin (Figure A1.1B, C), which we also expected since Polη is the 
TLS polymerase dedicated to bypassing UV-induced pyrimidine dimers. Due to our 
inability to purify an active recombinant Polη, I could not rescue the effect of the 
depletion.  
A1.3.2 Polη and ATR checkpoint signaling 
We were particularly interested in the effects of Polη depletion or addition on ATR 
checkpoint signaling due to the relationship between Polη and checkpoint signaling in 
nematodes. However, depletion of Polη from extract did not affect checkpoint signaling 
(Figure A1.1D), and the addition of recombinant Polη to extract gave inconsistent results 
(data not shown), likely due to differences in recombinant Polη activity. Hence, I 
terminated this project. 
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Figure A1.1: Polη affects DNA replication of UV-damaged chromatin but not ATR 
checkpoint signaling. A) Polη interacts strongly with replicating UV-damaged sperm 
chromatin and weakly with replicating undamaged sperm chromatin. B) A single-round 
Polη depletion removes most Polη from crude S phase extract. C) Depletion of Polη 
impairs DNA replication of sperm chromatin, especially UV-damaged sperm chromatin. 
D) Depletion of Polη does not affect ATR checkpoint signaling during replication of UV-
damaged sperm chromatin as measured by Chk1 phosphorylation. M and D indicate 
mock-depleted and Polη-depleted, respectively. These experiments were performed in 
crude S phase extract in the Michael lab.
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A1.3.3 Putative CRL4Cdt2 regulation of Polη 
Because Polη is a CRL4Cdt2 substrate in C. elegans, I set out to characterize its 
proteolysis in Xenopus egg extract and test the hypothesis that CRL4Cdt2-dependent 
destruction is necessary to limit continued replication by Polη after lesion bypass. 
Xenopus Polη contains a putative PIP degron (Figure A1.2A); there is a basic residue 
four amino acids downstream of its previously established C-terminal PIP box (Acharya 
et al., 2008). I first looked for ubiquitylation of Polη on MMS-damaged linear DNA that I 
could easily recover from extract. This template supports the ubiquitylation of known 
CRL4Cdt2 substrates Cdt1 (Chapter 2 and Figure A1.2B, upper panel) and TDG (Chapter 
2). I optionally supplemented extract with methyl ubiquitin, which allows 
monoubiquitylation but prevents polyubiquitin chain formation and proteasome-
dependent destruction. This template triggered Cdt1 destruction in the absence of 
methyl ubiquitin and resulted in Cdt1 ubiquitylation when methyl ubiquitin was included 
(Figure A1.2B, upper panel). However, Polη remained unmodified on chromatin (Figure 
A1.2B, lower panel). I also tested for destruction of Polη during DNA repair in HSS. I 
again used MMS-damaged DNA, which triggers proteolysis of other known substrates. 
However, Polη remained stable under conditions that stimulated rapid Cdt1 destruction 
(Figure A1.2). Finally, replication of both undamaged and UV-damaged sperm chromatin 
did not trigger any change in Polη levels (Figure A1.2C). 
To independently confirm that Polη is not destroyed in a CRL4Cdt2-dependent manner, I 
immunodepleted PCNA from HSS and replaced it with a PCNA mutant that supports 
substrate binding but not ligase recruitment (D122A/E124A) (Havens et al., 2012). I 
tested the effect of this mutant on levels of Polη associated with both undamaged and 
UV-damaged sperm chromatin and found no accumulation of Polη in either case (Figure 
A1.3). The ligase-recruitment dead version of PCNA led to increased Cdt1 binding under 
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Figure A1.2: Polη is not ubiquitylated or destroyed under conditions that trigger 
Cdt1 ubiquitylation and destruction. A) Sequence alignment of Xenopus Polη 
compared to known CRL4Cdt2 substrates. B) Polη is not ubiquitylated on MMS-damaged 
linear DNA in HSS. Cdt1 is shown as a positive control for ubiquitylation. Methyl ubiquitin 
was optionally added to allow monoubiquitylation but prevent polyubiquitylation and 
destruction. C) An MMS-damaged plasmid does not trigger destruction of Polη in HSS. 
D) Polη is not destroyed during replication of UV-damaged or undamaged chromatin in 
LSS. These experiments were performed in the Walter lab.  
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Figure A1.2 (continued) 
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Figure A1.3: Mutation of PCNA residues critical for CRL4Cdt2 recruitment does not 
lead to the accumulation of Polη on chromatin. A) Chromatin-associated proteins 
during DNA replication of normal sperm chromatin in LSS. Rcc1 is shown as a loading 
control. B) Chromatin-associated proteins during replication of UV-damaged sperm 
chromatin.
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both conditions, as expected (Figure A1.3). 
These new data indicate that Polη is not a target for the CRL4Cdt2 ubiquitin ligase in 
Xenopus egg extract under conditions known to cause ubiquitylation and degradation of 
other CRL4Cdt2 substrates, like Cdt1. Mass spectrometry results confirmed this final 
observation (Appendix A2). Though it remains a formal possibility that CRL4Cdt2 
somehow regulates Polη, it does not appear to do so following any of the types of 
damage tested. 
The fact that Polη contains a conserved PIP box and basic +4 residue, but is apparently 
not a target for destruction in Xenopus, slightly expands our understanding of sequence 
requirements for CRL4Cdt2 substrates. Within the PIP box, Polη contains an aspartate 
and alanine at positions five and six where most other substrates contain a TD motif 
(Figure A1.2). The PCNA-binding protein Fen1 contains two aspartates at these 
positions and does not contain a B+4 residue at all (Havens and Walter, 2009 and 
Chapter 3, Figure 3.1). Replacement of the first aspartate with threonine leads to tighter 
binding to PCNA. When a B+4 residue is also added, Fen1 becomes a substrate for 
CRL4Cdt2 (Havens and Walter, 2009). Importantly, both changes are necessary to make 
Fen1 a target. Therefore, it is possible that PCNA-Polη binding is not strong enough to 
recruit Cdt2, so there is no destruction. Nonetheless, C. elegans Polη does not contain 
the important TD motif either, yet it is a target. It is thus possible that other residues 
compensate for the lack of a TD motif in nematode Polη that are not present in Xenopus 
Polη or that there is a difference in CRL4Cdt2 requirements between species.
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Appendix A2 
 
A strategy for the proteomic 
identification of new CRL4Cdt2 
substrates in Xenopus egg 
extract 
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A2.1 Introduction 
Unlike other ubiquitin ligases, CRL4Cdt2 functions specifically during DNA replication or 
following DNA damage. CRL4Cdt2 negatively regulates the stability of many proteins 
whose presence in S phase is detrimental. The best-characterized substrate of CRL4Cdt2 
is Cdt1 (Jin et al., 2006), which functions to recruit the replicative MCM2-7 helicase 
during origin licensing. After cells progress into S phase, Cdt1 activity could facilitate 
detrimental origin licensing on regions of the genome that have already been replicated 
(Arias and Walter, 2005) so CRL4Cdt2 targets Cdt1 for destruction at the start of S phase.  
Fewer than ten CRL4Cdt2 substrates are known, but all have a role in DNA replication or 
repair (Havens and Walter, 2011). Other substrates of CRL4Cdt2 include Drosophila 
E2f1(Shibutani et al., 2008), human Set8 (Centore et al., 2010), Xenopus Xic1 (Kim et 
al., 2010), S. pombe Spd1 (Liu et al., 2003; Salguero et al., 2012), C. elegans POLH-1 
(the DNA Polη homologue) (Kim et al., 2010) and p21 in multiple organisms (Kim et al., 
2008). We recently characterized a new substrate, thymine DNA glycosylase (TDG), as 
well (Chapter 2). Destruction of each CRL4Cdt2 substrate helps to ensure accurate DNA 
replication, and most CRL4Cdt2 substrates are toxic during S phase. Addressing why 
each substrate must be destroyed has helped us understand important molecular details 
about DNA replication and repair. For example, the identification of Set8 as a substrate 
led to the model that H4K20 methylation during DNA replication somehow leads to 
relicensing (Beck et al., 2012). Before the discovery that Set8 is a CRL4Cdt2 substrate, 
the relationship between H4K20 methylation and cell cycle progression was unknown. 
Therefore, I expect that identification of novel CRL4Cdt2 substrates will similarly improve 
our knowledge of DNA replication and repair, as well as help us gain more insight to the 
activities of new substrates. 
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To identify new CRL4Cdt2 substrates and expand our knowledge of DNA replication and 
repair, I used a novel screening method developed by Dr. Courtney Havens, Dr. 
Johannes Walter, and myself. 
A2.2 Materials and Methods 
Extract preparation, immunological methods, DNA damage, tissue culture, and recovery 
of bead-bound DNA are described above (Chapter 2, Chapter 3). Recombinant PCNA 
was prepared as described in Chapter 3. 
A2.2.1 Preparation of samples for mass spectrometry 
PCNA was immunodepleted from HSS and replaced with either wildtype or 
D122A/E124A PCNA. Bead-bound MMS-damaged DNA were added to the extract. At a 
time point that leads to near-complete degradation of Cdt1 on wildtype PCNA but 
minimal loss of Cdt1 on mutant PCNA, bead-bound DNA and associated proteins were 
isolated. Proteins were eluted in 1% SDS and then TCA precipitated: the eluate was 
adjusted to 20% TCA, vortexed, and incubated on ice for 20 minutes. Precipitated 
protein was recovered via centrifugation at max speed, 4°C, washed with cold 10% TCA, 
and then washed twice with cold acetone. The dried pellet was stored at -80°C and 
subsequently submitted to the Gygi lab for trypsinization, differential labeling and 
analysis. 
A2.2.2 Isolation of nuclear extract from HeLa cells 
HeLa cells were cultured to confluency, harvested via trypsinization, and washed with 
PBS containing 1 mM MgCl2. Cells were lysed on ice first in hypotonic buffer (1.5 mM 
MgCl2, 10 mM KCl, 300 mM sucrose, 1 mM EDTA, 0.1% NP-40, 1 mM DTT, 1 mM 
NaVO4, 10 mM HEPES, pH 7.9, and protease inhibitors) until they were permeable to 
the vital dye Trypan Blue. Cells were mixed via repeated pipetting to release the 
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cytoplasmic content and centrifuged to separate the cytoplasm from the insoluble 
fraction. The insoluble fraction containing the nuclei was permeabilized with hypertonic 
buffer (250 mM NaCl, 1 mM EDTA, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-
100, 1 mM DTT, 1 mM NaVO4, 1 mM NaF, 20 mM HEPES, pH 7.4, and protease 
inhibitors) on ice. The nuclei were mixed via repeated pipetting and nuclear contents 
were isolated via centrifugation at high speed. The nuclear lysate was in the supernatant 
of this final spin. 
A2.3 Results and Troubleshooting 
A2.3.1 Experimental set up 
To identify new CRL4Cdt2 substrates, I used a mutant of PCNA that contains mutations in 
the part of the protein that is predicted to make contacts with Cdt2 (D122A/E124A, 
dotted in Figure 1.2B). The two mutated acidic residues normally sandwich the B+4 
residue on the substrate’s PIP degron. This mutant does not affect substrate binding, but 
it prevents ligase recruitment, thereby stabilizing CRL4Cdt2 substrates on DNA (Havens 
et al., 2012). After completing this screen, Dr. Courtney Havens found that mutation of 
D122A alone leads to the same effect (Havens et al., 2012). Substrates like Cdt1 and 
human Set8 rapidly bind a short, MMS-damaged DNA fragment (1kb). They then 
become modified with ubiquitin and are subsequently degraded (Centore et al., 2010; 
Havens and Walter, 2009). Ubiquitylation and degradation depend on proper CRL4Cdt2 
recruitment. Since the D122A/E124A mutant of PCNA fails to make the necessary 
contacts with Cdt2, substrates like Cdt1 remain bound to DNA in samples containing the 
mutant protein. Thus, comparing DNA-bound proteins in the presence of wildtype and 
D122A/E124A PCNA should lead to the identification of other CRL4Cdt2 targets, as they 
will be enriched on DNA in the presence of the mutant PCNA. 
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I immunodepleted PCNA from HSS and replaced it with the D122A/E124A mutant and 
immobilized MMS-treated DNA. I recovered the DNA and eluted the samples in SDS 
buffer before TCA precipitating them and submitting them for differential labeling with a 
heavy and light isotope followed by mass spectrometry.  
A2.3.2 Optimization 
To optimize the amount of CRL4Cdt2 substrates present in the samples relative to other 
proteins, I varied the salt and detergent conditions during sample isolation. I used Cdt1 
as an example substrate and planned all optimization around the amount of Cdt1 relative 
to background proteins in each sample. At the lowest salt concentration tested (50mM 
KCl), Cdt1 peptide hits were low compared to other DNA binding proteins and to some 
soluble proteins as well (Table 1). I made various adjustments to the experiment to 
enrich for substrates over abundant background proteins. Increasing salt concentrations 
during the chromatin spin downs reduced background levels at the cost of decreased 
DNA-associated Cdt1 (Figure A2.1A, B, showing both WT PCNA and D122A/E124A, 
labeled AA), but did not have a large affect on Cdt1 peptide hits or identify any additional 
Cdt2 targets (Table 1 and data not shown). With more stringent isolation conditions (100 
mM and 150 mM KCl), the single-stranded DNA binding protein RPA bound with much 
greater efficiency than a background, cytoplasmic protein (β-actin) suggesting that the 
additional salt present was successful in eliminating nonspecific binding (Table 1).  
I also tried adding undamaged competitor DNA to the reactions to titrate away some 
non-specific chromatin binding proteins from the damaged immobilized DNA. The mass 
spectrometer can only detect a finite number of peptides. If the sample is full of DNA-
binding proteins that bind both damaged and undamaged DNA, they will overwhelm the 
number of specific hits. However, addition of undamaged competitor DNA did not affect 
total protein in the recovered DNA fraction as measured by silver staining 
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Table 1: Total peptide hits with increasing salt concentrations 
Salt concentration: 50 100 150 mM KCl 
Cdt2 10 10 3  
Cdt1 1 4 0  
RPA 354 333 570  
β-actin 466 84 171  
     
DNA-specificity 0.76 3.96 3.33  
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Figure A2.1: Optimization of sample preparation for differential labeling and mass 
spectrometry. A) The effect of increasing salt concentration (KCl) on total DNA-
associated protein as detected by silver staining. Here, WT indicates wildtype PCNA, 
and AA indicates ligase recruitment-defective PCNA (D122A/E124A). B) The effect of 
increasing salt concentration (KCl) on DNA-associated Cdt1. This Western blot 
corresponds to (A). C) Undamaged competitor plasmid (2 µg) was added to titrate away 
non-specific DNA binding proteins. Lanes are as follows: 1) Buffer was added to DNA-
bound beads before adding HSS to start the reaction, 2) Plasmid was mixed with DNA-
bound beads before adding HSS to start the reaction, 3) Plasmid was added to the 
entire reaction one minute before isolating bead-bound DNA, 4) Plasmid was added to 
the diluted reaction before separating through the sucrose cushion, 5) Buffer was added 
to the wash solution after separating the beads through the sucrose cushion, 6) Plasmid 
was added to the wash solution after separating the beads through the sucrose cushion, 
7) No plasmid or buffer was included. D) The effect of increasing Triton X-100 on Cdt1 
and PCNA recovery. This experiment was performed with 150 mM KCl. 
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Figure A2.1 (continued) 
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(Figure A2.1C), so I did not pursue this approach with our samples submitted for mass 
spectrometry. Finally, I optimized the amount of Triton X-100 (Figure A2.1D). 
A2.3.3 Mass spectrometry results 
Despite the low number of total Cdt1 peptides identified during mass spectrometry  
(Table 1), the difference between Cdt1 in samples containing wildtype PCNA compared 
to the ligase recruitment-dead PCNA (D122A/E124A) was measurable (four hits in 
samples containing WT PCNA and no hits in samples containing the ligase recruitment-
dead PCNA). The final differential labeling results indicated that Cdt1 was enriched 15.5-
fold in samples containing D122A/E124A PCNA, as expected (Table 2). Cdt2 and Ddb1, 
the CRL4Cdt2 adapter protein, drastically decreased in samples containing the mutant 
PCNA, as well (Table 2 for Cdt2 comparison and number of peptide hits only—27 in the 
wildtype samples and 0 in the mutant samples—for Ddb1), indicating that both ligase 
recruitment and substrate destruction were defective. 
Of the other proteins enriched on DNA in samples containing mutant PCNA, a few 
proteins stood out due to their roles in DNA replication or repair: Sub1/PC4, HMG1, and 
YB-1 (in bold font in Table 2). I identified a putative PIP box in Sub1/PC4, which has 
been shown to be recruited to sites of DNA damage (Mortusewicz et al., 2008) (Figure 
A2.2A). Though there is no B+4 residue following the PIP box of Sub1/PC4, there are 
several basic residues upstream of the PIP box. Upstream basic residues play a role in 
CRL4Cdt2 function (Havens et al., 2012), so it is plausible that they could circumvent the 
requirement for downstream basic residues for some substrates. I generated a construct 
containing the Sub1/PC4 gene under control of the Sp6 promoter to generate in vitro 
transcribed and translated Sub1/PC4. I added this Sub1/PC4 to HSS containing an 
MMS-damaged plasmid to trigger destruction of CRL4Cdt2 substrates. In vitro transcribed 
and translated Sub1/PC4 remained stable over the course of an hour in extract 
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Table 2: Proteins enriched in samples containing CRL4Cdt2 recruitment-dead PCNA 
or containing wildtype PCNA. Note: The PCNA ratio does not include peptides that 
contain the mutation (6 peptides out of 73 total peptides in the sample containing mutant 
PCNA). The WT sample contains 63 total peptide hits. 
Protein 
Log2 
Ratio Fold Enrichment 
Higher in AA samples   
YB-2 1.3 2.5 
YB-1 1.3 2.5 
MCM4B 1.4 2.7 
zMCM6A 1.5 2.7 
glutaminyl-tRNA synthetase 1.5 2.7 
MCM5A 1.5 2.8 
mMCM6 1.5 2.8 
MCM2 1.5 2.9 
MCM3 1.5 2.9 
MCM5B 1.6 2.9 
MCM7A 1.6 3.0 
methionyl-tRNA synthetase 1.7 3.2 
importin alpha 1 1.8 3.4 
MCM7B 1.8 3.4 
glutathione S-transferase mu 2 2.0 3.9 
SUB1/PC4 2.0 4.1 
HMG1 2.8 7.0 
Cdt1 4.0 15.5 
   
No difference   
PCNA -0.2 0.8 
Polymerase delta 1 -0.2 0.9 
Polymerase delta 2 -0.1 0.9 
Polymerase delta 3 -­‐0.2	   0.8 
   
Higher in WT samples (inverse enrichment reported) 
Cdt2 -3.5 11.5 
DNA polymerase epsilon -2.7 6.6 
DNA polymerase epsilon 2  -2.2 4.6 
Histone H4 -2.0 4.0 
Orc5 -1.9 3.8 
DNA ligase 1 -1.7 3.1 
RNA binding motif protein -1.5 2.9 
MCM10 -1.2 2.4 
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Figure A2.2: In vitro transcribed and translated Sub1/PC4 is not destroyed during 
DNA repair in HSS. A) The putative PIP box of Sub1/PC4 is shown aligned to 
confirmed CRL4Cdt2 substrates. B) Sub1/PC4 levels do not change in HSS containing 
MMS-damaged plasmid. C) Quantification of (B). 
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(Figure A2.2B, C), however, suggesting that it is not destroyed in a DNA damage-
dependent fashion. It remains possible that the in vitro transcribed and translated form of 
Sub1/PC4 folds improperly or that its removal from DNA was impaired without affecting 
the overall pool of protein, but it seems unlikely that Sub1/PC4 is a CRL4Cdt2 substrate 
based on these data alone. 
HMG1 and YB-1 are also known to bind chromatin and were enriched in samples 
containing D122A/E124A PCNA. However, another group looked for PCNA binding of 
HMG1 and found no association (Ise et al., 1999), and though YB-1 has been shown to 
interact with PCNA (Ise et al., 1999), I could not identify a PIP box and therefore did not 
pursue these potential targets. 
Despite the inability of the mass spectrometry results to identify new CRL4Cdt2 targets, it 
did identify several DNA-binding proteins that were greatly enriched in the samples 
containing wildtype PCNA (Table 2). The most likely explanation for this observation is 
that a variety of CRL4Cdt2 substrates that were bound to the ligase recruitment-defective 
PCNA prevented other PIP box-containing proteins from binding DNA through PCNA. 
Among these proteins enriched in the wildtype sample were several origin recognition 
complex (ORC) subunits and the replicative DNA polymerase epsilon (Polε) (Table 2). 
Notably, there was no difference in Polδ binding. MCM7, on the other hand, increased 
appreciably in the presence of the mutant PCNA (Table 2). It is possible that Cdt1, which 
is stabilized on DNA in the presence of the mutant PCNA, triggers additional recruitment 
of the MCM helicase. I confirmed that the PCNA depletion at the start of the experiment 
was successful and that these DNA replication proteins followed the trends indicated by 
mass spectrometry by Western blotting (Figure A2.3).  
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Figure A2.3: Confirmation of mass spectrometry results. A) The PCNA depletion in 
samples analyzed via mass spectrometry was complete. B) A comparison of replication 
proteins in samples containing wildtype PCNA or CRL4Cdt2-recruitment dead PCNA 
(labeled AA to indicate the D122A/E124A ligase recruitment-defective mutant). Notably, 
the PCNA antibody does not detect the mutant PCNA (AA) as well as wildtype PCNA, 
though samples containing mutant PCNA contain equal or greater amounts of total 
PCNA (Table 2). 
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A2.3.4 Supplementation of the screening method with human cell lysates 
To advance this screening method further, I attempted to supplement Xenopus egg 
extract with nuclear lysate from human cells. Many proteins are not expressed during the 
early cleavage divisions of Xenopus development that our extracts mimic. Transcription 
of most zygotic genes does not begin until the mid-blastula transition after the first 12 
cleavage divisions, and controlled regulation of gene expression begins during 
gastrulation (Bouvet et al., 1994; Rupp and Weintraub, 1991; Veenstra et al., 1999; 
Wormington and Brown, 1983). We reasoned that some developmentally regulated 
genes might not be expressed in our extract, so they would not appear in our screen. 
CRL4Cdt2 could be regulated developmentally as well, allowing it to target different 
substrates for destruction in different environments. Thus, I generated nuclear lysate 
from HeLa cells (Singh et al., 1998), which contains substrates for CRL4Cdt2-dependent 
destruction that might not be present in Xenopus egg extract. Additionally, factors in 
HeLa cells might regulate CRL4Cdt2 differently. All elements of the CRL4Cdt2 pathway are 
interchangeable (Centore et al., 2010; Havens and Walter, 2009), so the Xenopus 
machinery should destroy human substrates. I successfully isolated nuclear extract 
(Figure A2.4A). However, the nuclear extract impaired CRL4Cdt2 in extracts containing 
nuclear lysate, likely due to the detergent present in lysis buffer. The addition of nuclear 
lysates to HSS inhibited destruction of endogenous Xenopus Cdt1, human Cdt1, and 
human Set8 (Figure A2.4), even though recombinant human Cdt1 and recombinant 
human Set8 can be destroyed in HSS (Centore et al., 2010; Havens and Walter, 2009). 
A2.4 Future Directions 
I designed a new screening method to identify CRL4Cdt2 substrates in Xenopus egg 
extract based on the differential retention of CRL4Cdt2 substrates on DNA in the presence 
of a ligase recruitment-defective version of PCNA. Although I did not identify any new 
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Figure A2.4: Attempts to identify new CRL4Cdt2 substrates from human cells using 
the Xenopus egg extract system. A) Isolation of nuclear lysate. B) Addition of nuclear 
lysate (25% by volume) to HSS eliminates CRL4Cdt2 function.
!-actin (cytoplasmic) 
Myc (nuclear) 
Loading control 
hSet8 
hCdt1 
xCdt1 
0 10 30 60 min 
A B 
 141 
substrates, it is possible that this screening technique can be modified to identify new 
CRL4Cdt2 substrates. Firstly, not all CRL4Cdt2 substrates are present in extracts at 
appreciable levels. For example, TDG is barely detectable in extracts or early embryos 
(Chapter 2). Different substrates are also destroyed at different rates; TDG is destroyed 
much more slowly than Cdt1 (Chapter 2). This screen, as conducted, did not identify 
DNA-bound TDG in samples containing wildtype or D122A/E124A. Repeating the 
experiment at later time points could lead to a different pool of DNA-bound proteins to 
compare, leading to the identification of imperfect substrates like TDG (Chapter 2) if they 
are abundant enough in extract to allow detection by mass spectrometry. Additionally, 
supplementation of extracts with either human cell lysates or lysates from developing 
Xenopus embryos could lead to the identification of novel substrates if we can do so 
without impairing the ability of the extract to trigger destruction. A detergent-free protocol 
for isolating nuclear extracts has been used successfully as an extract system for 
transcription and might be usable in this scheme as well (Carey et al., 2009; Dignam et 
al., 1983). Finally, using the HSS/NPE system instead of HSS alone could lead to more 
robust destruction of CRL4Cdt2 substrates and cope with dilution of the extract machinery 
better. In the case of TDG, destruction is barely detectable until about an hour after the 
addition of MMS-damaged plasmid in HSS, but there is a clear difference in protein 
levels by 15 minutes in HSS/NPE (Chapter 2). 
It might also be of interest to determine why Polε levels on chromatin are so much lower 
in samples containing D122A/E124A PCNA. One hypothesis is that competition for 
PCNA binding by the nondegraded CRL4Cdt2 substrates causes decreased levels of Polε. 
This explanation is not in complete agreement with the literature, however, as Polε binds 
not only to the IDCL of PCNA but also to another region of the clamp, and the IDCL is 
more important for Polδ binding (Eissenberg et al., 1997). The PCNA mutant did not 
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affect Polδ levels on DNA (Table 2). One simple approach to address this hypothesis is 
to titrate a p21 PIP box peptide into extract. This peptide will bind the IDCL of PCNA, 
prohibiting binding of other PIP box containing proteins, such as Polε and Polδ. If my 
hypothesis is correct, I expect that the PIP box peptide will block Polε binding at a much 
lower concentration than is necessary to block Polδ binding. This would explain the 
results of the spin down experiments: Polδ might simply bind to PCNA with a higher 
affinity than Polε and would therefore be more competitive despite the presence of 
nondegraded CRL4Cdt2 substrates. Preliminary data from this experiment was 
inconclusive (data not shown). However, this hypothesis might prove incorrect, and then 
identifying an alternative explanation for the extreme difference in Polε levels between 
the wildtype and D122A/E124A PCNA samples, despite similar Polδ levels, could point 
toward unknown regulatory mechanisms during DNA replication and repair. 
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Appendix A3 
 
Additional studies on thymine 
DNA glycosylase 
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This appendix provides additional material that corresponds to Chapter 2. The 
motivation for these experiments is outlined in Chapter 2, Section 2.1. 
A3.1 Materials and Methods  
All methods used in this section were identical to those used in Chapter 2 except those 
described below. 
A3.1.1 Plasmid construction, mutagenesis, and protein purification 
Constructs encoding human TDG were provided by Dr. Primo Schär from the University 
of Basel in Switzerland. The human TDG gene was transferred to a pIRES2-EGFP 
vector through PCR with the primers 5’-AAAAAGCTAGCCACCATGGATTACAAGGAT 
GACGATGACAAGGATTACAAGGATGACGATGACAAGGAAGCGGAGAACGCGGGCA
GC-3’ and 5’-TTTTTGGAATTCTAAG CATGGCTTTCTTCTTCC-3’ and an NheI (NEB) 
and EcoRI (NEB) restriction enzyme digest. The final construct encodes Flag-tagged 
hTDG and GFP on two separate transcripts. To insert human TDG into a vector that 
does not co-express GFP, the human TDG gene was mistakenly inserted into a vector 
thought to be pIRES2-EGFP using the same primers and restriction enzymes. 
Importantly, the TDG coding region of this final plasmid was identical to that of pIRES2-
hTDG-EGFP described above.  
All point mutants described here (human TDG ΔPIP, Xenopus TDG ΔDBD, and 
Xenopus TDG ΔSUMO/ΔDBD) were generated with a QuikChange II Site-Directed 
Mutagenesis Kit (Agilent). 
A3.1.2 Human cell tissue culture and transfection 
T98G cells were maintained in MEM (Invitrogen). Cells were transfected using the 
Effectene transfection reagent (Qiagen) or the Lipofectamine transfection reagent 
(Invitrogen) according to the manufacturers’ protocols. The amount of DNA, transfection 
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reagent, and additional buffers were varied according to the manufacturers ‘protocols to 
optimize protein expression. However, this optimization needs to be repeated and fine-
tuned for future transfections. 
For cell cycle analysis, cells were fixed in 4% paraformaldehyde for 10 minutes at room 
temperature. Cells were then permeabilized in PBS with 0.1% Triton for five minutes on 
ice. Triton was removed through a wash in PBS, and cells were resuspended in PBS 
containing 15 µg/mL propidium iodide and 200 µg/mL RNase. DNA content was 
analyzed with a FACS machine (BD). Fixation with ethanol could not be used in these 
experiments because the GFP signal would be quenched, and GFP would leak out of 
cells during fixation/permeabilization. 
A3.2 Results and Discussion 
A3.2.1 How the DNA-binding domain of TDG contributes to proteolysis 
Because mutation of the TDG PIP box does not affect DNA binding (Chapter 2, Figure 
2.11), and because the PIP box of TDG is weaker than most CRL4Cdt2 substrates 
(Chapter 2), we hypothesized that the DNA binding domain might be cooperate with the 
PIP box for docking onto chromatin. If this hypothesis is correct, then abolishing the 
initial interaction between TDG and DNA by mutation of the DNA binding domain should 
stabilize the protein, as TDG would not be able to form a productive interaction with 
PCNA or CRL4Cdt2 in the absence of DNA binding. To test this hypothesis, we attempted 
to generate a TDG mutant that cannot associate with DNA. Based on the crystal 
structure of TDG associated with DNA (Figure 1.4), we mutated three residues within the 
catalytic core of TDG that interact directly with DNA (Maiti et al., 2008) to generate TDG 
ΔDBD (ΔDNA-binding domain; K265A/K279A/K281A), both in the context of a wildtype 
TDG and TDG  ΔSUMO. 
 146 
The base hydrolysis activity of TDG ΔDBD on a uracil opposite guanine decreased to 
approximately 1/3 that of wildtype TDG (Figure A3.1A, B). Increasing the concentration 
of TDG ΔDBD in the activity assay restored most activity, suggesting that catalytic 
activity is not abolished in this mutant  (Figure A3.1A, B). The association between 
MMS-damaged DNA and TDG ΔSUMO/ΔDBD was weakened, as expected  (Figure 
A3.1C). Nonetheless, destruction of TDG ΔDBD occurred normally  (Figure A3.1D, 
compare lanes 1-4 to lanes 5-8), suggesting that either 1) the DNA binding domain 
mutation does not eliminate the initial TDG binding step and instead only affects the 
stability of the DNA-TDG association, or 2) an initial association between TDG and DNA, 
independently of the association between TDG and PCNA, is not required for destruction. 
I also found that TDG destruction does not require the catalytic activity of TDG  (Figure 
A3.1D, lanes 9-12), but it is possible that catalytic activity is required in another context, 
such as during TDG destruction in S phase. 
We chose our DNA-binding domain mutant based on the published crystal structure of 
the TDG catalytic core in a complex with DNA. However, the N-terminus of TDG is 
involved in DNA binding. Therefore, it is likely that residues in TDG’s N-terminus 
contribute to the TDG-DNA association as well. Since the exact DNA binding domain of 
TDG has not been characterized, and there is no available crystal structure of the N-
terminus, we cannot say with confidence that the direct association between TDG and 
DNA is not required for TDG proteolysis. It is possible that a partial N-terminal truncation 
mutant in combination with the ΔDBD mutation used here would eliminate any additional 
TDG binding to DNA. However, the PIP degron is in the N-terminal domain, so even a 
partial N-terminal truncation could affect proteolysis directly. A full mutational analysis of 
the TDG N-terminus would be necessary to fully test our hypothesis regarding TDG 
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Figure A3.1: Mutation of the DNA binding domain of TDG does not affect CRL4Cdt2-
dependent proteolysis. A) TDG ΔDBD is only ~1/3 as active in a base hydrolysis assay 
as WT TDG at a concentration that results in full activity of the wildtype protein. 
Increasing the concentration of TDG ΔDBD partially rescues this defect, indicating the 
active site of the protein is not impaired. B) Quantification of (A). C) TDG ΔSUMO/ΔDBD 
does not associate with DNA as well as TDG ΔSUMO or TDG ΔSUMO/ΔPIP, which 
associate similarly. Lanes 1 and 2 (wildtype and ΔSUMO) were previously shown in 
Figure 2.5. A lane was skipped on the Orc2 blot shown as a loading control. D) TDG 
ΔDBD and the catalytic inactive TDG are destroyed normally during DNA repair.  
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binding to DNA. 
A3.2.2 The effects of expressing non-degradable TDG in human cells 
High overexpression of TDG (20-30-fold) causes S phase arrest in 293T cells, and such 
high overexpression blocks cell proliferation (Hardeland et al., 2007). We therefore 
suspected that specifically disrupting the ability of cells to destroy TDG during S phase 
might have a similar effect. I transfected T98G cells with Flag-hTDG or the PIP box 
mutant. Transfection led to the expression of at least two TDG isoforms in T98G cells 
(Figure A3.2A). One of the two isoforms lost the N-terminal Flag tag and could be a 
cleavage product of the higher migrating isoform (Figure A3.2A). Transfection with Flag 
hTDG ΔPIP led to consistently higher protein expression than transfection with wildtype 
Flag hTDG despite transfection with the same plasmid concentrations and transfection 
reagents (Figure A3.2A). This is consistent with a failure to destroy Flag hTDG ΔPIP at 
stages of the cell cycle where endogenous TDG and wildtype Flag hTDG are normally 
destroyed.  
Additionally, I generated another construct in which the open reading frame for hTDG 
also contains an internal ribosomal entry site followed by the GFP gene, so all 
transfected cells also express GFP, allowing us to measure transfection efficiency and 
look at the cell cycle profiles of transfected cells only. It also allows better comparison of 
transfection efficiency because GFP is not regulated like TDG, so we can look at total 
GFP intensity as a measure of transfection. Transfection with this TDG construct was 
successful. Approximately 60% of cells were transfected in each sample based on 
observation of GFP-positive cells. Lysates of cells transfected with pIRES2-hTDG-EGFP 
contained Flag-tagged TDG, and Flag-hTDG ΔPIP accumulated to higher levels than the 
wildtype protein despite equal transfection as measured by GFP intensity (data not 
shown, GFP measured by observation only).
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Figure A3.2: Transfection of T98G cells with Flag-hTDG. A) Flag-hTDG is expressed 
in T98G cells, and Flag-hTDG ΔPIP accumulates to even higher levels. Φ indicates 
transfection with an empty vector. When GFP was included in the construct, control cells 
were GFP-positive but did not express TDG. B) The cell cycle profiles of transfected 
cells are shown. Though Flag-hTDG ΔPIP does not appear to affect the cell cycle, these 
cell cycle profiles display no clear G2 peak or S phase.  
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Preliminary observation of the cell cycle profile after transfection with the construct that 
contains both hTDG and GFP was inconclusive (Figure A3.2B). The cell cycle profiles do 
not have a clear G2 peak, and I was unable to select for only GFP-expressing cells 
during FACS analysis. Cell cycle profiles in cells expressing the non-degradable hTDG 
mutant (Flag hTDG ΔPIP) are nearly identical to those of cells expressing wildtype Flag 
hTDG; I did not observe any accumulation in S phase after Flag-hTDG had been 
expressed for 2-3 cell cycles (Figure A3.2B). However, the experimental conditions need 
to be improved to allow for cleaner cell cycle profiles and clear detection of GFP during 
FACS.  
A3.2.3 Human TDG in Xenopus egg extract  
Before generating Xenopus TDG, I added recombinant human TDG to Xenopus egg 
extract and monitored destruction. Under conditions where I have since seen destruction 
of Xenopus TDG, human TDG remained stable, though it was quickly SUMOylated like 
the Xenopus protein (Figure A3.3A). However, when I added a surplus of human Cdt2, I 
saw a modest decrease in hTDG ΔSUMO levels in response to damaged DNA (Figure 
A3.3B). Xenopus TDG destruction is much slower in HSS than in HSS/NPE, but 
Xenopus TDG is still destroyed in a PCNA-dependent manner without the addition of 
Cdt2 in HSS (Figure A3.3C). Other known human CRL4Cdt2 substrates, like hCdt1 and 
hSet8, are destroyed in HSS despite the species difference (Centore et al., 2010; 
Havens and Walter, 2009). This means that there is some difference between TDG 
destruction and destruction of other known substrates. It is possible that species-specific 
factors regulate CRL4Cdt2-dependent proteolysis.
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Figure A3.3: Human TDG requires the addition of human Cdt2 to serve as a  
CRL4Cdt2 substrate in Xenopus egg extract. A) Human TDG is rapidly SUMOylated in 
HSS but is not destroyed in the presence of MMS-damaged plasmid. B) Human TDG 
ΔSUMO is destroyed in HSS upon the addition of an excess of recombinant human Cdt2. 
C) Xenopus TDG is destroyed slowly in HSS in a PCNA-dependent manner during DNA 
repair. The extract-specific, non-Cdt1 band detected by the Cdt1 antibody was used as a 
loading control.
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Appendix A4 
 
The generation of plasmids 
containing TDG substrates
 153 
A4.1 Introduction 
This appendix describes attempts to generate a new tool to study TDG function. 
Wildtype TDG is not destroyed during DNA replication in Xenopus egg extract. We 
therefore hypothesized that destruction might require TDG activity on the undamaged 
plasmid. During repair-dependent TDG destruction, abasic sites are likely present on the 
MMS-damaged plasmid, and TDG could bind directly to them. Thus, we tried several 
different approaches to generate a plasmid containing a site-specific TDG substrate. 
Ultimately, we used a plasmid containing a G-T mispair generated in the Takahashi 
laboratory at Osaka University in Japan (Chapter 2). Before using this plasmid construct, 
however, we tried several other approaches that are outlined here. 
A4.2 Materials, Methods, and Results 
A4.2.1 Incorporation of 5-FU via nick translation 
TDG acts on 5-fluorouracil (5-FU) in DNA (Cortázar et al., 2007; Hardeland et al., 2000; 
2003; Kunz et al., 2009). We therefore reasoned that if we incorporated 5-FU into a 
plasmid, TDG would bind to and catalytically act on that plasmid. We used a nick-
translation approach to replace a small number of thymine moieties with 5-FU. In this 
approach, DNase I generates nicks within the plasmid, and then DNA Polymerase I 
performs strand displacement reactions to incorporate the dNTPs included in the 
reaction, generating short stretches of newly synthesized DNA on the plasmid. I included 
5-FdUTP in place of dTTP in nick translation reactions on a small, undamaged plasmid 
(pCITE4a) and varied the timing of the reaction as well as the concentration of DNase I 
to control how many nicks occurred during nick translation.  As a control, I included a 
small amount of α-32P-dATP in a fraction of the total reaction to calculate the total 
incorporation nick translation for a given set of conditions. After the nick translation 
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reaction was complete, reactions were stopped and treated with Proteinase K to remove 
DNase I and DNA Polymerase I from the DNA. Plasmids were recovered through 
phenol-chloroform extraction and ethanol precipitation. 
Initial reactions set up based on nick translation kit protocols (Amersham, Invitrogen) led 
to high nucleotide incorporation. In these reactions, the concentration of DNase I varied 
from 0.25-100 µUnit DNase, and the total reaction time was 2 hours at 15°C. Reactions 
also contained 20 µM each dNTP, 5 mM MgCl2, 10 mM β-mercaptoethanol, 50 mU/µL 
DNA Polymerase I, and 50mM Tris, pH 7.7. However, even at the lowest concentration 
of DNase tested, a fraction of the resultant plasmid was linear, indicating that DNase 
activity and/or strand displacement activity was extensive (Figure A4.1A, B). I titrated the 
concentration of DNase even further, but the plasmid did not replicate well in HSS/NPE 
(Figure A4.1C). 
I modified the nick translation protocol to be more similar to one that was previously 
used in the Walter lab to label the parental strand during DNA replication (Knipscheer et 
al., 2009). In this modified nick translation protocol, the undamaged plasmid is first 
incubated with DNase (28.4 µU/µL) at room temperature for 1 minute before being 
diluted to a final concentration of 7.8 µU/µL with buffer containing dNTPs (20 µM each, 
final concentration) and DNA Polymerase I (250 mU/µL final concentration). Other 
conditions remained the same. I varied the time of the DNA Polymerase I reaction from 
10-30 minutes at 15°C. After nick translation for 10 minutes, a negligible amount of 
incorporated dNTPs was detected (0.71%). Additionally, the ratio of nicked to 
supercoiled plasmid did not change upon the nick translation reaction, which was 
unexpected given the presence of a nicking enzyme (data not shown). This plasmid 
replicated well  (Figure A4.1D), but we questioned whether it actually contained 5-FU. 
After a 30 minute nick translation reaction, however, we saw a greater amount of 
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Figure A4.1: Nick translation incorporates 5-FU into an undamaged plasmid. A) 
Nick translation was monitored through the addition of a trace amount of α-32P-dATP. 
DNase concentrations were varied from 0-100 µUnits/µL during a two-hour nick 
translation reaction. B) DNase concentrations were varied from 0-10 µUnits/µL during a 
two-hour nick translation reaction. C) The plasmid that was generated through a two-
hour nick-translation reaction led to weak DNA replication, even though the DNase 
concentration was very slow (2µUnits/µL). D) A 10-minute nick translation reaction with 
either 5-FdUTP or dTTP using the second nick-translation approach did not impair DNA 
replication. The 5-FU incorporation under these conditions was less than 1%. E) A 30-
minute nick translation reaction using the second nick-translation approach impaired 
DNA replication. Total incorporation was 8.6%. A single figure legend is shown for (C)-
(E).  
  
 156 
Figure A4.1 (continued) 
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dNTP incorporation (8.65%). Unfortunately, this plasmid did not replicate in HSS/NPE 
(Figure A4.1E). We terminated this approach at this point and moved on to the other 
approaches described below. 
A4.2.2 Incorporation of a short stretch of 5-FU-containing DNA via PCR and 
ligation 
As an alternative approach to incorporate 5-FU into a plasmid, I included 5-FdUTP in a 
PCR reaction in place of dTTP and amplified a short region of pCITE4a. Notably, the 
high fidelity polymerase KOD Hi-Fi (Millipore) did not lead to any PCR products in 
reactions containing 5-FU, suggesting that it cannot incorporate the aberrant nucleotide. 
Taq polymerase generated the desired PCR product. TDG bound to this PCR product 
and also was active in a base release assay (Figure A4.2A, B), confirming that TDG acts 
on 5-FU, even when it is paired with adenine.  
Attempts to use a restriction enzyme digest and ligation to insert this short PCR product 
containing 5-FU were unsuccessful. I chose to digest with the restriction enzyme NotI on 
both ends of the PCR product and in a single position on the plasmid because its 
recognition sequence contains only guanines and cytosines, so the presence of 5-FU 
would not impair its ability to cleave the insert. However, upon ligation, several higher 
migrating bands were visible on an agarose gel (Figure A4.2C), likely due to the 
insertion of multiple PCR products into a single plasmid. Though I could have changed 
the approach to use two distinct restriction enzymes, we decided to terminate this 
approach because we reasoned that the high number of aberrant bases would impair 
DNA replication, even in the absence of TDG. 
A4.2.3 Generation of plasmids containing site-specific G-U and G-T mispairs 
The most successful approach for the generation of a plasmid containing a TDG
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Figure A4.2: A short PCR fragment containing 5-FU serves as a TDG substrate but 
was not successfully ligated into a plasmid. A) TDG binds to a short PCR fragment 
containing standard nucleotides or 5-FU. Shown here is a native acrylamide gel. TDG 
binds the PCR product containing dTTP similarly to that containing 5F-dUTP. B) TDG 
activity assay on this same PCR product. TDG processed the 5-FU-containing PCR 
product to a smaller end labeled product. C) Ligation of the 5-FU-containing PCR 
product into pCITE4a results in numerous higher migrating bands, thought to be ligation 
products. 
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substrate involved generating a gapped plasmid and inserting a short oligo containing a 
site-specific mispair into the gap. This approach, based on a previously described 
method to generate a plasmid containing a site-specific abasic site (Matsumoto, 2006) 
successfully generated a plasmid containing a site-specific G-U mispair. This approach 
could be used in the future for the generation of mispaired plasmids or plasmids 
containing modified bases. 
This approach requires an undamaged plasmid that contains a restriction enzyme site 
sandwiched between two nicking sites separated by 20-30 base pairs. The desired 
mispair should fall within the restriction enzyme recognition site. To start, the plasmid is 
digested with the nicking enzymes. The nicked plasmid is then heated in the presence of 
an excess of competitor oligo (the complement of the short fragment between the 
nicking sites) to generate a gapped plasmid. The resulting mixture is then digested with 
the restriction enzyme that cleaves between the nicking sites. The digest should 
linearize the nicked plasmid but not the gapped plasmid, making them separable on an 
agarose gel. After purification of the gapped plasmid through gel electrophoresis and 
electroelution, a short oligo that complements the now single-stranded portion of the 
plasmid except at the desired site-specific mispair location is annealed to the gapped 
plasmid. Finally, the plasmid is ligated, and the closed circular plasmid is gel purified 
from an agarose gel containing 3.6 µM chloroquine. This final purification step could be 
modified to involve purification through a cesium chloride gradient to scale up the 
reaction. Many of the details regarding concentration of the nicking enzyme and timing of 
the nicking digest were determined by Thomas Graham of the Walter and Loparo labs. 
I attempted this approach on three separate parent plasmids. I first tried to insert the 
mispair into pCtrl, the plasmid that many Walter lab members use as a control to study 
interstrand crosslink repair (Knipscheer et al., 2009; Long et al., 2011; Räschle et al., 
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2008). I inserted two Nb.BbvcI nicking sites on either side of a SapI recognition site. 
Notably, pCtrl was not compatible with the QuikChange mutagenesis kit; I performed 
mutagenesis on a small region of pCtrl in the context of a pDonr backbone. Dr. David 
Long, a post-doctoral fellow in the Walter lab, generated this construct. This SapI 
recognition site also contains an interstrand crosslink in pICL (Knipscheer et al., 2009; 
Long et al., 2011; Räschle et al., 2008), which was ideal since reagents were already 
available in the lab to follow pICL replication and repair. However, after multiple failed 
attempts to ligate this plasmid, I switched to using pBluescript.  
I used two variations of pBluescript: pBSRon, generated by Dr. Ron Lebofsky and Dr. 
Courtney Havens, previously of the Walter lab, to contain two Nb.BtsI nicking sites 
sandwiching an NcoI restriction enzyme site, and pBSTom, generated by Thomas 
Graham, of the Walter and Loparo labs, to contain two Nb.BbvCI nicking sites 
sandwiching an EcoRI restriction enzyme site. I generated closed circular products from 
both of these parental plasmids, but I found that NcoI displays some activity on the 
plasmid containing a G-U mispair, so I ultimately used pBSTom exclusively. 
TDG acted on this mispair in the context of the plasmid (Figure A4.3A), though activity 
required a higher concentration than TDG activity on a short oligo of the same sequence, 
likely because TDG associates with non-specific DNA on the plasmid. However, the G-U 
mispair was repaired rapidly in extract to regenerate the EcoRI recognition site (Figure 
A4.3B), likely due to uracil DNA glycosylase (UDG) activity in extract. pBSTom (G-U) 
replicated normally (Figure A4.3C). We next wanted to generate a plasmid containing a 
G-T mispair. However, the designed G-U mispair was not in the context of a CpG 
sequence, and TDG prefers this sequence context. Recombinant Xenopus TDG did not 
act on a G-T mispair in the designed sequence. There is an EcoRV recognition site 
adjacent to the EcoRI recognition site that would allow the generation of a G-T mispair 
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Figure A4.3: The gapped plasmid method of generating a G-U mispaired plasmid 
was successful. A) TDG is active on the G-U mispair in the context of the plasmid. This 
reaction was performed as described in Chapter 2, Figure 2.1, except the mispair was 
adjacent to an EcoRI site instead of a NotI site. An EcoRI digest is shown to indicate the 
expected size of the final product. B) The G-U mispair is rapidly repaired in extract, 
regardless of pre-binding with TDG. Repair was measured by susceptibility to an EcoRI 
digest. C) The G-U mispaired plasmid replicates in extract. Quantification of DNA 
synthesis is shown. 
Uncut Plasmid 
Repaired Plasmid (linear) 
Supercoiled Plasmid 
Ec
oR
I 
U
nc
ut
 
0 6 3 
Untreated 
0 6 3 
TDG 
EcoRI, G-T 
G-C 
Substrate+Complement 
Product 
E
co
R
I 
20
00
 
0 20
0 
65
0 
11
00
 
15
50
 
20
00
 
nM TDG 
G-C G-U 
0% 
10% 
20% 
30% 
40% 
50% 
60% 
70% 
0 20 40 60 80 100 
Pe
rc
en
t R
ep
lic
at
io
n 
Time (mins) 
B 
A 
C 
 162 
within a CpG sequence. However, we opted to outsource the production of a G-T 
mispair-containing plasmid to the Takahashi lab at this point. 
Although we were not able to use this approach to generate a DNA template for use in 
extract experiments, this approach has now been optimized and could easily be modified 
for future use in the Walter lab. Gel electroelution of the gapped plasmid led to the 
recovery of 40-60% of the original input (approximately 85-95% of the gapped fraction). 
Once the gapped plasmid is generated, insertion of the mispair and subsequent 
purification is simple and has been previously outlined (Matsumoto, 2006). I chose to 
use electroelution as the final means of plasmid purification, but cesium chloride gradient 
purification might be even more successful for larger-scale production.
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List of Abbreviations 
5-FU 5-fluorouracil 
5caC 5-carboxylcytosine 
5fC 5-formylcytosine 
5hmC 5-hydroxymethylcytosine 
5hmU 5-hydroxymethyluracil 
5mC 5-methylcytosine 
AID Activation-induced cytosine deaminase 
AP Apurinic 
ATM Ataxia-telangiectasia mutated 
ATR ATM and Rad3-related 
BER Base excision repair 
Cdk Cyclin-dependent kinase 
Chk1 Checkpoint kinase 1 
CI Catalytically inactive 
CMG Cdc45/MCM2-7/GINS helicase 
CRL Cullin-RING-based ubiquitin ligase 
CSF Cytostatic factor 
DBD DNA binding domain 
Dnmt 
ELB 
HCG 
DNA methyltransferase 
Egg lysis buffer 
Human chorionic gonadotropin 
IDCL 
MMR 
Interdomain connector loop 
Marc’s modified ringer solution 
M phase Mitosis 
NER 
NLS 
Nucleotide excision repair 
Nuclear localization sequence 
ORC Origin recognition complex 
PCNA Proliferating cell nuclear antigen 
PCNASC Single-chain PCNA 
PIP 
PMSG 
PCNA-interacting peptide 
Pregnant mare serum gonadotropin 
Pol Polymerase 
pre-IC Pre-initiation complex 
pre-RC Pre-replication complex 
RFC Replication factor C 
RPA Replication protein A 
S phase Synthesis Phase 
ssDNA Single-stranded DNA 
TDG Thymine DNA glycosylase 
Tet Ten eleven translocation 
TLS Translesion synthesis 
UNG Uracil-N-glycosylase 
XPV Xeroderma pigmentosum variant 
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